As
filed
with the Securities and Exchange Commission on November 22, 2006
Registration
No. 333-
UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON
D.C. 20549
____________________________
FORM
SB-2
REGISTRATION
STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
_____________________________
BIOSOLAR,
INC.
(Name
of
small business issuer in its charter)
Nevada
|
|
3081
|
|
20-4754291
|
(State
or other Jurisdiction
|
|
(Primary
Standard
Industrial
|
|
(I.R.S.
Employer
|
of
Incorporation or
Organization)
|
|
Classification
Code Number)
|
|
Identification
No.)
|
27936
Lost Canyon Road, Suite 202
Santa
Clarita, California 91387
(661)
251-0001
(Address
and telephone number of principal executive offices and principal place of
business)
David
Lee
Chief
Executive Officer
BIOSOLAR,
INC.
27936
Lost Canyon Road, Suite 202
Santa
Clarita, California 91387
(661)
251-0001
(Name,
address and telephone number of agent for service)
Copies
to:
Gregory
Sichenzia, Esq.
Eric
A. Pinero, Esq.
Sichenzia
Ross Friedman Ference LLP
1065
Avenue of the Americas, 21st Flr.
New
York, New York 10018
(212)
930-9700
(212)
930-9725 (fax)
APPROXIMATE
DATE OF PROPOSED SALE TO THE PUBLIC:
From
time
to time after this Registration Statement becomes effective.
If
any
securities being registered on this Form are to be offered on a delayed or
continuous basis pursuant to Rule 415 under the Securities Act of 1933, other
than securities offered only in connection with dividend or interest
reinvestment plans, check the following box:
o
If
this
Form is filed to register additional securities for an offering pursuant to
Rule
462(b) under the Securities Act, check the following box and list the Securities
Act registration statement number of the earlier effective registration
statement for the same offering.
o
________
If
this
Form is a post-effective amendment filed pursuant to Rule 462(c) under the
Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same
offering.
o
________
If
this
Form is a post-effective amendment filed pursuant to Rule 462(d) under the
Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same
offering.
o
________
If
delivery of the prospectus is expected to be made
pursuant to Rule 434, please check the following box.
o
________
|
|
|
|
PROPOSED
|
|
PROPOSED
|
|
|
|
|
|
|
|
MAXIMUM
|
|
MAXIMUM
|
|
AMOUNT
OF
|
|
TITLE
OF EACH CLASS OF SECURITIES TO BE
|
|
AMOUNT
TO BE
|
|
OFFERING
PRICE
|
|
AGGREGATE
|
|
REGISTRATION
|
|
REGISTERED
|
|
REGISTERED
(1)
|
|
PER
SHARE (2)
|
|
OFFERING
PRICE
|
|
FEE
|
|
|
|
Common
stock, $.0001 par value
|
|
|
26,500,000
|
|
$
|
.10
|
|
$
|
2,650,000
|
|
$
|
283.55
|
|
Total
|
|
|
26,500,000
|
|
|
|
|
$
|
2,650,000
|
|
$
|
283.55
|
|
(1)
Includes shares of our common stock, par value $0.0001 per share, held by the
selling stockholders which may be offered pursuant to this registration
statement.
(2)
Estimated solely for the purpose of calculating the registration fee required
by
Section 6(B) of the Securities Act of 1933, as amended, and computed pursuant
to
Rule 457 under the Securities Act.
(3)
Includes 100% of the shares of our common stock which we issued to the selling
stockholders under certain Subscription Agreements in May and July
2006.
THE
REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES
AS
MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE
A
FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT
SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF THE
SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(A),
MAY DETERMINE.
THE
INFORMATION CONTAINED IN THIS PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED.
WE
MAY NOT SELL THESE SECURITIES UNTIL THE REGISTRATION STATEMENT FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN
OFFER
TO SELL THESE SECURITIES AND IT IS NOT SOLICITING AN OFFER TO BUY THESE
SECURITIES IN ANY STATE WHERE THE OFFER OR SALE IS NOT PERMITTED.
PRELIMINARY
PROSPECTUS SUBJECT TO COMPLETION, DATED NOVEMBER 22, 2006
BIOSOLAR,
INC.
26,500,000
SHARES OF
COMMON
STOCK
This
prospectus relates to the resale by the selling stockholders of up to 26,500,000
shares of our common stock presently outstanding. The selling stockholders
may
sell common stock from time to time in the principal market on which the stock
is traded at the prevailing market price or in negotiated transactions. The
selling stockholders may be deemed underwriters of the shares of common stock,
which they are offering. We will pay the expenses of registering these
shares.
We
are
not selling any shares of common stock in this offering and therefore will
not
receive any proceeds from this offering.
We
have
paid the expenses of preparing this prospectus and the related registration
expenses.
Our
common stock is not traded on any national securities exchange and is not quoted
on any over-the-counter market. If our shares become quoted on the
Over-The-Counter Bulletin Board, sales will be made at prevailing market prices
or privately negotiated prices.
INVESTING
IN THESE SECURITIES INVOLVES SIGNIFICANT RISKS. SEE "RISK
FACTORS"
BEGINNING
ON PAGE 9.
Neither
the Securities and Exchange Commission nor any state securities commission
has
approved or disapproved of these securities or determined if this Prospectus
is
truthful or complete. Any representation to the contrary is a criminal
offense.
The
date
of this prospectus is ________, 2006.
The
information in this Prospectus is not complete and may be changed. This
Prospectus is included in the Registration Statement that was filed BioSolar,
Inc. with the Securities and Exchange Commission. The selling stockholders
may
not sell these securities until the registration statement becomes effective.
This Prospectus is not an offer to sell these securities and is not soliciting
an offer to buy these securities in any state where the sale is not
permitted.
TABLE
OF CONTENTS
|
|
|
|
Cautionary
Note Regarding Forward-Looking Statements
|
|
|
6
|
Prospectus
Summary
|
|
|
7
|
Risk
Factors
|
|
|
9
|
Use
Of Proceeds
|
|
|
12
|
Management’s
Discussion And Analysis Of Financial Condition And Results Of
Operations
|
|
|
13
|
Description
Of Business
|
|
|
16
|
Description
Of Property
|
|
|
17
|
Legal
Proceedings
|
|
|
17
|
Management
|
|
|
19
|
Executive
Compensation
|
|
|
20
|
Certain
Relationships And Related Transactions
|
|
|
20
|
Security
Ownership Of Certain Beneficial Owners And Management
|
|
|
20
|
Description
Of Securities
|
|
|
21
|
Commission’s
Position On Indemnification For Securities Act Liabilities
|
|
|
21
|
Plan
Of Distribution
|
|
|
22
|
Selling
Stockholders
|
|
|
24
|
Legal
Matters
|
|
|
29
|
Experts
|
|
|
29
|
Available
Information
|
|
|
29
|
Index
to Financial Statements
|
|
|
F-1
|
CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS
This
prospectus and any prospectus supplement contain forward-looking statements.
We
have based these forward-looking statements on our current expectations and
projections about future events.
In
some
cases, you can identify forward-looking statements by words such as "may,"
"should," "expect," "plan," "could," "anticipate," "intend," "believe,"
"estimate," "predict," "potential," "goal," or "continue" or similar
terminology. These statements are only predictions and involve known and unknown
risks, uncertainties and other factors, including the risks outlined under
"Risk
Factors," that may cause our or our industry's actual results, levels of
activity, performance or achievements to be materially different from any future
results, levels of activity, performance or achievements expressed or implied
by
such forward-looking statements.
Unless
we
are required to do so under U.S. federal securities laws or other applicable
laws, we do not intend to update or revise any forward-looking
statements.
PROSPECTUS
SUMMARY
The
following summary highlights selected information contained in this prospectus.
This summary does not contain all the information you should consider before
investing in the securities. Before making an investment decision, you should
read the entire prospectus carefully, including the "risk factors" section,
the
financial statements and the notes to the financial statements.
BIOSOLAR,
INC.
OUR
BUSINESS
We
are
developing new and innovative thin film solar cells produced on bio-based
plastic substrates with the intent to provide commercially viable solar cell
designs that convert sun light into electrical energy. The process for producing
electricity from sunlight is known as Photovoltaics. Photovoltaic ("PV") is
the
science of capturing and converting sun light into electricity.
We
are
focusing our research and product development efforts on thin film PV devices
in
an effort to capitalize on what we perceive as cost and application diversity
advantages to current rigid multi-crystalline silicon wafer technologies. Our
thin film cell design employs less than 1.5 microns of material thickness as
opposed to an approximate 400 microns of material thickness for
multi-crystalline cell designs. This significant reduction in cell thickness
and
flexibility of the completed cell structure leads to the use of "thin film"
terminology in describing the solar cell design.
We
are
focusing our research and product development efforts on thin film PV devices
produced on bio-based plastic substrates and the eventual marketing of such
products to the building materials, outdoor power, emergency power, mobile
computer and communications sectors.
We
were
incorporated in the State of Nevada on April 24, 2006, as BioSolar Labs, Inc.
Our name was changed to BioSolar, Inc. on June 8, 2006. Our principal executive
offices are located at
27936
Lost Canyon Road, Suite 202, Santa Clarita, California 91387
,
and our
telephone number is
(661)
251-0001
.
The Offering
|
|
|
|
|
|
Common stock offered by selling
stockholders
|
|
Up to 26,500,000 shares, including the
following:
|
|
|
|
|
|
-
up
to 25,000,000 shares of common stock issued to certain of the selling
stockholders pursuant to certain Subscription Agreements in May 2006
for
an aggregate purchase price of $375,000, and
|
|
|
|
|
|
-
1,500,000
shares of common stock issued to certain of the selling stockholders
pursuant to certain Subscription Agreements in July 2006, for an
aggregate
purchase price of $150,000.
|
|
|
|
|
|
This
number represents 20.6% of our current outstanding
stock.
|
|
|
|
Common stock to be outstanding after
the
offering
|
|
Up to 128,557,777 shares
|
|
|
|
Use of proceeds
|
|
We will not receive any proceeds from
the
sale
|
|
|
of
the common stock.
|
TRANSACTIONS
BEING REGISTERED IN THIS PROSPECTUS
ROUND
1
2006 SUBSCRIPTION AGREEMENT*
In
May
2006, we entered into Subscription Agreements with several accredited investors
pursuant to which the investors subscribed to purchase an aggregate amount
of up
to $375,000 in shares of our common stock, or a total of 25,000,000 shares.
We
granted “piggy-back” registration rights to the investors in our Round 1 2006
Subscription Agreements covering the shares of common stock on registration
statements (other than on Form S-8, S-4 or similar Forms) subsequently filed
by
us.
ROUND
2 2006 SUBSCRIPTION AGREEMENT*
In
July
2006, we entered into Subscription Agreements with several accredited investors
pursuant to which the investors subscribed to purchase an aggregate amount
of up
to $150,000 in shares of our common stock, or a total of 1,500,000
shares.
We
granted “piggy-back” registration rights to the investors in our Round 2 2006
Subscription Agreement covering the shares of common stock on registration
statements (other than on Form S-8, S-4 or similar Forms) subsequently filed
by
us.
*We
claim
an exemption from the registration requirements of the Act for the private
placement of these securities pursuant to Section 4(2) of the Act and/or
Regulation D promulgated thereunder since, among other things, the transaction
did not involve a public offering, the investors were accredited investors
and/or qualified institutional buyers, the investors had access to information
about us and their investment, the investors took the securities for investment
and not resale, and we took appropriate measures to restrict the transfer of
the
securities.
RISK
FACTORS
This
investment has a high degree of risk. Before you invest you should carefully
consider the risks and uncertainties described below and the other information
in this prospectus. If any of the following risks actually occur, our business,
operating results and financial condition could be harmed and the value of
our
stock could go down. This means you could lose all or a part of your
investment.
RISKS
RELATED TO OUR BUSINESS AND INDUSTRY
WE
HAVE A LIMITED OPERATING HISTORY UPON WHICH YOU CAN BASE AN INVESTMENT
DECISION.
Our
company was formed on April 24, 2006 and therefore, we have a limited operating
history upon which you can make an investment decision, or upon which we can
accurately forecast future sales. You should, therefore, consider us subject
to
the business risks associated with a new business. The likelihood of our success
must be considered in light of the expenses, difficulties and delays frequently
encountered in connection with the formation and initial operations of a new
business.
WE
HAVE A LIMITED HISTORY OF LOSSES. WE EXPECT TO CONTINUE TO INCUR LOSSES, AND
WE
MAY NEVER ACHIEVE AND SUSTAIN PROFITABILITY.
Since
inception, we have incurred losses and have negative cash flows from operations.
For the three months ended September 30, 2006, we incurred a net loss of
$67,119. From inception through June 30, 2006, we incurred a net loss of
$86,005. These factors, among others discussed in Note 1 to the financial
statements, raise substantial doubt about the ability to continue as a going
concern. We expect to continue to incur net losses until sales generate
sufficient revenues to fund our continuing operations. We may fail to achieve
significant revenues from sales or achieve or sustain profitability. There
can
be no assurance of when, if ever, we will be profitable or be able to maintain
profitability.
WE
MAY BE UNABLE TO MANAGE ITS GROWTH OR IMPLEMENT OUR EXPANSION
STRATEGY.
We
may
not be able to expand its product and service offerings, our client base and
markets, or implement the other features of our business strategy at the rate
or
to the extent presently planned. Our projected growth will place a significant
strain on our administrative, operational and financial resources. If we are
unable to successfully manage our future growth, establish and continue to
upgrade our operating and financial control systems, recruit and hire necessary
personnel or effectively manage unexpected expansion difficulties, our financial
condition and results of operations could be materially and adversely affected.
WE
MAY NOT BE ABLE TO SUCCESSFULLY DEVELOP AND COMMERCIALIZE OUR TECHNOLOGIES
WHICH
WOULD RESULT IN CONTINUED LOSSES AND MAY REQUIRE US TO CURTAIL OR CEASE
OPERATIONS.
While
we
have made progress in the development of our products, we have not generated
any
revenues and we are unable to project when we will achieve profitability, if
at
all. As is the case with any new technology, we expect the development process
to continue. We cannot assure that our engineering resources will be able to
modify the product fast enough to meet market requirements. We can also not
assure that our product will gain market acceptance and that we will be able
to
successfully commercialize the technologies. The failure to successfully develop
and commercialize the technologies would result in continued losses and may
require us to curtail or cease operations.
OUR
REVENUES ARE DEPENDENT UPON ACCEPTANCE OF OUR PRODUCTS BY THE MARKET; THE
FAILURE OF WHICH WOULD CAUSE TO CURTAIL OR CEASE OPERATIONS.
We
believe that virtually all of our revenues will come from the sale or license
of
our products. As a result, we will continue to incur substantial operating
losses until such time as we are able to generate revenues from the sale or
license of our products. There can be no assurance that businesses and customers
will adopt our technology and products, or that businesses and prospective
customers will agree to pay for or license our products. In the event that
we
are not able to significantly increase the number of customers that purchase
or
license our products, or if we are unable to charge the necessary prices or
license fees, our financial condition and results of operations will be
materially and adversely affected.
WE
DO NOT MAINTAIN THEFT OR CASUALTY INSURANCE, AND ONLY MAINTAIN MODEST LIABILITY
AND PROPERTY INSURANCE COVERAGE AND THEREFORE WE COULD INCUR LOSSES AS A RESULT
OF AN UNINSURED LOSS.
We
do not
maintain theft or casualty insurance and we have modest liability and property
insurance coverage. We cannot assure that we will not incur uninsured
liabilities and losses as a result of the conduct of our business. Any such
uninsured or insured loss or liability could have a material adverse affect
on
our results of operations.
IF
WE LOSE KEY EMPLOYEES AND CONSULTANTS OR ARE UNABLE TO ATTRACT OR RETAIN
QUALIFIED PERSONNEL, OUR BUSINESS COULD SUFFER.
Our
success is highly dependent on our ability to attract and retain qualified
scientific, engineering and management personnel. We are highly dependent on
our
management, including Mr. David Lee who has been critical to the development
of
our technologies and business. The loss of the services of Mr. Lee could have
a
material adverse effect on our operations. We do not have an employment
agreement with Mr. Lee and do not maintain key man insurance with respect to
Mr.
Lee. Accordingly, there can be no assurance that he will remain associated
with us. His efforts will be critical to us as we continue to develop our
technology and as we attempt to transition from a development state company
to a
company with commercialized products and services. If we were to lose Mr. Lee,
or any other key employees or consultants, we may experience difficulties in
competing effectively, developing our technology and implementing our business
strategies.
THE
LOSS OF STRATEGIC RELATIONSHIPS USED IN THE DEVELOPMENT OF OUR PRODUCTS AND
TECHNOLOGY COULD IMPEDE OUR ABILITY TO COMPLETE OUR PRODUCT AND RESULT IN A
MATERIAL ADVERSE EFFECT CAUSING THE BUSINESS TO SUFFER.
We
may
rely on strategic relationships with technology development partners to provide
personnel, and expertise in the research and development of the technology
and
manufacturing process underlying our thin film PV product. A loss of these
relationships for any reason could cause us to experience difficulties in
completing the development of our product and implementing our business
strategy. There can be no assurance that we could establish other relationships
of adequate expertise in a timely manner or at all.
OUR
PATENT APPLICATION FOR OUR TECHNOLOGY IS PENDING AND THERE IS NO ASSURANCE
THAT
THIS APPLICATION WILL BE GRANTED. FAILURE TO OBTAIN THE PATENT FOR OUR
APPLICATION COULD PREVENT US FROM SECURING ROYALTY PAYMENTS IN THE FUTURE,
IF
APPROPRIATE.
We
have
filed a patent to protect the intellectual property rights for “A Method for
Building Thin Film Flexible Solar Cells on Bio-Based Plastic Substrates”. To
date our patent application has not been granted. We cannot be certain that
this
patent will be granted nor can we be certain that other companies have not
filed
for patent protection for this technology before us. Even if we are granted
patent protection for our technology, there is no assurance that we will be
in a
position to enforce our patent rights. Failure to be granted patent protection
for our technology could result in greater competition or in limited royalty
payments. This could result in inadequate revenue and cause us to cease
operations.
OUR
CURRENT AND POTENTIAL COMPETITORS, SOME OF WHOM HAVE GREATER RESOURCES THAN
WE
DO, MAY DEVELOP PRODUCTS AND TECHNOLOGIES THAT MAY CAUSE DEMAND FOR, AND THE
PRICES OF, OUR PRODUCTS TO DECLINE.
While
there are a number of companies manufacturing thin film PV devices, we do not
know of any employing the use of bio-based plastic substrates. Competitors
in
the thin film PV devices market include Iowa Thin Film Technologies, Inc, United
Solar Ovonic and Mitsubishi Heavy Industries. Furthermore, our competitors
may
combine with each other, and other companies may enter our markets by acquiring
or entering into strategic relationships with our competitors. Current and
potential competitors have established, or may establish, cooperative
relationships among themselves or with third parties to increase the abilities
of their thin film PV devices products to address the needs of our prospective
customers.
Many
of
our current and potential competitors have longer operating histories,
significantly greater financial, technical, product development and marketing
resources, greater name recognition and larger customer bases than we do. Our
present or future competitors may be able to develop products comparable or
superior to those we offer, adapt more quickly than we do to new technologies,
evolving industry trends and standards or customer requirements, or devote
greater resources to the development, promotion and sale of their products
than
we do. Accordingly, we may not be able to compete effectively in our markets,
competition may intensify and future competition may harm our
business.
WE
ARE CONTROLLED BY CURRENT OFFICERS, DIRECTORS AND PRINCIPAL
STOCKHOLDERS.
Our
directors, executive officers and principal stockholders and their affiliates
will beneficially own approximately 86.7% of the outstanding shares of common
stock. Accordingly, our executive officers, directors, principal stockholders
and certain of their affiliates will have the ability to control the election
of
our Board of Directors and the outcome of issues submitted to our stockholders.
RISKS
RELATING TO OUR COMMON STOCK
THERE
IS NO PUBLIC (TRADING) MARKET FOR OUR COMMON STOCK AND THERE IS NO ASSURANCE
THAT THE COMMON STOCK WILL EVER TRADE ON A RECOGNIZED EXCHANGE OR DEALER’S
NETWORK; THEREFORE, YOU MAY NOT BE ABLE TO SELL YOUR
SHARES.
There
is
no established public trading market for our securities. Hence, there is no
central place, such as a stock exchange or electronic trading system, to resell
your common stock. If you want to resell your shares, you will have to locate
a
buyer and negotiate your own sale. It is our plan to utilize a market maker
who
will apply to have our common stock quoted on the Over-the-Counter Bulletin
Board in the United States. Our shares are not and have not been listed or
quoted on any exchange or quotation system. There can be no assurance that
a
market maker will agree to file the necessary documents with the National
Association of Securities Dealers, which operates the Over-the-Counter Bulletin
Board, nor can there be any assurance that such an application for quotation
will be approved or that a regular trading market will develop or that if
developed, will be sustained. In the absence of a trading market, an investor
will be unable to liquidate his investment except by private sale.
IF
YOU PURCHASE SHARES IN THIS OFFERING, YOU WILL EXPERIENCE IMMEDIATE AND
SUBSTANTIAL DILUTION.
The
$0.10
per share offering price of the common stock being sold under this prospectus
has been arbitrarily set. The price does not bear any relationship to our
assets, book value, earnings or net worth and it is not an indication of actual
value. Accordingly, if you purchase shares in this offering, you will experience
immediate and substantial dilution. You may also suffer additional dilution
in
the future from the sale of additional shares of common stock or other
securities.
SHOULD
OUR STOCK BECOME LISTED ON THE OTC BULLETIN BOARD, IF WE FAIL TO REMAIN CURRENT
ON OUR REPORTING REQUIREMENTS, WE COULD BE REMOVED FROM THE OTC BULLETIN BOARD
WHICH WOULD LIMIT THE ABILITY OF BROKER-DEALERS TO SELL OUR SECURITIES AND
THE
ABILITY OF STOCKHOLDERS TO SELL THEIR SECURITIES IN THE SECONDARY
MARKET.
Companies
trading on the Over-The-Counter Bulletin Board, such as us we are seeking to
become, must be reporting issuers under Section 12 of the Securities Exchange
Act of 1934, as amended, and must be current in their reports under Section
13,
in order to maintain price quotation privileges on the OTC Bulletin Board.
If we
fail to remain current on our reporting requirements, we could be removed from
the OTC Bulletin Board. As a result, the market liquidity for our securities
could be severely adversely affected by limiting the ability of broker-dealers
to sell our securities and the ability of stockholders to sell their securities
in the secondary market. In addition, we may be unable to get re-listed on
the
OTC Bulletin Board, which may have an adverse material effect on our
Company.
ONCE
PUBLICLY TRADING, THE APPLICATION OF THE "PENNY STOCK" RULES COULD ADVERSELY
AFFECT THE MARKET PRICE OF OUR COMMON SHARES AND INCREASE YOUR TRANSACTION
COSTS
TO SELL THOSE SHARES.
The
Securities and Exchange Commission has adopted Rule 15g-9 which establishes
the
definition of a "penny stock," for the purposes relevant to us, as any equity
security that has a market price of less than $5.00 per share or with an
exercise price of less than $5.00 per share, subject to certain exceptions.
For
any transaction involving a penny stock, unless exempt, the rules
require:
·
|
that
a broker or dealer approve a person's account for transactions in
penny
stocks; and
|
·
|
the
broker or dealer receive from the investor a written agreement to
the
transaction, setting forth the identity and quantity of the penny
stock to
be purchased.
|
In
order
to approve a person's account for transactions in penny stocks, the broker
or
dealer must:
·
|
obtain
financial information and investment experience objectives of the
person;
and
|
·
|
make
a reasonable determination that the transactions in penny stocks
are
suitable for that person and the person has sufficient knowledge
and
experience in financial matters to be capable of evaluating the risks
of
transactions in penny stocks.
|
The
broker or dealer must also deliver, prior to any transaction in a penny stock,
a
disclosure schedule prescribed by the Commission relating to the penny stock
market, which, in highlight form:
·
|
sets
forth the basis on which the broker or dealer made the suitability
determination; and
|
·
|
that
the broker or dealer received a signed, written agreement from the
investor prior to the transaction.
|
Generally,
brokers may be less willing to execute transactions in securities subject to
the
"penny stock" rules. This may make it more difficult for investors to dispose
of
our common stock and cause a decline in the market value of our
stock.
Disclosure
also has to be made about the risks of investing in penny stocks in both public
offerings and in secondary trading and about the commissions payable to both
the
broker-dealer and the registered representative, current quotations for the
securities and the rights and remedies available to an investor in cases of
fraud in penny stock transactions. Finally, monthly statements have to be sent
disclosing recent price information for the penny stock held in the account
and
information on the limited market in penny stocks.
USE
OF PROCEEDS
DETERMINATION
OF OFFERING PRICE
Since
our
shares of our common stock are not listed or quoted on any exchange or quotation
system, the offering price of the shares of common stock was arbitrarily
determined. The facts considered in determining the offering price were our
financial condition, prospects, our limited operating history and the general
condition of the securities market. The offering price is not an indication
of
and is not based upon our actual value. The offering price bears no relationship
to book value, asset or earnings of our company or any other recognized criteria
of value. The offering price should not be regarded as an indicator of the
future market price of the securities.
Market
for Securities
Our
common stock is not traded on any national securities exchange and is not quoted
on any over-the-counter market. If our shares become quoted on the
Over-The-Counter Bulletin Board, sales will be made at prevailing market prices
or privately negotiated prices.
HOLDERS
As
of
November 13, 2006, our common stock were held by 117 stockholders of record
and
we had 128,557,777 shares of common stock issued and outstanding. We believe
that the number of beneficial owners is substantially greater than the number
of
record holders because a significant portion of our outstanding common stock
is
held of record in broker street names for the benefit of individual investors.
The transfer agent of our common stock is U.S. Stock Transfer Corporation,
1745
Gardena Avenue, Glendale, CA 91204.
We
have
not declared any dividends to date. We have no present intention of paying
any
cash dividends on our common stock in the foreseeable future, as we intend
to
use earnings, if any, to generate growth. The payment by us of dividends, if
any, in the future, rests within the discretion of our Board of Directors and
will depend, among other things, upon our earnings, our capital requirements
and
our financial condition, as well as other relevant factors. There are no
restrictions in our articles of incorporation or bylaws that restrict us from
declaring dividends.
The
following table shows information with respect to each equity compensation
plan
under which our common stock is authorized for issuance as from inception (April
24, 2006) through June 30, 2006.
EQUITY
COMPENSATION PLAN INFORMATION
Plan
category
|
Number
of securities
to
be issued upon
exercise
of
outstanding
options,
warrants
and rights
|
Weighted
average
exercise
price of
outstanding
options,
warrans
and rights
|
Number
of securities
remaining
available for future issuance under equity compensation plans (excluding
securities reflected in column (a)
|
|
(a)
|
(b)
|
(c)
|
Equity
compensation plans approved by security holders
|
-0-
|
-0-
|
-0-
|
|
|
|
|
Equity
compensation plans not approved by security
holders
|
-0-
|
-0-
|
-0-
|
|
|
|
|
Total
|
-0-
|
-0-
|
-0-
|
MANAGEMENT'S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS
Some
of
the information in this prospectus contains forward-looking statements that
involve substantial risks and uncertainties. You can identify these statements
by forward-looking words such as "may," "will," "expect," "anticipate,"
"believe," "estimate" and "continue," or similar words. You should read
statements that contain these words carefully because they:
·
|
discuss
our future expectations;
|
·
|
contain
projections of our future results of operations or of our financial
condition; and
|
·
|
state
other "forward-looking"
information.
|
We
believe it is important to communicate our expectations. However, there may
be
events in the future that we are not able to accurately predict or over which
we
have no control. Our actual results and the timing of certain events could
differ materially from those anticipated in these forward-looking statements
as
a result of certain factors, including those set forth under "Risk Factors,"
"Business" and elsewhere in this prospectus. See "Risk Factors."
OVERVIEW
We
are
developing new and innovative thin film solar cells produced on bio-based
plastic substrates with the intent to provide commercially viable solar cell
designs that convert sun light into electrical energy. The process for producing
electricity from sunlight is known as Photovoltaics. Photovoltaic ("PV")
is the science of capturing and converting sun light into
electricity.
We
are
focusing our research and product development efforts on thin film PV devices
in
an effort to capitalize on what we perceive as cost and application diversity
advantages to current rigid multi-crystalline silicon wafer technologies. Our
thin film cell design employs less than 1.5 microns of material thickness as
opposed to an approximate 400 microns of material thickness for
multi-crystalline cell designs. This significant reduction in cell thickness
and
flexibility of the completed cell structure leads to the use of "thin film"
terminology in describing the solar cell design.
We
are
focusing our research and product development efforts on thin film PV devices
produced on bio-based plastic substrates and the eventual marketing of such
products to the building materials, outdoor power, emergency power, mobile
computer and communications sectors.
We
were
incorporated in the State of Nevada on April 24, 2006, as BioSolar Labs, Inc.
Our name was changed to BioSolar, Inc. on June 8, 2006. Our principal executive
offices are located at
27936
Lost Canyon Road, Suite 202, Santa Clarita, California 91387
,
and our
telephone number is
(661)
251-0001
.
Critical
Accounting Policies
Our
discussion and analysis of our financial condition and results of operations
are
based upon our financial statements, which have been prepared in accordance
with
accounting principles generally accepted in the United States of America. The
preparation of these financial statements requires us to make estimates and
judgments that affect the reported amounts of assets, liabilities, revenues
and
expenses, and related disclosures of contingent assets and liabilities. On
an
ongoing basis, we evaluate our estimates, including those related to impairment
of property, plant and equipment, intangible assets, deferred tax assets and
fair value computation using the Black Scholes option pricing model. We base
our
estimates on historical experience and on various other assumptions, such as
the
trading value of our common stock and estimated future undiscounted cash flows,
that we believe to be reasonable under the circumstances, the results of which
form the basis for making judgments about the carrying value of assets and
liabilities that are not readily apparent from other sources. Actual results
may
differ from these estimates under different assumptions or conditions; however,
we believe that our estimates, including those for the above-described items,
are reasonable.
Revenue
Recognition
Revenue on product sales is
recognized when persuasive evidence of an
arrangement exists, such as when a purchase order or contract is
received from the customer, the selling price is fixed, title to the goods
has changed and there is a reasonable assurance of collection of the
sales proceeds. We obtain written purchase authorizations from
our customers for a specified amount of product at a specified price
and consider delivery to have occurred at the time
of shipment. Revenue is recognized at shipment and we
record a reserve for estimated sales returns, which
is reflected as a reduction of revenue at the time of revenue recognition.
We defer revenue on products sold directly to the consumer with a fifteen day
right of return. Revenue is recognized upon the expiration of the right of
return.
Revenues
from research and development activities relating to firm fixed-price
contracts are generally recognized on the percentage-of-completion
method of accounting as costs are incurred (cost-to-cost basis).
Revenues from research and development activities relating to
cost-plus-fee contracts include costs incurred plus a portion of
estimated fees or profits based on the relationship of costs incurred to
total estimated costs. Contract costs include all direct
material and labor costs and an allocation of allowable
indirect costs as defined by each contract, as periodically adjusted to
reflect revised agreed upon rates. These rates are subject to audit by the
other party.
Use
of Estimates
In
accordance with accounting principles generally accepted in the United States,
management utilizes estimates and assumptions that affect the reported amounts
of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements as well as the reported
amounts of revenues and expenses during the reporting period. Actual results
could differ from those estimates. These estimates and assumptions relate to
recording net revenue, collectibility of accounts receivable, useful lives
and
impairment of tangible and intangible assets, accruals, income taxes, inventory
realization, stock-based compensation expense and other factors. Management
believes it has exercised reasonable judgment in deriving these estimates.
Consequently, a change in conditions could affect these estimates.
Fair
Value of Financial Instruments
The
Company's cash, cash equivalents, investments, accounts receivable and accounts
payable are stated at cost which approximates fair value due to the short-term
nature of these instruments.
Recently
Issued Accounting Pronouncements
In
December 2004, the Financial Accounting Standards Board issued two FASB Staff
Positions - FSP FAS 109-1, Application of FASB Statement 109 "Accounting for
Income Taxes" to the Tax Deduction on Qualified Production Activities Provided
by the American Jobs Creation Act of 2004, and FSP FAS 109-2 Accounting and
Disclosure Guidance for the Foreign Earnings Repatriation Provision within
the
American Jobs Creation Act of 2004. Neither of these affected the Company as
it
does not participate in the related activities.
In
May
2005, the FASB issued FASB Statement No. 154, “Accounting Changes and Error
Corrections.” This new standard replaces APB Opinion No. 20, “Accounting
Changes, and FASB Statement No. 3, Reporting Accounting Changes in Interim
Financial Statements,” and represents another step in the FASB’s goal to
converge its standards with those issued by the IASB. Among other changes,
Statement 154 requires that a voluntary change in accounting principle be
applied retrospectively with all prior period financial statements presented
on
the new accounting principle, unless it is impracticable to do so. Statement
154
also provides that (1) a change in method of depreciating or amortizing a
long-lived non-financial asset be accounted for as a change in estimate
(prospectively) that was effected by a change in accounting principle, and
(2)
correction of errors in previously issued financial statements should be termed
a “restatement.” The new standard is effective for accounting changes and
correction of errors made in fiscal years beginning after December 15, 2005.
Early adoption of this standard is permitted for accounting changes and
correction of errors made in fiscal years beginning after June 1, 2005. The
Company has evaluated the impact of the adoption of Statement 154 and does
not
believe the impact will be significant to the Company's overall results of
operations or financial position
L
iquidity
and Capital Resources
As
of
September 30, 2006, we had $1,255,134 of working capital as compared to $320,225
from inception (April 24, 2006) through June 30, 2006. This increase of $934,909
was due primarily to private placements of shares of common stock pursuant
to
Subscription Agreements which we entered into with accredited and/or
institutional buyers.
Cash
flow
used in operating activities was $63,007 for the three months ended September
30, 2006 as compared to cash used of $86,801 from inception (April 24, 2006)
through June 30, 2006. This decrease of $23,794 was primarily attributable
to a
decrease in professional fees to our patent counsel.
Cash
used
in investing activities was $1,003,270 for the three months ended September
30,
2006 as compared to cash used of $0 from inception (April 24, 2006) through
June
30, 2006. The increase of cash used in investing activities was primarily due
to
equity financing.
Cash
provided from financing activities during the three months ended September
30,
2006 was $1,002,028 as compared to $407,000 from inception (April 24, 2006)
through June 30, 2006. We received $1,409,028 from the sale of shares of
our
common stock through private placements of shares of common stock pursuant
to
Subscription Agreements which we entered into with accredited and/or
institutional buyers.
Our
financial statements as of September 30, 2006 have been prepared under the
assumption that we will continue as a going concern from inception (April
24,
2006) through September 30, 2006. Our independent registered public accounting
firm have issued their report dated September 27
,
2006
that included an explanatory paragraph expressing substantial doubt in our
ability to continue as a going concern without additional capital becoming
available.
Our
ability to continue as a going concern ultimately is dependent on our ability
to
generate a profit which is dependent upon our ability to obtain additional
equity or debt financing, attain further operating efficiencies and, ultimately,
to achieve profitable operations. The financial statements do not include
any
adjustments that might result from the outcome of this uncertainty.
Financing
On
May
19, 2006, we issued an aggregate of 93,000,000 shares of our common stock,
par
value $.0001 per share, to the founders of our company, including our Chief
Executive Officer, for an aggregate purchase price of $23,250.
In
May
2006, we entered into Subscription Agreements with several accredited investors
pursuant to which the investors subscribed to purchase an aggregate amount
of up
to $375,000 in shares of our common stock, or a total of 25,000,000 shares.
In
July
2006, we entered into Subscription Agreements with several accredited investors
pursuant to which the investors subscribed to purchase an aggregate amount
of up
to $150,000 in shares of our common stock, or a total of 1,500,000
shares.
In
October 2006, we entered into Subscription Agreements with several accredited
investors pursuant to which the investors subscribed to purchase an aggregate
amount of up to approximately $905,777 in shares of our common stock, or a
total
of 9,057,777 shares.
PLAN
OF OPERATION AND FINANCING NEEDS
We
are
engaged in the development of new and innovative thin film solar cells produced
on bio-based plastic substrates with the intent to provide commercially viable
solar cell designs that convert sun light into electrical energy. We plan to
develop our products and thereafter focus our efforts on establishing markets
in
the building materials, outdoor power, emergency power, mobile computer and
communications sectors by 2010.
Operating
Expenses
Operating
expenses for the three months ended September 30, 2006 were $73,736 and
consisted primarily of $36,000 in salary expense, $12,362 for professional
fees,
and $13,300 for marketing expenses.
Net
Loss
Our
net
loss for the three months ended September 30, 2006 was $67,119. We recently
began operating our business, including efforts to market and sell our products,
and revenues generated were not sufficient to cover our operating costs.
Off-Balance
Sheet Arrangements
We
do not
have any off balance sheet arrangements that are reasonably likely to have
a
current or future effect on our financial condition, revenues, results of
operations, liquidity or capital expenditures.
BUSINESS
INTRODUCTION
We
are
focusing our research and product development efforts on thin film PV devices
in
an effort to capitalize on what we perceive as cost and application diversity
advantages to current rigid multi-crystalline silicon wafer technologies. Our
thin film cell design employs less than 1.5 microns of material thickness as
opposed to an approximate 400 microns of material thickness for
multi-crystalline cell designs. This significant reduction in cell thickness
and
flexibility of the completed cell structure leads to the use of "thin film"
terminology in describing the solar cell design.
Thin
film
PV technology has a further advantage over rigid multi-crystalline silicon
wafer
technologies in that thin film PV devices can be manufactured using high speed,
reel-to-reel processing methods on flexible rolled substrates within vacuum
deposition systems. These production methods result in lower manufacturing
costs.
We
believe that d
ue
to
both cost and environmental concerns, high volume manufacturing of thin film
PV
devices should be produced on bio-based plastic substrates rather than
petroleum-based plastic substrates. Petroleum, the principle component of
conventional plastics, is a depleting resource and its supply is highly
dependent on a number of geo-political factors, resulting in uncertain costs,
For a number of years, the cost of petroleum has been steadily increasing.
Bio-based plastics are currently made by a number of manufacturers from
renewable resources such as corn and potato starch. The supply and costs of
these renewable resources is likely to be far more stable in the future than
the
supply and costs of petroleum. A further problem with the continued use of
petroleum is the
damaging
effects that production, distribution, and use have on the
environment.
We
are
focusing our research and product development efforts on thin film PV devices
produced on bio-based plastic substrates and the eventual marketing of such
products to the building materials, outdoor power, emergency power, mobile
computer and communications sectors.
Industry
Overview
We
believe that the fastest-growing solar technology is “
Photovoltaics
”,
which
is derived from the words photo, meaning light, and voltaic, meaning voltage
producing. Sunlight, not heat, fuels photovoltaic cells. The cells, made mostly
of the semiconductor silicon, convert sunlight directly
i
nto
electricity.
There
remains a variety of techniques for manufacturing the coatings needed to create
solar cells. Emerging thin film cell manufacturing holds much promise because
the coatings use
l
ess
silicon than traditional films and can be manufactured at low cost and in large
volume. Many market observers expect thin-film photovoltaics to become the
dominant technology.
The
simplest cells power watches and calculators; more complex systems provide
power
to the electric grid, and provide electricity to pump water, power
communications equipment, light homes and run appliances.
In
photovoltaics, light particles called photons penetrate the cell and knock
electrons free from the silicon atoms, creating an electric current. As long
as
light flows into the cell, electrons flow out of the cell. The cell does not
use
up its electrons and lose power, similar to a battery, as it is a converter
that
turns one kind of energy (sunlight) into another (flowing
electrons).
Photovoltaic
cells are typically combined into modules that hold about 40 cells. Ten such
modules are mounted in photovoltaic arrays. Such arrays can be used to generate
electricity for a single building or, in large numbers, for a power
plant.
Stand-alone
photovoltaic systems produce power independently of the utility grid. In some
off-the-grid locations even one half kilometer from power lines, stand-alone
photovoltaic systems can be more cost-effective than extending power lines.
They
are especially appropriate for remote, environmentally sensitive areas, such
as
national parks, cabins, and remote homes.
In
rural
areas, small stand-alone solar arrays often power farm lighting, fence chargers
for electric fences, and solar water pumps, which provide water for livestock.
Some hybrid systems combine solar power with other power sources such as wind
or
diesel.
P
hotovoltaic
technology can be combined with construction materials and be built into a
building rather than added on top of a building. In such building-integrated
photovoltaics, photovoltaic systems are incorporated into or become elements
of
a building’s structure.
Companies
are manufacturing solar panels that look like construction materials, such
as
roof shingles. It is also possible to produce windows that have solar cells
integrally constructed as part of the window surface or by placing thin films
on
the window.
Marketing
Strategy
We
intend
to enhance and promote the idea that our thin film technologies, when ready
to
market, present a compelling and efficient solution for the manufacture of
diverse photovoltaic thin films. In order to create a favorable environment
for
sales, we plan to undertake advertising and promotion efforts. These efforts
may
be outsourced and will require the services of an advertising relations firm.
We
plan to interview various firms and select those most capable of assisting
us
with comprehensive advertising and promotion plans. We intend to commence
building and staffing our marketing department to accelerate these efforts
in
2007 and 2008. We have not yet finalized the potential costs of our marketing
strategy.
We
will
invest in small test campaigns before committing to large promotions or
marketing campaigns. Our initial marketing strategy we will be to market to
potential manufacturer partners in our target markets representing solar device
manufactures, glass, and building materials manufacturers.
Backlog
of Orders
There
are
currently no orders for sales at this time.
Government
Contracts
There
are
no government contracts at this time.
Compliance
with Environmental Laws and Regulations
Our
operations are subject to local, state and federal laws and regulations
governing environmental quality and pollution control. To date, our compliance
with these regulations by has had no material effect on our operations, capital,
earnings, or competitive position, and the cost of such compliance has not
been
material. We are unable to assess or predict at this time what effect additional
regulations or legislation could have on our activities.
Manufacturing
and Distribution
The
Company currently does not have any mechanism for the distribution of its thin
film, flexible solar cells produced on bio-based plastic substrates, but, with
adequate financing, we plan on addressing this issue with a multi-pronged
distribution operation to make our products available concurrently with out
marketing campaign.
Intellectual
Property
We
have
filed a patent to protect the intellectual property rights for “A Method for
Building Thin Film Flexible Solar Cells on Bio-Based Plastic Substrates”. The
inventor listed on the patent application is David Lee, the Company’s Chief
Executive Officer. The Company is listed as the assignee.
We
rely
upon confidentiality agreements signed by our employees, consultants and third
parties to protect our intellectual property.
Competition
While
there are a number of companies manufacturing thin film PV devices, such as
Iowa
Thin Film Technologies, Inc, United Solar Ovonic and Mitsubishi Heavy
Industries.
We
do not
know of any employing the use of bio-based plastic substrates.
Technology
Development Partners
To
assist
us in the development of our technology, we intend to seek out and enter into
technology development agreements with other entities with thin film PV and
bio-based plastics expertise.
DESCRIPTION
OF PROPERTY
Our
headquarters are located
at
27936
Lost Canyon Road, Suite 202, Santa Clarita, California 91387.
We
lease
our facility under a lease that expires on May 14, 2007. The size of our office
is 144 square feet. Rent expense, net of sublease income, amounted to $1,527
and
$1,018 for the three months ended September 30, 2006 and from inception (April
24, 2006) through June 30, 2006, respectively.
LEGAL
PROCEEDINGS
The
Company is not currently a party to any legal proceedings. There has been no
bankruptcy, receivership or similar proceedings.
There
have been no material reclassifications, mergers, consolidations, or purchase
or
sale of a significant amount of assets not in the ordinary course of
business.
Employees
As
of the
date of this prospectus, we had one (1) employee. We have not experienced any
work stoppages and we consider relations with our employees to be good.
EXECUTIVE
OFFICERS, DIRECTORS AND KEY EMPLOYEES
The
following table sets forth information about our executive officers, key
employees and directors as of November 21, 2006.
Name
|
Age
|
Position
|
David
Lee
|
47
|
Chief
Executive Officer and Acting Chief Financial Officer
|
Steven
C. Bartling
|
44
|
Director
|
Dennis
LePon
|
58
|
Director
|
Directors
serve until the next annual meeting and until their successors are elected
and
qualified.
The
Directors of the Company are elected by the vote of a majority in interest
of
the holders of the voting stock of the Company and hold office until the
expiration of the term for which he or she was elected and until a successor
has
been elected and qualified.
A
majority of the authorized number of directors constitutes a quorum of the
Board
for the transaction of business. The directors must be present at the meeting
to
constitute a quorum. However, any action required or permitted to be taken
by
the Board may be taken without a meeting if all members of the Board
individually or collectively consent in writing to the action.
Directors
receive compensation for their services and reimbursement for their expenses
as
shall be determined from time to time by resolution of the Board. The Company’s
directors currently do not receive monetary compensation for their service
on
the Board of Directors.
Officers
are appointed to serve for one year until the meeting of the board of directors
following the annual meeting of stockholders and until their successors have
been elected and qualified.
The
principal occupations for the past five years (and, in some instances, for
prior
years) of each of our executive officers and directors, followed by our key
employees, are as follows:
David
Lee
-
Chief
Executive Officer and Acting Chief Financial Officer:
David
D.
Lee has over 20 years of engineering, marketing, sales, and corporate management
experience in the areas of military and consumer communication systems,
automotive electronics, software development and consulting. From 2004 to
2006, Mr. Lee was with Ramsey-Shilling Co. in the business of Commercial Real
Estate Investment and Brokerage. From 2000 to 2004, he served as Chief
Operating Officer for Applied Reasoning, Inc., a Delaware company engaged in
the
business of Internet Software Development. From 1994 to 2000, he served as
Vice
Present and General Manager for RF-Link Technology, Inc., a California company
engaged in the business of Wireless Technology Development and Manufacturing.
Mr. Lee received a Ph.D. in Electrical Engineering from Purdue University in
1989, a Master of Science in Electrical Engineering from University of Michigan
in 1986 and a Bachelor of Science in Electrical Engineering from the University
of Texas at Austin in 1984.
Steven
C. Bartling -
Director:
Steven
C.
Bartling has over 20 years of engineering and corporate management experience
in
the areas of ultra high performance digital CMOS (Complementary Metal Oxide
Semiconductor) circuit design, high performance microprocessor
architecture/design, systems on a chip, packaging, and testing. From 2002 to
the
present, Mr. Bartling has been employed in ASIC (Application Specific Integrated
Circuit) research and development for Texas Instruments, Inc. From 2001 to
2002,
he served as
Director
of Custom Design
for
Celerence, an Oragon company engaged in the business of Optical Communication
Networking. Mr. Bartling received a Master of Science in Electrical Engineering
from Georgia Institute of Technology in 1987 and a Bachelor of Science in
Electrical Engineering from the University of Texas at Austin in
1985.
Dennis
LePon -
Director:
Dennis
LePon has over 35 years of financial, managerial, and business experience
working for a bank, real estate finance companies, as well as a start up high
tech company. From 1992 to the present, Mr. LePon has served as Chief Financial
officer of Catalyst Resource Group, Inc., a real estate finance and consulting
firm offering specialized financing for healthcare, C-Store, gasoline station
and other varied commercial properties nationwide. From 2002 to 2004, he
served as Chief Financial Officer for FoodMarket Place.com, a California company
engaged in the business of
Web
Based
marketing for food and restaurant industry partnered with Hewlett
Packard
.
Mr.
LePon received a Bachelor of Arts from California State University at Northridge
in 1969 and a Master of Business Administration from the University of Southern
California in 1977.
COMMITTEES
OF THE BOARD
We
currently have no audit committee, compensation committee, nominations and
governance committee of our board of directors.
INDEBTEDNESS
OF EXECUTIVE OFFICERS AND DIRECTORS
No
executive officer, director or any member of these individuals' immediate
families or any corporation or organization with whom any of these individuals
is an affiliate is or has been indebted to us since the beginning of our last
fiscal year.
FAMILY
RELATIONSHIPS
There
are
no family relationships among our executive officers and directors.
LEGAL
PROCEEDINGS
As
of the
date of this prospectus, there are no material proceedings to which any of
our
directors, executive officers, affiliates or stockholders is a party adverse
to
us.
CODE
OF ETHICS
We
have
not adopted a Code of Ethics within the meaning of Item 406(b) of Regulation
S-B
of the Securities Exchange Act of 1934.
EXECUTIVE
COMPENSATION
The
following table sets forth the cash compensation (including cash bonuses) paid
or accrued by us to our Chief Executive Officer and our four most highly
compensated officers other than the Chief Executive Officer from inception
(April 24, 2006) to June 30, 2006.
|
|
|
|
SUMMARY
COMPENSATION TABLE
|
|
|
|
|
|
|
|
Annual
Compensation
|
|
Long-term
Compensation
|
|
|
|
|
|
|
|
|
|
|
|
Awards
|
|
Payouts
|
|
|
|
|
|
|
|
|
|
|
|
Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Underlying
|
|
LTIP
|
|
All
Other
|
|
|
|
Fiscal
|
|
Salary
|
|
Bonus
|
|
Options/
|
|
Payouts
|
|
Compensation
|
|
Name
and Principal Position
|
|
Year
($)
|
|
($)
|
|
($)
|
|
SARs
(#)
|
|
($)
|
|
($)
|
|
David
Lee
|
|
|
2006
|
|
$
|
144,000
|
|
|
--
|
|
|
--
|
|
|
--
|
|
|
--
|
|
Chief
Executive Officer and Acting
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chief
Financial Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPTIONS/SAR
GRANTS IN THE LAST FISCAL YEAR
No
individual grants of stock options, whether or not in tandem with stock
appreciation rights ("SARs") and freestanding SARs have been made to any
executive officer or any director from inception (April 24, 2006) to June 30,
2006.
AGGREGATED
OPTION/SAR EXERCISES IN LAST FISCAL YEAR AND FISCAL YEAR END OPTION/SAR
VALUES
No
individual exercises of stock options, whether or not in tandem with stock
appreciation rights ("SARs") and freestanding SARs have been made by executive
officer or any director from inception (April 24, 2006) to June 30,
2006.
LONG-TERM
INCENTIVE PLANS - AWARDS IN LAST FISCAL YEAR
We
had no
long-term incentive plans and made no stock awards from inception (April 24,
2006) to June 30, 2006.
EMPLOYMENT
AGREEMENTS
The
Company current has no employment agreements with its executive
officers.
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The
following tables sets forth, as of November 21, 2006, the number of and percent
of our common stock beneficially owned by:
·
|
all
directors and nominees, naming
them,
|
·
|
our
executive officers,
|
·
|
our
directors and executive officers as a group, without naming them,
and
|
·
|
persons
or groups known by us to own beneficially 5% or more of our common
stock:
|
We
believe that all persons named in the table have sole voting and investment
power with respect to all shares of common stock beneficially owned by
them.
A
person
is deemed to be the beneficial owner of securities that can be acquired by
him
within 60 days from November 21, 2006 upon the exercise of options, warrants
or
convertible securities. Each beneficial owner's percentage ownership is
determined by assuming that options, warrants or convertible securities that
are
held by him, but not those held by any other person, and which are exercisable
within 60 days of November 21, 2006 have been exercised and converted.
Title
of Class
|
|
Name
of
Beneficial
Owner
|
|
Number
of Shares
Beneficially
Owned
|
|
Prior
to Offering as a
Percent
of Total
|
|
Post-Offering
as a
Percent
of
Total
|
|
Common
Stock
|
|
|
David
Lee
|
|
|
49,500,000
|
|
|
38.5
%
|
|
|
38.5
%
|
|
Common
Stock
|
|
|
Douglas
O’Rear
|
|
|
12,500,000
|
|
|
9.72
%
|
|
|
9.72
%
|
|
Common
Stock
|
|
|
Robert
M. Silverman
|
|
|
12,500,000
|
|
|
9.72
%
|
|
|
9.72
%
|
|
Common
Stolck
|
|
|
Tommie
Kay Riddle
|
|
|
12,500,000
|
|
|
9.72
%
|
|
|
9.72
%
|
|
Common
Stock
|
|
|
Shane
Barr
|
|
|
10,000,000
|
|
|
7.78
%
|
|
|
7.78
%
|
|
Common
Stock
|
|
|
Wings
Fund, Inc.
|
|
|
6,250,000
|
|
|
4.86
%
|
|
|
4.86
%
|
|
Common
Stock
|
|
|
William
E. Beifuss, Jr. and Alice Beifuss
|
|
|
6,250,000
|
|
|
4.86
%
|
|
|
4.86
%
|
|
Common
Stock
|
|
|
Steven
C. Bartling
|
|
|
1,000,000
|
|
|
0.78
%
|
|
|
0.78
%
|
|
Common
Stock
|
|
|
Dennis
LePon
|
|
|
1,000,000
|
|
|
0.78
%
|
|
|
0.78
%
|
|
Common
Stock
|
|
|
All
Executive Officers and Directors as a Group (3 persons
)
|
|
|
51,500,000
|
|
|
40.1
%
|
|
|
40.1
%
|
|
DESCRIPTION
OF SECURITIES
Our
Amended Articles of Incorporation authorize the issuance of 500,000,000 shares
of common stock, $.0001 par value per share. Holders of shares of common stock
are entitled to one vote for each share on all matters to be voted on by the
stockholders. Holders of common stock have cumulative voting rights. Holders
of
shares of common stock are entitled to share ratably in dividends, if any,
as
may be declared, from time to time by the Board of Directors in its discretion,
from funds legally available therefor. In the event of a liquidation,
dissolution, or winding up of the Company, the holders of shares of common
stock
are entitled to share pro rata all assets remaining after payment in full of
all
liabilities. Holders of common stock have no preemptive or other subscription
rights, and there are no conversion rights or redemption or sinking fund
provisions with respect to such shares.
COMMISSION'S
POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES
Under
the
Nevada General Corporation Law and our Articles of Incorporation, as amended,
and our Bylaws, our directors will have no personal liability to us or our
stockholders for monetary damages incurred as the result of the breach or
alleged breach by a director of his "duty of care." This provision does not
apply to the directors' (i) acts or omissions that involve intentional
misconduct or a knowing and culpable violation of law, (ii) acts or omissions
that a director believes to be contrary to the best interests of the corporation
or its stockholders or that involve the absence of good faith on the part of
the
director, (iii) approval of any transaction from which a director derives an
improper personal benefit, (iv) acts or omissions that show a reckless disregard
for the director's duty to the corporation or its stockholders in circumstances
in which the director was aware, or should have been aware, in the ordinary
course of performing a director's duties, of a risk of serious injury to the
corporation or its stockholders, (v) acts or omissions that constituted an
unexcused pattern of inattention that amounts to an abdication of the director's
duty to the corporation or its stockholders, or (vi) approval of an unlawful
dividend, distribution, stock repurchase or redemption. This provision would
generally absolve directors of personal liability for negligence in the
performance of duties, including gross negligence.
The
effect of this provision in our Articles of Incorporation and Bylaws is to
eliminate the rights of our Company and our stockholders (through stockholder's
derivative suits on behalf of our Company) to recover monetary damages against
a
director for breach of his fiduciary duty of care as a director (including
breaches resulting from negligent or grossly negligent behavior) except in
the
situations described in clauses (i) through (vi) above. This provision does
not
limit nor eliminate the rights of our Company or any stockholder to seek
non-monetary relief such as an injunction or rescission in the event of a breach
of a director's duty of care. In addition, our Bylaws provide that if the Nevada
General Corporation Law is amended to authorize the future elimination or
limitation of the liability of a director, then the liability of the directors
will be eliminated or limited to the fullest extent permitted by the law, as
amended. The Nevada General Corporation Law grants corporations the right to
indemnify their directors, officers, employees and agents in accordance with
applicable law.
Insofar
as indemnification for liabilities arising under the Securities Act of 1933
(the
"Act" or "Securities Act") may be permitted to directors, officers or persons
controlling our Company pursuant to the foregoing provisions, or otherwise,
we
have been advised that in the opinion of the Securities and Exchange Commission,
such indemnification is against public policy as expressed in the Act and is,
therefore, unenforceable.
PLAN
OF DISTRIBUTION
The
selling stockholders and any of their respective pledgees, donees, assignees
and
other successors-in-interest may, from time to time, sell any or all of their
shares of common stock on any stock exchange, market or trading facility on
which the shares are traded or in private transactions. These sales may be
at
fixed or negotiated prices. The selling stockholders may use any one or more
of
the following methods when selling shares:
·
|
ordinary
brokerage transactions and transactions in which the broker-dealer
solicits the purchaser;
|
·
|
block
trades in which the broker-dealer will attempt to sell the shares
as agent
but may position and resell a portion of the block as principal to
facilitate the transaction;
|
·
|
purchases
by a broker-dealer as principal and resale by the broker-dealer for
its
account;
|
·
|
an
exchange distribution in accordance with the rules of the applicable
exchange;
|
·
|
privately-negotiated
transactions;
|
·
|
broker-dealers
may agree with the selling stockholders to sell a specified number
of such
shares at a stipulated price per
share;
|
·
|
a
combination of any such methods of sale;
and
|
·
|
any
other method permitted pursuant to applicable
law.
|
The
selling stockholders may also sell shares under Rule 144 under the Securities
Act, if available, or Regulation S, rather than under this prospectus. The
selling stockholders shall have the sole and absolute discretion not to accept
any purchase offer or make any sale of shares if they deem the purchase price
to
be unsatisfactory at any particular time.
The
selling stockholders or their respective pledgees, donees, transferees or other
successors in interest, may also sell the shares directly to market makers
acting as principals and/or broker-dealers acting as agents for themselves
or
their customers. Such broker-dealers may receive compensation in the form of
discounts, concessions or commissions from the selling stockholders and/or
the
purchasers of shares for whom such broker-dealers may act as agents or to whom
they sell as principal or both, which compensation as to a particular
broker-dealer might be in excess of customary commissions. Market makers and
block purchasers purchasing the shares will do so for their own account and
at
their own risk. It is possible that a selling stockholder will attempt to sell
shares of common stock in block transactions to market makers or other
purchasers at a price per share which may be below the then market price. The
selling stockholders cannot assure that all or any of the shares offered in
this
prospectus will be issued to, or sold by, the selling stockholders. The selling
stockholders and any brokers, dealers or agents, upon effecting the sale of
any
of the shares offered in this prospectus, may be deemed to be "underwriters"
as
that term is defined under the Securities Act of 1933, as amended, or the
Securities Exchange Act of 1934, as amended, or the rules and regulations under
such acts. In such event, any commissions received by such broker-dealers or
agents and any profit on the resale of the shares purchased by them may be
deemed to be underwriting commissions or discounts under the Securities
Act.
We
are
required to pay all fees and expenses incident to the registration of the
shares, including fees and disbursements of counsel to the selling stockholders,
but excluding brokerage commissions or underwriter discounts.
The
selling stockholders, alternatively, may sell all or any part of the shares
offered in this prospectus through an underwriter. No selling stockholder has
entered into any agreement with a prospective underwriter and there is no
assurance that any such agreement will be entered into.
The
selling stockholders may pledge their shares to their brokers under the margin
provisions of customer agreements. If a selling stockholders defaults on a
margin loan, the broker may, from time to time, offer and sell the pledged
shares. The selling stockholders and any other persons participating in the
sale
or distribution of the shares will be subject to applicable provisions of the
Securities Exchange Act of 1934, as amended, and the rules and regulations
under
such act, including, without limitation, Regulation M. These provisions may
restrict certain activities of, and limit the timing of purchases and sales
of
any of the shares by, the selling stockholders or any other such person. In
the
event that the selling stockholders are deemed affiliated purchasers or
distribution participants within the meaning of Regulation M, then the selling
stockholders will not be permitted to engage in short sales of common stock.
Furthermore, under Regulation M, persons engaged in a distribution of securities
are prohibited from simultaneously engaging in market making and certain other
activities with respect to such securities for a specified period of time prior
to the commencement of such distributions, subject to specified exceptions
or
exemptions.
We
have
agreed to indemnify the selling stockholders, or their transferees or assignees,
against certain liabilities, including liabilities under the Securities Act
of
1933, as amended, or to contribute to payments the selling stockholders or
their
respective pledgees, donees, transferees or other successors in interest, may
be
required to make in respect of such liabilities.
If
the
selling stockholders notify us that they have a material arrangement with a
broker-dealer for the resale of the common stock, then we would be required
to
amend the registration statement of which this prospectus is a part, and file
a
prospectus supplement to describe the agreements between the selling
stockholders and the broker-dealer.
PENNY
STOCK
The
Securities and Exchange Commission has adopted Rule 15g-9 which establishes
the
definition of a "penny stock," for the purposes relevant to us, as any equity
security that has a market price of less than $5.00 per share or with an
exercise price of less than $5.00 per share, subject to certain exceptions.
For
any transaction involving a penny stock, unless exempt, the rules
require:
·
|
that
a broker or dealer approve a person's account for transactions in
penny
stocks; and
|
·
|
the
broker or dealer receive from the investor a written agreement to
the
transaction, setting forth the identity and quantity of the penny
stock to
be purchased.
|
In
order
to approve a person's account for transactions in penny stocks, the broker
or
dealer must
·
|
obtain
financial information and investment experience objectives of the
person;
and
|
·
|
make
a reasonable determination that the transactions in penny stocks
are
suitable for that person and the person has sufficient knowledge
and
experience in financial matters to be capable of evaluating the risks
of
transactions in penny stocks.
|
The
broker or dealer must also deliver, prior to any transaction in a penny stock,
a
disclosure schedule prescribed by the Commission relating to the penny stock
market, which, in highlight form:
·
|
sets
forth the basis on which the broker or dealer made the suitability
determination; and
|
·
|
that
the broker or dealer received a signed, written agreement from the
investor prior to the transaction.
|
Disclosure
also has to be made about the risks of investing in penny stocks in both public
offerings and in secondary trading and about the commissions payable to both
the
broker-dealer and the registered representative, current quotations for the
securities and the rights and remedies available to an investor in cases of
fraud in penny stock transactions. Finally, monthly statements have to be sent
disclosing recent price information for the penny stock held in the account
and
information on the limited market in penny stocks.
SELLING
STOCKHOLDERS
The
table
below sets forth information concerning the resale of the shares of common
stock
by the selling stockholders. We will not receive any proceeds from the resale
of
the common stock by the selling stockholders. We will receive proceeds from
the
exercise of the warrants. Assuming all the shares registered below are sold
by
the selling stockholders, none of the selling stockholders will continue to
own
any shares of our common stock.
The
following table also sets forth the name of each person who is offering the
resale of shares of common stock by this prospectus, the number of shares of
common stock beneficially owned by each person, the number of shares of common
stock that may be sold in this offering and the number of shares of common
stock
each person will own after the offering, assuming they sell all of the shares
offered.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
Shares
of
|
|
|
|
|
|
Beneficial
|
|
of
Common
|
|
|
|
|
|
Total
|
|
Common
Stock
|
|
Beneficial
|
|
Percentage
of
|
|
Ownership
|
|
Stock
Owned
|
|
|
|
|
|
Percentage
|
|
Included
in
|
|
Ownership
|
|
Common
Stock
|
|
After
the
|
|
After
|
|
|
|
Total
Shares
|
|
of
Common
|
|
Prospectus
|
|
Before
the
|
|
Owned
Before
|
|
Offering
|
|
Offering
|
|
Name
|
|
of
Common Stock
|
|
Stock
|
|
(1)
|
|
Offering
|
|
Offering**
|
|
(1)
|
|
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adrian
Y. Won and
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Sylvia
J. Won
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amy
E. Gibbons
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Andrew
and Anna Yu
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Andrew
Berk
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Anthony
B. Lee
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Arthur
E. and Kelli
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
D.
Altounian
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Barry
and Linda
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Ewing
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Ben
and Maureen
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Hunter
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Brett
J. Cohen
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Chris
Miller
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Clive
and Mari Otsuka
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Dana
Henry
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Dana
Matsunaga
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Daniel
B. Peters and
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Elizabeth
H. Peters,
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
Trustees
of the Peters
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
Family
Trust
dated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April
30, 2004 (2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Daniel
J. and
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Josephine
P. Carlile
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
David
Van Middlesworth
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Derek
and Susan
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Johansen
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
Shares
of
|
|
|
|
|
|
Beneficial
|
|
of
Common
|
|
|
|
|
|
Total
|
|
Common
Stock
|
|
Beneficial
|
|
Percentage
of
|
|
Ownership
|
|
Stock
Owned
|
|
|
|
|
|
Percentage
|
|
Included
in
|
|
Ownership
|
|
Common
Stock
|
|
After
the
|
|
After
|
|
|
|
Total
Shares
|
|
of
Common
|
|
Prospectus
|
|
Before
the
|
|
Owned
Before
|
|
Offering
|
|
Offering
|
|
Name
|
|
of
Common Stock
|
|
Stock
|
|
(1)
|
|
Offering
|
|
Offering**
|
|
(1)
|
|
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dorothy
J. Kim
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Trustee
of the Dorothy
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
J.
Kim Living Trust
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
dated
December
19, 2002 (3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dorothy
Sarkozy
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Douglas
C. O'Rear
|
|
12,500,000
|
|
9.72
|
%
|
Up
to
|
|
12,500,000
|
|
10.5
|
%
|
0
|
|
--
|
|
|
|
|
|
|
|
12,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Dr.
and Mrs. Ivan
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Barrett
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Edward
and Esther
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Bouryng
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Edward
H. Nakamoto
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Edward
N. Shen
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Eloy
and Ellen Corona
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Emmanuel
C. Vasilomanolakis
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Enrique
Clare
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Eric
Belusa
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Felix
Rodriguez
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Franklyn
E. DeFoe
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Fred
J. Choy
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Fred
Jakobsen
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Gary
Stephenson
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Greg
Hampson
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gregory
L. Barnhill
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Harinder
Dhillon
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Helene
Pretsky
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Michael
G. Hoffman, as
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
trustee
of the
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
Hoffman
Family Trust
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
dated
February 8, 1990 (4)
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Howard
K. Brodwin
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
Shares
of
|
|
|
|
|
|
Beneficial
|
|
of
Common
|
|
|
|
|
|
Total
|
|
Common
Stock
|
|
Beneficial
|
|
Percentage
of
|
|
Ownership
|
|
Stock
Owned
|
|
|
|
|
|
Percentage
|
|
Included
in
|
|
Ownership
|
|
Common
Stock
|
|
After
the
|
|
After
|
|
|
|
Total
Shares
|
|
of
Common
|
|
Prospectus
|
|
Before
the
|
|
Owned
Before
|
|
Offering
|
|
Offering
|
|
Name
|
|
of
Common Stock
|
|
Stock
|
|
(1)
|
|
Offering
|
|
Offering**
|
|
(1)
|
|
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
James
K. Kahla
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
James
Standaert
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Jay
and Terry Hartman
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Jeannie
Melacon
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Jeff
F. Konecke
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Jene
Verchick
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Jessica
Gordon
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
John
Hayward
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Joseph
F. Koch
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Justin
Gordon
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Karen
S. Schneider
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Kari
A. Negri
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Kenneth
K. Tam
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kenneth
Schneider
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kimberly
Conlin and
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
James
LaWare
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Larry
J. Kaufman
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Lee
A. Chamberlain
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Lora
K. Ball
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Luka
J. DeKelaita
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Malissa
Wise
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Marc
E. and Melissa D.
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Royer
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Marilyn
Gilbert and
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Nathan
Rundlett
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Martin
N. Gordon
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
Shares
of
|
|
|
|
|
|
Beneficial
|
|
of
Common
|
|
|
|
|
|
Total
|
|
Common
Stock
|
|
Beneficial
|
|
Percentage
of
|
|
Ownership
|
|
Stock
Owned
|
|
|
|
|
|
Percentage
|
|
Included
in
|
|
Ownership
|
|
Common
Stock
|
|
After
the
|
|
After
|
|
|
|
Total
Shares
|
|
of
Common
|
|
Prospectus
|
|
Before
the
|
|
Owned
Before
|
|
Offering
|
|
Offering
|
|
Name
|
|
of
Common Stock
|
|
Stock
|
|
(1)
|
|
Offering
|
|
Offering**
|
|
(1)
|
|
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mary
E. Falso
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Max
and Elizabeth
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Rodriguez
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Michael
Brown and
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Linda
Engelsiepen
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Michael
G.S. and
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Marianne
Diamond
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Mitchell
B. Cohen
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mohammadali
Vaghar
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Nadereh
Salarpour
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Nelson
A. Abiva
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Noa
Krauss and Erin
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Wilhelm
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pamela
M. King
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patrick
J. Howard and
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Vickie
E. Howard
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paul
W. Ronan
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Peter
Chakos
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Phillip
A. and Alice
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
M.
Conlin
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Ramin
Ramhormozi and
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Jennifer
E. Romeyn
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Randall
and Ruth
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Greenberg
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Richard
and Elizabeth
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Weingart
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Richard
and Madeline
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Peters
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Robert
D. King
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Robert
F. DeFoe
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Ronald
Belusa
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Ronald
D. Hejnal and
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Barbara
A. Hejnal
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Royce
Shimamoto
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
Shares
of
|
|
|
|
|
|
Beneficial
|
|
of
Common
|
|
|
|
|
|
Total
|
|
Common
Stock
|
|
Beneficial
|
|
Percentage
of
|
|
Ownership
|
|
Stock
Owned
|
|
|
|
|
|
Percentage
|
|
Included
in
|
|
Ownership
|
|
Common
Stock
|
|
After
the
|
|
After
|
|
|
|
Total
Shares
|
|
of
Common
|
|
Prospectus
|
|
Before
the
|
|
Owned
Before
|
|
Offering
|
|
Offering
|
|
Name
|
|
of
Common Stock
|
|
Stock
|
|
(1)
|
|
Offering
|
|
Offering**
|
|
(1)
|
|
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Russell
Wong, trustee
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
Russell
D. Wong
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
Revocable
Trust (5)
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Samuel
J. Zinberg
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Scott
Pansky
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Scott
Piwonka-Totten
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Scott
Tredennick
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stanley
K. Kawanishi
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Steve
Shakespeare
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Steven
and Mary Gordon
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Steven
Timmerman
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Susan
Iwakoshi Craig
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Tauna
Tuokkola
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Theodore
Wong
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Tim
Kaiser
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Trisha
Speer
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Troy
A. Smith
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
William
E. Beifuss, Jr
|
|
6,250,000
|
|
4.86%
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
and
Alice Beifuss
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
William
E. Boyd
|
|
15,000
|
|
*
|
|
Up
to
|
|
15,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
Wings
Fund, Inc. (6)
|
|
6,250,000
|
|
4.86%
|
|
Up
to
|
|
6,250,000
|
|
*
|
|
0
|
|
--
|
|
|
|
|
|
|
|
6,250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shares
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
common
stock
|
|
|
|
|
|
|
|
|
|
|
*
Less
than 1%
The
number and percentage of shares beneficially owned is determined in accordance
with Rule 13d-3 of the Securities Exchange Act of 1934, and the information
is
not necessarily indicative of beneficial ownership for any other purpose. Under
such rule, beneficial ownership includes any shares as to which the selling
stockholders has sole or shared voting power or investment power and also any
shares, which the selling stockholders has the right to acquire within 60 days.
The actual number of shares of common stock issuable upon the conversion of
the
secured convertible notes is subject to adjustment depending on, among other
factors, the future market price of the common stock, and could be materially
less or more than the number estimated in the table.
(1)
Assumes that all securities will be sold.
(2)
In
accordance with rule 13d-3 under the securities exchange act of 1934, Daniel
B.
Peters and Elizabeth H. Peters, as co-trustees, may be deemed control persons
of
the shares owned by such entity, with final voting power and investment control
over such shares.
(3)
In
accordance with rule 13d-3 under the securities exchange act of 1934, Dorothy
J.
Kim, as trustee, may be deemed a control person of the shares owned by such
entity, with final voting power and investment control over such
shares.
(4)
In
accordance with rule 13d-3 under the securities exchange act of 1934, Michael
G.
Hoffman, as trustee, may be deemed a control person of the shares owned by
such
entity, with final voting power and investment control over such
shares.
(5)
In
accordance with rule 13d-3 under the securities exchange act of 1934, Russell
Wong, as trustee, may be deemed a control person of the shares owned by such
entity, with final voting power and investment control over such
shares.
(6)
In
accordance with rule 13d-3 under the securities exchange act of 1934, Karen
M.
Graham may be deemed a control person of the shares owned by such entity, with
final voting power and investment control over such shares
LEGAL
MATTERS
Sichenzia
Ross Friedman Ference LLP, New York, New York will issue an opinion with respect
to the validity of the shares of common stock being offered hereby.
EXPERTS
Our
financial statements at from inception (April 24, 2006) through June 30, 2006
appearing in this prospectus and registration statement have been audited by
HJ
Associates & Consultants, LLP
,
independent registered public accountants, as set forth on their report thereon
appearing elsewhere in this prospectus, and are included in reliance upon such
report given upon the authority of such firm as experts in accounting and
auditing.
AVAILABLE
INFORMATION
We
have
filed a registration statement on Form SB-2 under the Securities Act of 1933,
as
amended, relating to the shares of common stock being offered by this
prospectus, and reference is made to such registration statement. This
prospectus constitutes the prospectus of Itronics Inc., filed as part of the
registration statement, and it does not contain all information in the
registration statement, as certain portions have been omitted in accordance
with
the rules and regulations of the Securities and Exchange
Commission.
We
are
subject to the informational requirements of the Securities Exchange Act of
1934
which requires us to file reports, proxy statements and other information with
the Securities and Exchange Commission. Such reports, proxy statements and
other
information may be inspected at public reference facilities of the SEC at 100
F
Street N.E. Washington, D.C. 20549. Copies of such material can be obtained
from
the Public Reference Section of the SEC at 100 F Street N.E. Washington, D.C.
20549 at prescribed rates. Because we file documents electronically with the
SEC, you may also obtain this information by visiting the SEC's Internet website
at http://www.sec.gov.
INDEX
TO FINANCIAL STATEMENTS
BIOSOLAR,
INC.
FINANCIAL
STATEMENTS
CONTENTS
|
|
Page
|
|
|
|
|
|
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
|
|
F-1
|
|
AUDITED
FINANCIAL STATEMENTS: INCEPTION (APRIL 24, 2006) TO
|
|
|
|
JUNE
30, 2006
|
|
|
|
Balance
Sheets
|
|
F-2
|
|
Statements
of Operations
|
|
F-3
|
|
Statements
of Stockholders' Equity
|
|
F-4
|
|
Statements
of Cash Flows
|
|
F-5
|
|
Notes
to Financial Statements
|
|
F-6
- F-7
|
|
INTERIM
FINANCIAL STATEMENTS: THREE MONTHS ENDED SEPTEMBER 30,
2006
|
|
|
|
COMPARED
TO INCEPTION (APRIL 24, 2006) TO JUNE 30, 2006
|
|
|
|
Balance
Sheets
|
|
F-8
|
|
Statements
of Operations
|
|
F-9
|
|
Statements
of Stockholders' Equity
|
|
F-10
|
|
Statements
of Cash Flows
|
|
F-11
|
|
Notes
to Financial Statements
|
|
F-12
- F-13
|
|
Report
of Independent Registered Public Accounting Firm
To
the
Board of Directors
BioSolar,
Inc.
(A
Development Stage Company)
Santa
Clarita, California
We
have
audited the balance sheet of BioSolar, Inc. (a development stage company) as
of
June 30, 2006, and the related statements of operations, stockholders’ equity,
and cash flows for the period from inception on April 25, 2006 through June
30,
2006. These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these financial
statements based on our audit.
We
conducted our audit in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we
plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining,
on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used
and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audit provided a
reasonable basis for our opinion.
In
our
opinion, the financial statements referred to above present fairly, in all
material respects, the financial position of BioSolar, Inc. (a development
stage
company) as of June 30, 2006, and the results of its operations and its cash
flows for the period from inception on April 25, 2006 through June 30, 2006,
in
conformity with U.S. generally accepted accounting principles.
The
accompanying financial statements have been prepared assuming that the Company
will continue as a going concern. As discussed in Note 2 to the financial
statements, the Company has not generated any revenue, and has negative cash
flows from operations, which raise substantial doubt about the Company’s ability
to continue as a going concern
.
Management’s plans in regards to these matters are also described in Note 2. The
financial statements do not include any adjustments that might result from
the
outcome of this uncertainty.
HJ
Associates & Consultants, LLP
Salt
Lake
City, UT
September
27, 2006
BIOSOLAR, INC.
(A Development Stage Company)
BALANCE SHEET
JUNE 30, 2006
ASSETS
|
|
|
|
|
|
|
|
CURRENT
ASSETS
|
|
|
|
Cash
|
|
$
|
320,199
|
|
Prepaid
Expenses
|
|
|
1,176
|
|
|
|
|
|
|
Total
Current Assets
|
|
|
321,375
|
|
|
|
|
|
|
OTHER
ASSETS
|
|
|
|
|
Deposit
|
|
|
770
|
|
|
|
|
|
|
TOTAL
ASSETS
|
|
$
|
322,145
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES
AND SHAREHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
|
TOTAL
CURRENT LIABILITIES
|
|
|
|
|
Accounts
Payable
|
|
|
1,150
|
|
|
|
|
|
|
SHAREHOLDERS'
EQUITY
|
|
|
|
|
Common
Stock, $0.0001 par value;
|
|
|
|
|
500,000,000
authorized common shares
|
|
|
|
|
118,090,000
shares issued and outstanding
|
|
|
11,809
|
|
Additional
Paid in Capital
|
|
|
395,441
|
|
Subscription
receivable
|
|
|
(250
|
)
|
Deficit
Accumulated during the Development Stage
|
|
|
(86,005
|
)
|
|
|
|
|
|
TOTAL
SHAREHOLDERS' EQUITY
|
|
|
320,995
|
|
|
|
|
|
|
TOTAL
LIABILITIES AND SHAREHOLDERS' EQUITY
|
|
$
|
322,145
|
|
The
accompanying notes are an integral part of these financial
statements
BIOSOLAR,
INC.
(A
Development Stage Company)
STATEMENT
OF OPERATIONS
JUNE
30, 2006
|
|
From
Inception
|
|
|
|
April
25, 2006
|
|
|
|
through
|
|
|
|
June
30, 2006
|
|
|
|
|
|
REVENUE
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING
EXPENSES
|
|
|
|
|
Salaries
|
|
|
12,000
|
|
Professional
fees
|
|
|
60,100
|
|
Rent
|
|
|
990
|
|
Payroll
taxes
|
|
|
1,212
|
|
Office
expense
|
|
|
541
|
|
Advertising
|
|
|
500
|
|
Taxes
& Licenses
|
|
|
10,251
|
|
Telephone
expense
|
|
|
411
|
|
|
|
|
|
|
TOTAL
COSTS AND EXPENSES
|
|
|
86,005
|
|
|
|
|
|
|
NET
LOSS
|
|
|
(86,005
|
)
|
|
|
|
|
|
|
|
|
|
|
BASIC
AND DILUTED LOSS PER SHARE
|
|
$
|
(0.00
|
)
|
|
|
|
|
|
WEIGHTED-AVERAGE
COMMON SHARES OUTSTANDING
|
|
|
|
|
BASIC
AND DILUTED
|
|
|
49,957,033
|
|
|
|
|
|
|
The
accompanying notes are an integral part of these
financial statements
BIOSOLAR,
INC.
(A
Development Stage Company)
STATEMENT
OF SHAREHOLDERS EQUITY
|
|
|
|
|
|
|
|
Deficit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
during
the
|
|
|
|
|
|
|
|
Common
stock
|
|
Paid-in
|
|
Development
|
|
Subscription
|
|
|
|
|
|
Shares
|
|
Amount
|
|
Capital
|
|
Stage
|
|
Receivable
|
|
Total
|
|
Issuance
of common stock in April 2006 for services
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,000
common shares issued at $0.001 per share )
|
|
|
1,000
|
|
$
|
1
|
|
$
|
-
|
|
$
|
-
|
|
$
|
-
|
|
$
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of founders shares in May 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(29,999,000
common shares issued at $0.00025 per share )
|
|
|
29,999,000
|
|
|
2,999
|
|
|
4,500
|
|
|
-
|
|
|
|
|
|
7,499
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of founders shares in May 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(20,000,000
common shares issued at $0.00025 per share )
|
|
|
20,000,000
|
|
|
2,000
|
|
|
3,000
|
|
|
-
|
|
|
|
|
|
5,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of founders shares in May 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,000,000
common shares issued at $0.00025 per share )
|
|
|
1,000,000
|
|
|
100
|
|
|
150
|
|
|
-
|
|
|
|
|
|
250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of founders shares in May 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,000,000
common shares issued at $0.00025 per share )
|
|
|
1,000,000
|
|
|
100
|
|
|
150
|
|
|
-
|
|
|
|
|
|
250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of unregistered shares in May 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5,000,000
common shares issued at $0.00025 per share )
|
|
|
5,000,000
|
|
|
500
|
|
|
750
|
|
|
-
|
|
|
|
|
|
1,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of unregistered shares in May 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,000,000
common shares issued at $0.00025 per share )
|
|
|
2,000,000
|
|
|
200
|
|
|
300
|
|
|
-
|
|
|
(250
|
)
|
|
250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common stock in May 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(12,500,000
common shares issued at $0.015 per share )
|
|
|
12,500,000
|
|
|
1,250
|
|
|
186,250
|
|
|
-
|
|
|
|
|
|
187,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common stock in May 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(12,500,000
common shares issued at $0.015 per share )
|
|
|
12,500,000
|
|
|
1,250
|
|
|
186,250
|
|
|
-
|
|
|
|
|
|
187,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of founders shares in June 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,000,000
common shares issued at $0.00025 per share )
|
|
|
2,000,000
|
|
|
200
|
|
|
300
|
|
|
-
|
|
|
|
|
|
500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of founders shares in June 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(20,000,000
common shares issued at $0.00025 per share )
|
|
|
20,000,000
|
|
|
2,000
|
|
|
3,000
|
|
|
-
|
|
|
|
|
|
5,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of founders shares in June 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(10,000,000
common shares issued at $0.00025 per share )
|
|
|
10,000,000
|
|
|
1,000
|
|
|
1,500
|
|
|
-
|
|
|
|
|
|
2,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of founders shares in June 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,000,000
common shares issued at $0.00025 per share )
|
|
|
1,000,000
|
|
|
100
|
|
|
150
|
|
|
-
|
|
|
|
|
|
250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of founders shares in June 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,000,000
common shares issued at $0.00025 per share )
|
|
|
1,000,000
|
|
|
100
|
|
|
150
|
|
|
-
|
|
|
|
|
|
250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common shares in June 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15,000
common shares issued at $0.10 per share )
|
|
|
15,000
|
|
|
2
|
|
|
1,498
|
|
|
-
|
|
|
|
|
|
1,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common shares in June 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(30,000
common shares issued at $0.10 per share )
|
|
|
30,000
|
|
|
3
|
|
|
2,997
|
|
|
-
|
|
|
|
|
|
3,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common shares in June 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15,000
common shares issued at $0.10 per share )
|
|
|
15,000
|
|
|
2
|
|
|
1,498
|
|
|
-
|
|
|
|
|
|
1,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common shares in June 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15,000
common shares issued at $0.10 per share )
|
|
|
15,000
|
|
|
1
|
|
|
1,499
|
|
|
-
|
|
|
|
|
|
1,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common shares in June 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15,000
common shares issued at $0.10 per share )
|
|
|
15,000
|
|
|
1
|
|
|
1,499
|
|
|
-
|
|
|
|
|
|
1,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Loss
|
|
|
-
|
|
|
-
|
|
|
|
|
|
(86,005
|
)
|
|
|
|
|
(86,005
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance
at June 30, 2006
|
|
|
118,090,000
|
|
$
|
11,809
|
|
$
|
395,441
|
|
$
|
(86,005
|
)
|
$
|
(250
|
)
|
$
|
320,995
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The
accompanying notes are an integral part of these
financial statements
BIOSOLAR,
INC.
(A
Development Stage Company)
STATEMENT
OF CASH FLOWS
JUNE
30, 2006
|
|
|
|
|
|
From
Inception
|
|
|
|
April
25, 2006
|
|
|
|
through
|
|
|
|
June
30, 2006
|
|
CASH
FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
Net
loss
|
|
$
|
(86,005
|
)
|
Adjustment
to reconcile net loss to net cash
|
|
|
|
|
used
in operating activities
|
|
|
|
|
(Increase)
Decrease in:
|
|
|
|
|
Prepaid
expenses
|
|
|
(1,176
|
)
|
Deposits
|
|
|
(770
|
)
|
Increase
(Decrease) in:
|
|
|
|
|
Accrued
Expenses
|
|
|
1,150
|
|
|
|
|
|
|
NET
CASH USED IN OPERATING ACTIVITIES
|
|
|
(86,801
|
)
|
|
|
|
|
|
|
|
|
|
|
CASH
FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
Proceeds
from issuance of common stock
|
|
|
407,000
|
|
|
|
|
|
|
NET
CASH PROVIDED BY FINANCING ACTIVITIES
|
|
|
407,000
|
|
|
|
|
|
|
NET
INCREASE IN CASH
|
|
|
320,199
|
|
|
|
|
|
|
CASH,
BEGINNING OF YEAR
|
|
|
-
|
|
|
|
|
|
|
CASH,
END OF YEAR
|
|
$
|
320,199
|
|
|
|
|
|
|
SUPPLEMENTAL
DISCLOSURES OF CASH FLOW INFORMATION
|
|
|
|
|
Interest
paid
|
|
$
|
-
|
|
|
|
|
|
|
The
accompanying notes are an integral part of these
financial statements
BIOSOLAR,
INC.
(A
Development Stage
Company)
NOTES
TO AUDITED FINANCIAL STATEMENTS
JUNE
30, 2006
1.
|
ORGANIZATION
AND LINE OF BUSINESS
|
Organization
BioSolar,
Inc. (the "Company") was incorporated in the state of Nevada on April 24, 2006.
The Company, based in Santa Clarita, California, began operations on April
25,
2006 to develop and market a solar cell technology.
Line
of Business
The
Company is currently in the stage of developing a thin film/flexible
photovoltaics, which are solar cells produced on bio-based plastic substrates.
The photovoltaics can be marketed in sectors, such as building materials,
outdoor power, emergency power, mobile computers and
communications.
2.
|
SUMMARY
OF SIGNIFICANT ACCOUNTING POLICIES
|
This
summary of significant accounting policies of BioSolar, Inc. is presented to
assist in understanding the Company’s financial statements. The financial
statements and notes are representations of the Company’s management, which is
responsible for their integrity and objectivity. These accounting policies
conform to accounting principles generally accepted in the United States of
America and have been consistently applied in the preparation of the financial
statements.
Going
Concern
The
accompanying financial statements have been prepared on a going concern basis
of
accounting, which contemplates continuity of operations, realization of assets
and liabilities and commitments in the normal course of business. The
accompanying financial statements do not reflect any adjustments that might
result if the Company is unable to continue as a going concern. The Company
does
not generate significant revenue, and has negative cash flows from operations,
which raise substantial doubt about the Company’s ability to continue as a going
concern. The ability of the Company to continue as a going concern and
appropriateness of using the going concern basis is dependent upon, among other
things, additional cash infusion. The Company has obtained funds from its
shareholders since its’ inception through June 2006. Management believes this
funding will continue, and has also obtained funding from new investors.
Management believes the existing shareholders and the prospective new investors
will provide the additional cash needed to meet the Company’s obligations as
they become due, and will allow the development of its core of
business.
Development
Stage Activities and Operations
The
Company has been in its initial stages of formation and for the three months
ended June 30, 2006, had insignificant revenues. FASB #7 defines a development
stage activity as one in which all efforts are devoted substantially to
establishing a new business and even if planned principal operations have
commenced, revenues are insignificant.
Revenue
Recognition
The
Company will recognize revenue when services are performed, and at the time
of
shipment of products, provided that evidence of an arrangement exists, title
and
risk of loss have passed to the customer, fees are fixed or determinable, and
collection of the related receivable is reasonably assured. To date, the Company
has had no revenues and is in the development stage.
2.
|
SUMMARY
OF SIGNIFICANT ACCOUNTING POLICIES
(Continued)
|
Cash
and Cash Equivalent
The
Company considers all highly liquid investments with an original maturity of
three months or less to be cash equivalents.
Loss
per Share Calculations
The
Company adopted Statement of Financial Standards (“SFAS”) No. 128 for the
calculation of “Loss per Share”. SFAS No. 128 dictates the calculation of basic
earnings per share and diluted earnings per share. Basic earnings per share
is
computed by dividing income available to common shareholders by the
weighted-average number of common shares available. Diluted earnings per share
is computed similar to basic earnings per share except that the denominator
is
increased to include the number of additional common shares that would have
been
outstanding if the potential common shares had been issued and if the additional
common shares were dilutive. The Company’s diluted loss per share is the same as
the basic loss per share for the three months ended June 30, 2006 as the
inclusion of any potential shares would have had an anti-dilutive effect due
to
the Company generating a loss.
At
June
30, 2006, the Company’s authorized stock consists of 500,000,000 shares of
common stock, par value $0.0001 per share. During the three months ended June
30, 2006, the Company issued 93,000,000 founders shares of common stock for
$23,250, of which 1,000,000 is a subscription receivable; 25,000,000 shares
of
common stock at a purchase price of $0.015 per share; 90,000 shares of common
stock at a purchase price of $0.10 per share pursuant to a private placement
made pursuant to Rule 506 of Regulation D promulgated under section 4(2) of
the
Securities Act of 1933, as amended.
May
15,
2006, the Company entered into a lease agreement for office space with monthly
rents of $509, which expires on November 14, 2006.
|
At
June 30, 2006, the Company had net operating loss carry-forwards
of
approximately $86,000 that may be offset against future taxable income
from the year 2006 through 2026. No tax benefit has been reported
in the
June 30, 2006 consolidated financial statements since the potential
tax
benefit is offset by a valuation allowance of the same
amount.
|
|
A
reconciliation of income tax expense that would result from applying
the
U.S. Federal and State rate of 40% to pretax income from continuing
operations for the three months ended June 30, 2006, with federal
income
tax expense presented in the financial statements is as
follows:
|
|
|
2006
|
|
Income
tax benefit computed at U.S. Federal
|
|
|
|
statutory
rate of 34%
|
|
$
|
(29,240
|
)
|
State
Income taxes, net of benefit of federal taxes
|
|
|
(5,160
|
)
|
Valuation
Allowance
|
|
|
34,400
|
|
Income
tax expense
|
|
$
|
-
|
|
5.
|
DEFERRED
TAX BENEFIT (continued)
|
|
Deferred
taxes are provided on a liability method whereby deferred tax assets
are
recognized for deductible differences and operating loss and tax
credit
carry-forwards and deferred tax liabilities are recognized for taxable
temporary differences. Temporary differences are the difference between
the reported amounts of assets and liabilities and their tax bases.
Deferred tax assets are reduced by a valuation allowance when, in
the
opinion of management, it is more likely than not that some portion
or all
of the deferred tax assets will not be realized. Deferred tax assets
and
liabilities are adjusted for the effects of changes in tax laws and
rates
on the date of enactment.
|
The
items
as of June 30, 2006, which comprise a significant portion of deferred tax assets
and liabilities are approximately as follows:
|
|
2006
|
|
Deferred
tax assets:
|
|
|
|
NOL
Carryover
|
|
$
|
34,400
|
|
Deferred
tax liabilites:
|
|
|
|
|
Depreciation
|
|
|
-
|
|
Less
Valuation Allowance
|
|
|
(34,400
|
)
|
Net
deferred tax asset
|
|
$
|
-
|
|
|
Due
to the change in ownership provisions of the Tax Reform Act of 1986,
net
operating loss carry-forwards for Federal income tax reporting purposes
are subject to annual limitations. Should a change in ownership occur,
net
operating loss carryforwards may be limited as to use in future
years.
|
On
or
about July 21, 2006, the Company commenced a private placement of up to fifteen
million (15,000,000) shares of its common stock (the “Shares”) at a price of ten
cents ($0.10) per Share. The private placement, which was made in reliance
upon
an exemption from registration under Rule 506 of Regulation D promulgated under
Section 4(2) of the Securities Act of 1933.
BIOSOLAR,
INC.
(A
Development Stage Company)
BALANCE
SHEET
SEPTEMBER
30, 2006
(Unaudited)
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
CURRENT
ASSETS
|
|
|
|
Cash
& Cash Equivalents
|
|
$
|
255,950
|
|
Certificates
of Deposits
|
|
|
1,003,270
|
|
Prepaid
Expenses
|
|
|
972
|
|
|
|
|
|
|
Total
Current Assets
|
|
|
1,260,192
|
|
|
|
|
|
|
OTHER
ASSETS
|
|
|
|
|
Deposit
|
|
|
770
|
|
|
|
|
|
|
TOTAL
ASSETS
|
|
$
|
1,260,962
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES
AND SHAREHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
|
TOTAL
CURRENT LIABILITIES
|
|
|
|
|
Accounts
Payable
|
|
|
5,058
|
|
|
|
|
|
|
|
|
|
|
|
SHAREHOLDERS'
EQUITY EQUITY
|
|
|
|
|
Common
Stock, $0.0001 par value;
|
|
|
|
|
500,000,000
authorized common shares
|
|
|
|
|
128,107,777
shares issued and outstanding
|
|
|
12,811
|
|
Additional
Paid in Capital
|
|
|
1,396,217
|
|
Deficit
Accumulated during the Development Stage
|
|
|
(153,124
|
)
|
|
|
|
|
|
TOTAL
SHAREHOLDERS' EQUITY
|
|
|
1,255,904
|
|
|
|
|
|
|
TOTAL
LIABILITIES AND SHAREHOLDERS' EQUITY
|
|
$
|
1,260,962
|
|
|
|
|
|
|
The
accompanying notes are an integral part of these financial
statements
BIOSOLAR,
INC.
(A
Development Stage Company)
STATEMENTS
OF OPERATIONS
SEPTEMBER
30, 2006
(Unaudited)
|
|
|
|
From
Inception
|
|
|
|
|
|
April
25, 2006
|
|
|
|
Quarter
Ended
|
|
through
|
|
|
|
September
30, 2006
|
|
September
30, 2006
|
|
|
|
|
|
|
|
REVENUE
|
|
|
-
|
|
|
-
|
|
|
|
|
|
|
|
|
|
OPERATING
EXPENSES
|
|
|
|
|
|
|
|
Salaries
|
|
|
36,000
|
|
|
48,000
|
|
Professional
fees
|
|
|
12,362
|
|
|
72,462
|
|
Rent
|
|
|
1,485
|
|
|
2,475
|
|
Payroll
taxes
|
|
|
2,754
|
|
|
3,966
|
|
Office
expense
|
|
|
583
|
|
|
1,124
|
|
Advertising
|
|
|
-
|
|
|
500
|
|
Insurance
|
|
|
204
|
|
|
204
|
|
Marketing
expenses
|
|
|
13,300
|
|
|
13,300
|
|
Printing
& Production expense
|
|
|
2,628
|
|
|
2,628
|
|
Professional
Development
|
|
|
1,640
|
|
|
1,640
|
|
Taxes
& Licenses
|
|
|
2,325
|
|
|
12,576
|
|
Telephone
expense
|
|
|
222
|
|
|
633
|
|
Travel
expense
|
|
|
233
|
|
|
233
|
|
|
|
|
|
|
|
|
|
TOTAL
OPERATING EXPENSES
|
|
|
73,736
|
|
|
159,741
|
|
|
|
|
|
|
|
|
|
LOSS
FROM OPERATIONS BEFORE OTHER INCOME
|
|
|
(73,736
|
)
|
|
(159,741
|
)
|
|
|
|
|
|
|
|
|
TOTAL
OTHER INCOME
|
|
|
|
|
|
|
|
Interest
income
|
|
|
6,617
|
|
|
6,617
|
|
|
|
|
|
|
|
|
|
NET
LOSS
|
|
$
|
(67,119
|
)
|
$
|
(153,124
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BASIC
AND DILUTED LOSS PER SHARE
|
|
$
|
(0.00
|
)
|
|
|
|
|
|
|
|
|
|
|
|
WEIGHTED-AVERAGE
COMMON SHARES OUTSTANDING
|
|
|
|
|
|
|
|
BASIC
AND DILUTED
|
|
|
124,377,379
|
|
|
|
|
|
|
|
|
|
|
|
|
The
accompanying notes are an integral part of these financial
statements
BIOSOLAR,
INC.
(A
Development Stage Company)
STATEMENTS
OF SHAREHOLDERS' EQUITY
(Unaudited)
|
|
|
|
|
|
|
|
Deficit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
during
the
|
|
|
|
|
|
|
|
Common
stock
|
|
Paid-in
|
|
Development
|
|
Subscription
|
|
|
|
|
|
Shares
|
|
Amount
|
|
Capital
|
|
Stage
|
|
Receivable
|
|
Total
|
|
Issuance
of common stock in April 2006 for services
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,000
common shares issued at $0.001 per share )
|
|
|
1,000
|
|
$
|
1
|
|
$
|
-
|
|
$
|
-
|
|
$
|
-
|
|
$
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of founders shares in May 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(29,999,000
common shares issued at $0.00025 per share )
|
|
|
29,999,000
|
|
|
2,999
|
|
|
4,500
|
|
|
-
|
|
|
|
|
|
7,499
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of founders shares in May 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(20,000,000
common shares issued at $0.00025 per share )
|
|
|
20,000,000
|
|
|
2,000
|
|
|
3,000
|
|
|
-
|
|
|
|
|
|
5,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of founders shares in May 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(9,000,000
common shares issued at $0.00025 per share )
|
|
|
9,000,000
|
|
|
900
|
|
|
1,350
|
|
|
-
|
|
|
(250
|
)
|
|
2,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common stock in May 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(25,000,000
common shares issued at $0.015 per share )
|
|
|
25,000,000
|
|
|
2,500
|
|
|
372,500
|
|
|
-
|
|
|
|
|
|
375,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of founders shares in June 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(34,000,000
common shares issued at $0.00025 per share )
|
|
|
34,000,000
|
|
|
3,400
|
|
|
5,100
|
|
|
-
|
|
|
|
|
|
8,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common shares in June 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(90,000
common shares issued at $0.10 per share )
|
|
|
90,000
|
|
|
9
|
|
|
8,991
|
|
|
-
|
|
|
|
|
|
9,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Loss for the period ended June 30, 2006
|
|
|
-
|
|
|
-
|
|
|
|
|
|
(86,005
|
)
|
|
|
|
|
(86,005
|
)
|
Balance
at June 30, 2006
|
|
|
118,090,000
|
|
|
11,809
|
|
|
395,441
|
|
|
(86,005
|
)
|
|
(250
|
)
|
|
320,995
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stocks
subscribed
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
250
|
|
|
250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common shares in July 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5,760,000
common shares issued at $0.10 per share ) (unaudited)
|
|
|
5,760,000
|
|
|
576
|
|
|
575,424
|
|
|
-
|
|
|
-
|
|
|
576,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common shares in August 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,807,777
common shares issued at $0.10 per share ) (unaudited)
|
|
|
2,807,777
|
|
|
281
|
|
|
280,497
|
|
|
-
|
|
|
-
|
|
|
280,778
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common shares in September 2006 for cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,450,000
common shares issued at $0.10 per share ) (unaudited)
|
|
|
1,450,000
|
|
|
145
|
|
|
144,855
|
|
|
-
|
|
|
-
|
|
|
145,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Loss for the period ended September 30, 2006 (unaudited)
|
|
|
-
|
|
|
-
|
|
|
|
|
|
(67,119
|
)
|
|
|
|
|
(67,119
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance
at September 30, 2006
|
|
|
128,107,777
|
|
$
|
12,811
|
|
$
|
1,396,217
|
|
$
|
(153,124
|
)
|
$
|
-
|
|
$
|
1,255,904
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The
accompanying notes are an integral part of these financial
statements
BIOSOLAR,
INC.
(A
Development Stage Company)
STATEMENTS
OF CASH FLOWS
SEPTEMBER
30, 2006
(Unaudited)
|
|
|
|
|
|
|
|
|
|
From
Inception
|
|
|
|
|
|
April
25, 2006
|
|
|
|
Quarter
Ended
|
|
through
|
|
|
|
September
30, 2006
|
|
September
30, 2006
|
|
CASH
FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
|
Net
loss
|
|
$
|
(67,119
|
)
|
$
|
(153,124
|
)
|
Adjustment
to reconcile net loss to net cash
|
|
|
|
|
|
|
|
used
in operating activities
|
|
|
|
|
|
|
|
(Increase)
Decrease in:
|
|
|
|
|
|
|
|
Prepaid
expenses
|
|
|
204
|
|
|
(972
|
)
|
Deposits
|
|
|
-
|
|
|
(770
|
)
|
Increase
(Decrease) in:
|
|
|
|
|
|
|
|
Accounts
Payable
|
|
|
3,908
|
|
|
5,058
|
|
|
|
|
|
|
|
|
|
NET
CASH USED IN OPERATING ACTIVITIES
|
|
|
(63,007
|
)
|
|
(149,808
|
)
|
|
|
|
|
|
|
|
|
NET
CASH FLOWS USED IN INVESTING ACTIVITIES:
|
|
|
|
|
|
|
|
Investment
in Certificate of Deposits
|
|
|
(1,003,270
|
)
|
|
(1,003,270
|
)
|
|
|
|
|
|
|
|
|
NET
CASH USED BY INVESTING ACTIVITIES
|
|
|
(1,003,270
|
)
|
|
(1,003,270
|
)
|
|
|
|
|
|
|
|
|
NET
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
|
|
Proceeds
from issuance of common stock
|
|
|
1,002,028
|
|
|
1,409,028
|
|
|
|
|
|
|
|
|
|
NET
CASH PROVIDED BY FINANCING ACTIVITIES
|
|
|
1,002,028
|
|
|
1,409,028
|
|
|
|
|
|
|
|
|
|
NET
INCREASE IN CASH
|
|
|
(64,249
|
)
|
|
255,950
|
|
|
|
|
|
|
|
|
|
CASH
AND CASE EQUIVALENTS, BEGINNING OF PERIOD
|
|
|
320,199
|
|
|
-
|
|
|
|
|
|
|
|
|
|
CASH
AND CASH EQUIVALENTS, END OF PERIOD
|
|
$
|
255,950
|
|
$
|
255,950
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL
DISCLOSURES OF CASH FLOW INFORMATION
|
|
|
|
|
|
|
|
Interest
paid
|
|
$
|
-
|
|
$
|
-
|
|
Taxes
paid
|
|
$
|
-
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
The
accompanying notes are an integral part of these
financial statements
BIOSOLAR,
INC.
(A
Development Stage
Company)
NOTES
TO UNAUDITED FINANCIAL STATEMENTS
SEPTEMBER
30, 2006
1.
|
ORGANIZATION
AND LINE OF BUSINESS
|
Organization
BioSolar,
Inc. (the "Company") was incorporated in the state of Nevada on April 24, 2006.
The Company, based in Santa Clarita, California, began operations on April
25,
2006 to develop and market a solar cell technology.
The
accompanying interim unaudited condensed financial statements have been prepared
in accordance with accounting principles generally accepted in the United States
for interim financial information and pursuant to the rules and regulations
of
the Securities and Exchange Commission. Accordingly, they do not include all
of
the information and footnotes required by accounting principles generally
accepted in the United States for complete financial statements. In the opinion
of management, all adjustments (consisting of normal recurring accruals)
considered necessary for a fair presentation have been included. Operating
results for the period ended September 30, 2006 are not necessarily indicative
of the results that may be expected for the year ending March 31, 2007. For
further information, refer to the audited financial statements for the period
ended June 30, 2006 and the notes thereto included in the Company’s
Report.
Line
of Business
The
Company is currently in the stage of developing a thin film/flexible
photovoltaics, which are solar cells produced on bio-based plastic substrates.
The photovoltaics can be marketed in sectors, such as building materials,
outdoor power, emergency power, mobile computers and
communications.
2.
|
SUMMARY
OF SIGNIFICANT ACCOUNTING POLICIES
|
This
summary of significant accounting policies of BioSolar, Inc. is presented to
assist in understanding the Company’s financial statements. The financial
statements and notes are representations of the Company’s management, which is
responsible for their integrity and objectivity. These accounting policies
conform to accounting principles generally accepted in the United States of
America and have been consistently applied in the preparation of the financial
statements.
Going
Concern
The
accompanying financial statements have been prepared on a going concern basis
of
accounting, which contemplates continuity of operations, realization of assets
and liabilities and commitments in the normal course of business. The
accompanying financial statements do not reflect any adjustments that might
result if the Company is unable to continue as a going concern. The Company
does
not generate significant revenue, and has negative cash flows from operations,
which raise substantial doubt about the Company’s ability to continue as a going
concern. The ability of the Company to continue as a going concern and
appropriateness of using the going concern basis is dependent upon, among other
things, additional cash infusion. The Company has obtained funds from its
shareholders since its’ inception through September 2006. Management believes
this funding will continue, and has also obtained funding from new investors.
Management believes the existing shareholders and the prospective new investors
will provide the additional cash needed to meet the Company’s obligations as
they become due, and will allow the development of its core of
business.
2.
|
SUMMARY
OF SIGNIFICANT ACCOUNTING POLICIES
(Continued)
|
Development
Stage Activities and Operations
The
Company has been in its initial stages of formation and for the period ended
September 30, 2006, had insignificant revenues. FASB #7 defines a development
stage activity as one in which all efforts are devoted substantially to
establishing a new business and even if planned principal operations have
commenced, revenues are insignificant.
Revenue
Recognition
The
Company will recognize revenue when services are performed, and at the time
of
shipment of products, provided that evidence of an arrangement exists, title
and
risk of loss have passed to the customer, fees are fixed or determinable, and
collection of the related receivable is reasonably assured. To date, the Company
has had no revenues and is in the development stage.
Cash
and Cash Equivalent
The
Company considers all highly liquid investments with an original maturity of
three months or less to be cash equivalents.
Investments
Certificate
of Deposits with banking institutions are short-term investments with initial
maturities of more than 90 days. The carrying amount of these investments is
a
reasonable estimate of fair value due to their short-term nature.
Loss
per Share Calculations
The
Company adopted Statement of Financial Standards (“SFAS”) No. 128 for the
calculation of “Loss per Share”. SFAS No. 128 dictates the calculation of basic
earnings per share and diluted earnings per share. Basic earnings per share
is
computed by dividing income available to common shareholders by the
weighted-average number of common shares available. Diluted earnings per share
is computed similar to basic earnings per share except that the denominator
is
increased to include the number of additional common shares that would have
been
outstanding if the potential common shares had been issued and if the additional
common shares were dilutive. The Company’s diluted loss per share is the same as
the basic loss per share for the period ended September 30, 2006 as the
inclusion of any potential shares would have had an anti-dilutive effect due
to
the Company generating a loss.
During
the period ended September 30, 2006, the Company’s issued 10,017,777 shares of
common stock at a purchase price of $0.10 per share pursuant to a private
placement made pursuant to Rule 506 of Regulation D promulgated under section
4(2) of the Securities Act of 1933, as amended; the Company received the
subscription receivable of $250.
During
the month of October 2006, the Company issued 300,000 shares of common stock
at
a purchase price of $0.10 per share pursuant to a private placement.
YOU
SHOULD RELY ONLY ON THE INFORMATION CONTAINED IN THIS PROSPECTUS. WE HAVE
NOT
AUTHORIZED ANYONE TO PROVIDE YOU WITH INFORMATION DIFFERENT FROM THE INFORMATION
CONTAINED IN THIS PROSPECTUS. THIS DOCUMENT MAY ONLY BE USED WHERE IT IS
LEGAL
TO SELL THE SECURITIES. THE INFORMATION IN THIS DOCUMENT MAY ONLY BE ACCURATE
ON
THE DATE OF THIS DOCUMENT.
|
|
|
UP
TO 26,500,000 SHARES
|
|
|
|
OF
OUR
|
|
|
|
OF
COMMON STOCK
|
TABLE
OF CONTENTS
|
|
|
|
|
Page
|
|
|
Cautionary
Note Regarding Forward-Looking Statements
|
6
|
|
|
|
Prospectus
Summary
|
7
|
|
|
|
Risk
Factors
|
11
|
|
|
|
Use
of Proceeds
|
16
|
|
|
Biosolar,
Inc.
|
Management's
Discussion And Analysis and Results of
|
|
|
|
Operations
|
17
|
|
|
|
Business
|
22
|
|
|
|
Description
of Property
|
25
|
|
|
|
Legal
Proceedings
|
25
|
|
|
|
Management
|
26
|
|
|
|
Executive
Compensation
|
27
|
|
|
|
Certain
Relationships And Related Transactions
|
29
|
|
|
|
Security
Ownership Of Certain Beneficial Owners
|
|
|
|
And
Management
|
29
|
|
|
PROSPECTUS
|
Description
of Securities
|
30
|
|
|
|
Indemnification
for Securities Act Liabilities
|
30
|
|
|
|
Plan
of Distribution
|
31
|
|
|
|
Selling
Stockholders
|
32
|
|
|
|
Legal
Matters
|
36
|
|
|
|
Experts
|
36
|
|
|
|
Available
Information
|
37
|
|
|
|
Index
To Financial Statements
|
F-1
|
|
|
November
22, 2006
|
PART
II
INFORMATION
NOT REQUIRED IN PROSPECTUS
ITEM
24. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
Under
the
Nevada General Corporation Law and our Articles of Incorporation, as amended,
and our Bylaws, our directors will have no personal liability to us or our
stockholders for monetary damages incurred as the result of the breach or
alleged breach by a director of his "duty of care." This provision does not
apply to the directors' (i) acts or omissions that involve intentional
misconduct or a knowing and culpable violation of law, (ii) acts or omissions
that a director believes to be contrary to the best interests of the corporation
or its stockholders or that involve the absence of good faith on the part of
the
director, (iii) approval of any transaction from which a director derives an
improper personal benefit, (iv) acts or omissions that show a reckless disregard
for the director's duty to the corporation or its stockholders in circumstances
in which the director was aware, or should have been aware, in the ordinary
course of performing a director's duties, of a risk of serious injury to the
corporation or its stockholders, (v) acts or omissions that constituted an
unexcused pattern of inattention that amounts to an abdication of the director's
duty to the corporation or its stockholders, or (vi) approval of an unlawful
dividend, distribution, stock repurchase or redemption. This provision would
generally absolve directors of personal liability for negligence in the
performance of duties, including gross negligence.
The
effect of this provision in our Articles of Incorporation and Bylaws is to
eliminate the rights of our Company and our stockholders (through stockholder's
derivative suits on behalf of our Company) to recover monetary damages against
a
director for breach of his fiduciary duty of care as a director (including
breaches resulting from negligent or grossly negligent behavior) except in
the
situations described in clauses (i) through (vi) above. This provision does
not
limit nor eliminate the rights of our Company or any stockholder to seek
non-monetary relief such as an injunction or rescission in the event of a breach
of a director's duty of care. In addition, our Bylaws provide that if the Nevada
General Corporation Law is amended to authorize the future elimination or
limitation of the liability of a director, then the liability of the directors
will be eliminated or limited to the fullest extent permitted by the law, as
amended. The Nevada General Corporation Law grants corporations the right to
indemnify their directors, officers, employees and agents in accordance with
applicable law.
Insofar
as indemnification for liabilities arising under the Securities Act of 1933
(the
"Act" or "Securities Act") may be permitted to directors, officers or persons
controlling our Company pursuant to the foregoing provisions, or otherwise,
we
have been advised that in the opinion of the Securities and Exchange Commission,
such indemnification is against public policy as expressed in the Act and is,
therefore, unenforceable.
ITEM
25. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.
The
following table sets forth an itemization of all estimated expenses, all of
which we will pay, in connection with the issuance and distribution of the
securities being registered:
NATURE
OF EXPENSE AMOUNT
SEC
Registration fee
|
|
$
|
283.55
|
|
Accounting
fees and expenses
|
|
|
20,000.00
|
*
|
Legal
fees and expenses
|
|
|
25,000.00
|
*
|
Miscellaneous
|
|
|
716.45
|
*
|
TOTAL
|
|
$
|
46,000
|
*
|
ITEM
26. RECENT SALES OF UNREGISTERED SECURITIES.
Following
is a summary of unregistered securities issued from inception (April 24, 2006)
through November 2006.
On
May
19, 2006, we issued an aggregate of 93,000,000 shares of our common stock,
par
value $.0001 per share, to the founders of our company, including our Chief
Executive Officer, for an aggregate purchase price of $23,250.
In
May
2006, we entered into Subscription Agreements with several accredited investors
pursuant to which the investors subscribed to purchase an aggregate amount
of up
to $375,000 in shares of our common stock, or a total of 25,000,000 shares.
In
July
2006, we entered into Subscription Agreements with several accredited investors
pursuant to which the investors subscribed to purchase an aggregate amount
of up
to $150,000 in shares of our common stock, or a total of 1,500,000
shares.
In
October 2006, we entered into Subscription Agreements with several accredited
investors pursuant to which the investors subscribed to purchase an aggregate
amount of up to approximately $905,777 in shares of our common stock, or a
total
of 9,057,777 shares.
*
All of
the above offerings and sales were deemed to be exempt under rule 506 of
Regulation D and Section 4(2) of the Securities Act of 1933, as amended. No
advertising or general solicitation was employed in offering the securities.
The
offerings and sales were made to a limited number of persons, all of whom were
accredited investors, business associates of Biosolar, Inc. or executive
officers of Biosolar, Inc., and transfer was restricted by Biosolar, Inc. in
accordance with the requirements of the Securities Act of 1933. In addition
to
representations by the above-referenced persons, we have made independent
determinations that all of the above-referenced persons were accredited or
sophisticated investors, and that they were capable of analyzing the merits
and
risks of their investment, and that they understood the speculative nature
of
their investment. Furthermore, all of the above-referenced persons were provided
with access to our Securities and Exchange Commission filings.
ITEM
27. EXHIBITS.
The
following exhibits are included as part of this Form SB-2.
Exhibit
No.
|
Description
|
|
|
3.1
|
Articles
of Incorporation of Biosolar Labs, Inc. filed
with
|
|
the
Nevada Secretary of State on April 24, 2006.*
|
|
|
|
Articles
of Amendment of Articles of Incorporation of Biosolar
Labs,
|
|
Inc.
filed with the Nevada Secretary of State on May 25,
2006.*
|
|
|
|
Articles
of Amendment of Articles of Incorporation of Biosolar Labs, Inc.
|
|
filed
with the Nevada Secretary of State on June 8, 2006.*
|
|
|
3.4
|
Bylaws
of Biosolar, Inc.*
|
MATERIAL
CONTRACTS
5.1
|
Opinion
of Sichenzia Ross Friedman Ference LLP.*
|
10.1
|
Form
of Subscription Agreement dated as of May 26, 2006.*
|
10.2
|
Form
of Subscription Agreement dated as of July 17, 2006.*
|
10.3
|
Form
of Subscription Agreement dated as of October 11,
2006.*
|
23.1
|
Consent
of Sichenzia Ross Friedman Ference LLP (included in Exhibit
5.1).*
|
23.2
|
Consent
of HJ Associates & Consultants,
LLP
|
*Filed
herewith.
ITEM
28. UNDERTAKINGS.
The
undersigned registrant hereby undertakes to:
(1)
File,
during any period in which offers or sales are being made, a post-effective
amendment to this registration statement to:
(i)
Include any prospectus required by Section 10(a)(3) of the Securities Act of
1933, as amended (the "Securities Act");
(ii)
Reflect in the prospectus any facts or events which, individually or together,
represent a fundamental change in the information in the registration statement.
Notwithstanding the foregoing, any increase or decrease in volume of securities
offered (if the total dollar value of the securities offered would not exceed
that which was registered) and any deviation from the low or high end of the
estimated maximum offering range may be reflected in the form of a prospectus
filed with the Commission pursuant to Rule 424(b) under the Securities Act
if,
in the aggregate, the changes in volume and price represent no more than a
20%
change in the maximum aggregate offering price set forth in the "Calculation
of
Registration Fee" table in the effective registration statement,
and
(iii)
Include any additional or changed material information on the plan of
distribution.
(2)
For
determining liability under the Securities Act, treat each post-effective
amendment as a new registration statement of the securities offered, and the
offering of the securities at that time to be the initial bona fide
offering.
(3)
File
a post-effective amendment to remove from registration any of the securities
that remain unsold at the end of the offering.
(4)
For
determining liability of the undersigned small business issuer under the
Securities Act to any purchaser in the initial distribution of the securities,
the undersigned undertakes that in a primary offering of securities of the
undersigned small business issuer pursuant to this registration statement,
regardless of the underwriting method used to sell the securities to the
purchaser, if the securities are offered or sold to such purchaser by means
of
any of the following communications, the undersigned small business issuer
will
be a seller to the purchaser and will be considered to offer or sell such
securities to such purchaser:
(i)
Any
preliminary prospectus or prospectus of the undersigned small business issuer
relating to the offering required to be filed pursuant to Rule 424;
(ii)
Any
free writing prospectus relating to the offering prepared by or on behalf of
the
undersigned small business issuer or used or referred to by the undersigned
small business issuer;
(iii)
The
portion of any other free writing prospectus relating to the offering containing
material information about the undersigned small business issuer or its
securities provided by or on behalf of the undersigned small business issuer;
and
(iv)
Any
other communication that is an offer in the offering made by the undersigned
small business issuer to the purchaser.
Insofar
as indemnification for liabilities arising under the Securities Act may be
permitted to directors, officers and controlling persons of the registrant
pursuant to the foregoing provisions, or otherwise, the registrant has been
advised that in the opinion of the Securities and Exchange Commission such
indemnification is against public policy as expressed in the Securities Act
and
is, therefore, unenforceable.
In
the
event that a claim for indemnification against such liabilities (other than
the
payment by the registrant of expenses incurred or paid by a director, officer
or
controlling person of the registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person
in connection with the securities being registered, the registrant will, unless
in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the
Securities Act and will be governed by the final adjudication of such
issue.
Each
prospectus filed pursuant to Rule 424(b) as part of a registration statement
relating to an offering, other than registration statements relying on Rule
430B
or other than prospectuses filed in reliance on Rule 430A, shall be deemed
to be
part of and included in the registration statement as of the date it is first
used after effectiveness. Provided, however, that no statement made in a
registration statement or prospectus that is part of the registration statement
or made in a document incorporated or deemed incorporated by reference into
the
registration statement or prospectus that is part of the registration statement
will, as to a purchaser with a time of contract of sale prior to such first
use,
supersede or modify any statement that was made in the registration statement
or
prospectus that was part of the registration statement or made in any such
document immediately prior to such date of first use.
SIGNATURES
In
accordance with the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form SB-2 and authorized this Registration Statement
to be signed on its behalf by the undersigned, thereunto duly authorized, in
the
City of Santa Clarita, State of California, on November 22, 2006.
|
|
|
|
BIOSOLAR,
INC.
|
|
|
|
|
By:
|
/s/ DAVID
LEE
|
|
DAVID
LEE
|
|
CHIEF
EXECUTIVE OFFICER (PRINCIPAL EXECUTIVE OFFICER) AND ACTING CHIEF
FINANCIAL
OFFICER (PRINCIPAL ACCOUNTING AND FINANCIAL
OFFICER)
|
In
accordance with the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on the dates stated.
SIGNATURE
|
TITLE
|
DATE
|
|
|
|
|
/S/
DAVID LEE
|
|
CHIEF
EXECUTIVE OFFICER
|
NOVEMBER
22, 2006
|
|
(PRINCIPAL
EXECUTIVE OFFICER),
|
|
|
ACTING
CHIEF FINANCIAL OFFICER
|
|
|
(PRINCIPAL
ACCOUNTING AND
|
|
|
FINANCIAL
OFFICER) AND
|
|
|
CHAIRMAN
OF THE BOARD
|
|
/S/
STEVEN C. BARTLING
|
|
DIRECTOR
|
NOVEMBER
22, 2006
|
|
|
|
|
|
|
/S/
DENNIS LEPON
|
|
DIRECTOR
|
NOVEMBER
22, 2006
|
|
|
|
|
|
|
EXHIBIT
5.1
SICHENZIA
ROSS FRIEDMAN FERENCE LLP
1065
Avenue of the Americas, 21st Flr.
New
York,
NY 10018
Telephone:
(212) 930-9700
Facsimile:
(212) 930-9725
November
22, 2006
VIA
ELECTRONIC TRANSMISSION
Securities
and Exchange Commission
100
F
Street, N.E.
Washington,
DC 20549
RE:
BIOSOLAR, INC.
FORM
SB-2 REGISTRATION STATEMENT (FILE NO. 333-)
Ladies
and Gentlemen:
We
refer
to the above-captioned registration statement on Form SB-2 (the "Registration
Statement") under the Securities Act of 1933, as amended (the "Act"), filed
by
Biosolar, Inc., a Nevada corporation (the "Company"), with the Securities and
Exchange Commission.
We
have
examined the originals, photocopies, certified copies or other evidence of
such
records of the Company, certificates of officers of the Company and public
officials, and other documents as we have deemed relevant and necessary as
a
basis for the opinion hereinafter expressed. In such examination, we have
assumed the genuineness of all signatures, the authenticity of all documents
submitted to us as certified copies or photocopies and the authenticity of
the
originals of such latter documents.
Based
on
our examination mentioned above, we are of the opinion that the securities
being
sold pursuant to the Registration Statement are duly authorized and will be,
when issued in the manner described in the Registration Statement, legally
and
validly issued, fully paid and non-assessable.
We
hereby
consent to the filing of this opinion as Exhibit 5.1 to the Registration
Statement and to the reference to our firm under "Legal Matters" in the related
Prospectus. In giving the foregoing consent, we do not hereby admit that we
are
in the category of persons whose consent is required under Section 7 of the
Act,
or the rules and regulations of the Securities and Exchange
Commission.
/S/
SICHENZIA ROSS FRIEDMAN FERENCE LLP
|
|
|
Sichenzia
Ross Friedman Ference LLP
|
|
|
|
|
|
INVESTOR
FINANCIAL QUESTIONNAIRE
Before
you make an investment, you must complete this questionnaire. Please check
the
appropriate box below and sign this questionnaire before a notary. We require
that this be returned with your Subscription Agreement for your purchase of
shares of common stock (the “
Common
Stock
”),
of
BioSolar Labs, Inc. (the “
Company
”).
Information will be held in strict confidence and used solely to ensure that
all
prospective investors are qualified under the relevant sections of the
Securities Act of 1933.
[
]
I
am a
natural person who has had individual income of more than US$200,000 in each
of
the most recent two years, or joint income with my spouse in excess of
US$300,000 in each of the most recent two years and reasonably expect to reach
that same income level for the current year (“income” for purposes hereof should
be computed as follows: individual adjusted gross income as reported, or to
be
reported, on a federal income tax return, increased by (i) any deduction of
long-term capital gains under section 1202 of the Internal Code of 1936 (the
“Code”), (ii) any deduction or depletion under Section 611 et. seq. of the Code,
(iii) any exclusion for interest under Section 103 of the Code and (iv) any
losses of a partnership as reported in Schedule E of Form 1040;
[
]
The
Subscriber is a natural person whose individual net worth (i.e. total assets
in
excess of total liabilities), or joint net worth with my spouse, will at the
time of purchase of the Common Shares be in excess of $1,000,000;
[
]
The
Subscriber is an investor satisfying the requirements of Section 501(a)(1)(2)
or
(3) of Regulation D promulgated under the Securities Act of 1933, which
includes, but is not limited to, a self-directed employee benefit plan where
investment decisions are made solely by persons who are “accredited investors”
as otherwise defined in Regulation D;
[
]
The
Subscriber is a trust, which trust has total assets in excess of $5,000,000.00
which was not formed for the specific purpose of acquiring the Common Shares
offered hereby and whose purchase is directed by a sophisticated person as
described in Rule 506(b)(ii) of Regulation D and who has such knowledge and
experience in financial and business matters that he is capable of evaluating
the risks and merits of an investment in the Common Shares;
[
]
The
Subscriber is a director or executive officer of the Company;
[
]
The
Subscriber is an entity (other than a trust) in which all of the equity owners
meet the requirements of at least one of the above paragraphs; or
[
]
The
Subscriber is not a resident of the United State of America, but acknowledges
he/she meets or exceeds at least one of the minimum financial requirements
set
forth above.
I
represent that I understand the merits and the risks involved in this
offering
,
that
I
have sufficient knowledge and experience in similar programs or investments
to
evaluate the merits and risks of an investment in the Company (or that I have
retained an attorney, accountant, financial advisor or consultant as my
purchaser representative); that because of my background, employment experience,
family or financial situation or economic bargaining power, I have received
and
have had access to material and relevant information enabling me to make an
informed investment decision, and that all information I have requested has
been
furnished to me; and that I am able to bear the economic risk of loss of the
entire investment which I may make in the Company.
By,
_______________
PRINT
NAME: ________________________________________
Investor
Signature
With
a
current address of___________________________________________________
In
the
City of____________________________, State/Province of
_______________,
Country
of_______________
DATE:_________________________________________
IN
WITNESS WHEREOF, I have hereunto witnessed the signature of the above
Investor;
By,___________________________________________
_________________________
Witness
Signature
Date
BIOSOLAR
LABS, INC. SUBSCRIPTION AGREEMENT
1.
Subscription. Subject to the terms and conditions hereof,
___________________,
the
undersigned Investor ("Investor") hereby subscribes to purchase __________
shares of BioSolar Labs, Inc.’s Common Stock at a price of $___ per share,
representing a total purchase price of $____________.
2.
Private Placement. The parties acknowledge that this offering has been made
and
this Subscription Agreement has been entered into as a private placement
negotiated between the parties. The issuance is considered exempt under Section
4(2) of the Securities Act of 1933.
3.
Knowledge of Financial and Business Status of Company. Investor acknowledges
that he/she has met in person or telephonically with management immediately
prior to this investment, and that he/she understand the merits and the risks
involved in this offering.
4.
Representations and Warranties. In consideration of the sale of such Common
Stock, intending to be legally bound and intending the Company to rely
thereupon, Investor hereby represents, warrants, and covenants, to the Company
as follows:
Neither
the Company nor any person acting on behalf of the Company has offered to sell,
offered for sale or sold the Common Stock by means of general solicitation
or
general advertising. Investor has not received, paid or given, directly or
indirectly, any commission or remuneration for or because of any sale or the
solicitation of any sale of the Common Stock.
Company
represents and warrants that the shares of common stock underlying the Common
Stock are restricted under SEC Rule 144, and Investor is aware of restricted
sale provisions that make up Rule 144.
Investor
has been offered full access to all underlying documents in connection with
this
transaction as well as such other information as Investor has deemed necessary
or appropriate for a prudent and knowledgeable investor to evaluate the purchase
of the Common Stock. Investor acknowledges that the Company has made available
to Investor the opportunity to obtain additional information from, to ask
questions of, and receive satisfactory answers from the officers of the Company
concerning the terms and conditions of the private placement and to verify
the
information given. Investor is satisfied that there is no material information
concerning the condition, properties, operations and prospects of the Company
of
which Investor is unaware. In making his or her investment decision, Investor
has relied solely upon his or her independent investigation of the
investment.
Investor
is aware that an investment in the Common Stock is a highly speculative
investment that involves a substantial degree of risk. Investor warrants that
he/she has such sufficient requisite knowledge and experience in business and
financial matters that Investor is capable of evaluating the merits and risks
of
an investment in the Company. Investor understands that the Company is relying
on Investor's representations for the purposes of confirming Investor's
suitability as an investor in the Company.
Investor
is aware that the Common Stock has not been registered under the Securities
Act
of 1933 (the "Act"), and that Investor must therefore bear the economic risk
of
the investment indefinitely because the Common Stock cannot be sold unless
subsequently registered under the Act or under an available exemption from
registration. Investor agrees not to sell his/her Common Stock without
registration under the Act and applicable state securities laws unless in a
transaction exempt therefrom.
The
Common Stock for which Investor hereby subscribes are being acquired for
investment purposes, solely for Investor's own account and not on behalf of
other persons, and not with a view to or for the resale, distribution,
subdivision, or fractionalization thereof; Investor has no present plans to
enter into any contract, undertaking, agreement, or arrangement for any such
resale, distribution, subdivision, or fractionalization thereof. Investor agrees
that he or she will not sell, assign, pledge, give, transfer or otherwise
dispose of any or all of the Common Stock or any interest therein unless and
until Investor has complied with all applicable provisions of federal and state
securities laws.
Investor
has reviewed his or her financial condition and commitments. Based upon such
review, Investor is satisfied that he or she has adequate means of providing
for
his or her financial needs and possible contingencies as well as those of any
dependents, and that he or she does not have any current or foreseeable future
need for liquidity of the funds being utilized in the purchase of the Common
Stock. Investor is capable of bearing the economic risk of the investment in
the
Common Stock for the indefinite future. At this time, Investor has assets or
sources of income that, if taken together, are more than sufficient so that
Investor could bear the risk of loss of its, his or her entire investment in
the
Common Stock.
Investor
is aware that this transaction is a "private placement" and has not been
reviewed by the United States Securities and Exchange Commission or by any
state
securities authorities. No agency, federal or state, has passed upon the
fairness or merits of this investment.
Neither
this Subscription Agreement nor Investor's rights hereunder, may be assigned,
sold or transferred in any manner and this Subscription Agreement may not be
altered, amended or revoked without the prior written consent of the
Company.
Investor
is a bona fide resident as set forth next to Investor's signature, such location
is Investor's principal residence, and Investor is at least 18 years of
age.
Investor
understands and agrees that if Investor's subscription is accepted, Investor
will be required to execute such additional documents as may be necessary to
effect the issuance of the Company's Common Stock which Investor has
purchased.
The
foregoing representations, warranties and covenants are true and accurate as
of
the date hereof and shall be true and accurate as of the date of completion
of
the Private Placement. If such representations and warranties shall not be
true
and accurate in any respect prior to completion of the Private Placement,
Investor shall give written notice of such fact to the Company, specifying
which
representations and warranties are not true and accurate and the reasons
therefore.
5.
Piggy-Back Registration Rights. The Investor will be entitled to “piggy-back”
registration rights of the shares of Common Stock pursuant to this Subscription
Agreement on registration statements (other than on Form S-8, S-4 or similar
Forms) filed by the Company.
6.
Indemnification. Investor acknowledges that he understands the meaning and
legal
consequences of the representations and warranties contained herein, and
Investor hereby agrees to indemnify and hold harmless the Company, its
directors, officers and representatives, and any person controlling the Company
within the meaning of Section 15 of the Act, from and against any and all claim,
loss, damage, expense and liability whatsoever (including, but not limited
to,
any and all expenses whatsoever reasonably incurred in investigating, preparing
or defending any litigation commenced or threatened or any claim whatsoever)
based upon, due to or arising out of a breach of any representation or warranty
or covenant of the undersigned contained in this Subscription Agreement or
in
the Financial Questionnaire or of any false representation by
Investor.
7.
Miscellaneous.
(a)
This
Subscription Agreement constitutes the entire agreement between the parties
with
respect to the subject matter hereof and supersedes all prior negotiations
and
understandings which are deemed to have been merged herein. No representations
were made or relied upon by either party, other than those expressly set forth
herein.
(b)
This
writing shall be amended only by a further writing. No agent, employee, or
other
representative of any party is empowered to alter any of the terms hereof,
including specifically this Paragraph, unless done in writing and signed by
both
parties.
(c)
Whenever
required by the context hereof: the masculine gender shall be deemed to include
the feminine and neuter; and the singular member shall be deemed to include
the
plural. Time is expressly declared to be of the essence of this Agreement.
This
Agreement shall be deemed to have been mutually prepared by all parties and
shall not be construed against any particular party as the draftsman. The
invalidity of any one or more of the words, phrases, sentences, clauses,
sections or subsections contained in this Agreement shall not affect the
enforceability of the remaining portions of this Agreement or any part hereof,
all of which are inserted conditionally on their being valid in law, and, in
the
event that any one or more of the words, phrases, sentences, clauses, sections
or subsections contained in this Agreement shall be declared invalid by a court
of competent jurisdiction, this Agreement shall be construed as if such invalid
word or words, phrase or phrases, sentence or sentences, clause or clauses,
section or sections, or subsection or subsections had not been
inserted.
(d)
The
validity, interpretation, and performance of this Agreement shall be controlled
by and construed under the laws of the State of New York. Venue and jurisdiction
of any controversy or claim arising out of, or relating to this Subscription
Agreement, or the breach thereof, that cannot be resolved by negotiation, shall
be in the County of New York, State of New York. In any legal action or other
proceeding involving, arising out of or in any way relating to this Agreement,
the prevailing party shall be entitled to recover reasonable attorneys' fees,
costs, and expenses of litigation.
(e)
The
failure of any party to object to, or to take affirmative action with respect
to, any conduct of any other party which is in violation of the terms of this
Agreement shall not be construed as a waiver of such violation or breach, or
of
any future breach, violation, or wrongful conduct. No delay or failure by any
party to exercise any right under this Agreement, and no partial or single
exercise of that right, shall constitute a waiver or exhaustion of that or
any
other right, unless otherwise expressly provided herein.
(f)
Headings
in this Subscription Agreement are for convenience only and shall not be used
to
interpret or construe its provisions.
(g)
This
Subscription Agreement may be executed in two or more counterparts, each of
which shall be deemed an original but all of which together shall constitute
one
and the same instrument.
(h)
The
provisions of this Subscription Agreement shall be binding upon and inure to
the
benefit of each of the parties and their respective successors and
assigns.
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]
IN
WITNESS WHEREOF
,
the
undersigned has executed and delivered this Subscription Agreement dated this
day of______________, in the year 2006.
By,
_______________________________________PRINT NAME:
______________________
(Signature
of
Investor)
With
a
current address of
___________________________________________________
In
the
City of____________________________, State/Province of
_______________,
Country
of_______________
ACCEPTED:
BIOSOLAR LABS, INC.
By,
__________________
Its:____________________________
Signature
of Officer
Title:
President
DATE,___________________________________________
SECURITIES
ISSUANCE INSTRUCTIONS
The
undersigned, as a condition to purchase up
________
shares
of
Common Stock of BioSolar Labs, Inc., a Nevada corporation (the "Company"),
hereby certifies to the Company as follows:
1.
I,
___________ (Purchaser Name) am purchasing the Common Stock on this ________day
of May, in the year 2006, in my own name and for my own account (or for a trust
account if I am a trustee), and no other person has any interest in or right
with respect to the Common Stock, nor have I agreed to give any person any
such
interest or right in the future.
2.
I am
acquiring the Common Stock for investment and not with a view to or for sale
in
connection with any distribution of the Common Stock. I recognize that the
Common Stock have not been registered under the Securities Act of 1933, that
any
disposition of the Common Stock is subject to restrictions imposed by federal
and state law and that the certificates representing the Common Stock will
bear
a restrictive legend. I also recognize that I cannot dispose of the Common
Stock
absent registration and qualification, or an available exemption from
registration and qualification, and that no undertaking has been made with
regard to registering or qualifying the Common Stock in the future. I understand
that the availability of an exemption in the future will depend in part on
circumstances outside my control and that I may be required to hold the Common
Stock for a substantial period. I understand that the United States Securities
and Exchange Commission has made no finding or determination relating to the
fairness for investment of the Common Stock offered by the Company and that
the
Commission has not and will not recommend or endorse the Common
Stock.
3.
I have
not seen or received any advertisement or general solicitation with respect
to
the sale of the Common Stock.
4.
I
believe, by reason of my business or financial experience that I am capable
of
evaluating the merits and risks of this investment and of protecting my own
interests in connection with this investment.
5.
I
acknowledge that during the course of this transaction and prior to purchasing
the Common Stock I have been provided with financial and other written
information about the Company, I have been given the opportunity by the Company
to obtain such information and ask such questions concerning the Company, the
Common Stock, and my investment as I felt necessary, and to the extent I availed
myself of such opportunity, I received satisfactory information and answers.
If
I requested any additional information, which the Company possessed or could
acquire without unreasonable effort or expense and which was necessary to verify
the accuracy of the financial and other written information furnished to me
by
the Company, that additional information was provided to me. In reaching the
decision to invest in the Common Stock, I have carefully evaluated my financial
resources and investment position and the risks associated with this investment,
and I acknowledge that I am able to bear the economic risks of this investment.
I further acknowledge that my financial condition is such that I am not under
any present necessity or constraint to dispose of the Common Stock to satisfy
any existent or contemplated debt or undertaking.
Please
PRINT below the exact information regarding the Purchaser:
INDIVIDUAL
____________
_________________________________________________________________________________
Individual
Name(s)
_________________________________________________________________________________
Street
Address, City, State/Province and Postal Code
_________________________________________________________________________________
Signature
(All record holders should sign)
(____)____________Telephone
Number
(____)_______________Fax
Number
___________________________
Email Address
CORPORATION,
PARTNERSHIP, TRUST, OR OTHER ENTITY
_________________________________________________________________________________
Name
of
Entity
_________________________________________________________________________________
Address
to Which Correspondence should be Directed
_________________________________________________________________________________
Type
of
Entity (i.e., corporation, partnership etc)
_________________________________________________________________________________
State/Province
of Formation of Entity
By:____________________________________Printed:____________________________________
Its:____________________________________
Title
(____)____________Telephone
Number
(____)_______________Fax
Number
___________________________
Email Address
If
Common
Stock are being subscribed for by an entity, the Certificate of Signatory below
must be completed.
CERTIFICATE
OF SIGNATORY
To
be
completed if Common Stock are being subscribed for by an entity.
I,
____________________________________, am the ________________________________
of
_________________________________________________________(the "Entity
").
I
certify
that I am empowered and duly authorized by the Entity to execute and carry
out
the terms of the Subscription Agreement to purchase and hold the Common Stock,
and certify that the Subscription Agreement has been duly and validly executed
on behalf of the Entity and constitute legal and binding obligations of the
Entity.
IN
WITNESS WHEREOF, I have hereto set my hand this _______day of ________________,
20_____.
__________________________________
Signature
SUBSCRIPTION
AGREEMENT
SUBSCRIPTION
AGREEMENT (this “Agreement”) made as of the last date set forth on the signature
page hereof between BioSolar, Inc. (the “Company”), and the undersigned (the
“Subscriber”).
W
I T N E
S S E T H:
WHEREAS,
the Company is conducting a private offering (the “Offering”) consisting of up
to 1,500,000 shares of common stock, par value $.0001 per share (“Shares”);
and
WHEREAS,
the Subscriber desires to purchase that number of Shares set forth on the
signature page hereof on the terms and conditions hereinafter set
forth.
NOW,
THEREFORE, in consideration of the premises and the mutual representations
and
covenants hereinafter set forth, the parties hereto do hereby agree as
follows:
I.
|
SUBSCRIPTION
FOR SHARES AND REPRESENTATIONS BY
SUBSCRIBER
|
1.1
Subject
to the terms and conditions hereinafter set forth and in the Confidential
Offering Memorandum dated June 26, 2006 (such memorandum, together with all
amendments thereof and supplements and exhibits thereto, the “Memorandum”), the
Subscriber hereby irrevocably subscribes for and agrees to purchase from the
Company such number of Shares, and the Company agrees to sell to the Subscriber
as is set forth on the signature page hereof, at a per share price equal to
$0.10 per Share. The purchase price is payable by personal or business check
or
money order made payable to “BioSolar, Inc.” contemporaneously with the
execution and delivery of this Agreement by the Subscriber. Subscribers may
also
pay the subscription amount by, wire transfer of immediately available funds
to:
|
Bank:
|
Bank
of America
19120 Soledad Canyon Road
Santa Clarita, California
91350
|
1.2
The
Subscriber recognizes that the purchase of the Shares involves a high degree
of
risk including, but not limited to, the following: (a) the Company remains
a
development stage business with limited operating history and requires
substantial funds in addition to the proceeds of the Offering; (b) an investment
in the Company is highly speculative, and only investors who can afford the
loss
of their entire investment should consider investing in the Company and the
Shares; (c) the Subscriber may not be able to liquidate its investment; (d)
transferability of the Shares (sometimes hereinafter collectively referred
to as
the “Securities”) is extremely limited; (e) in the event of a disposition, the
Subscriber could sustain the loss of its entire investment; (f) the Company
has
not paid any dividends since its inception and does not anticipate paying any
dividends; and (g) the Company may issue additional securities in the future
which have rights and preferences that are senior to those of the Common Stock.
Without limiting the generality of the representations set forth in Section
1.5
below, the Subscriber represents that the Subscriber has carefully reviewed
the
section of the Memorandum captioned “Risk Factors.”
1.3
The
Subscriber represents that the Subscriber is an “accredited investor” as such
term is defined in Rule 501 of Regulation D (“Regulation D”) promulgated under
the Securities Act of 1933, as amended (the “Securities Act”), as indicated by
the Subscriber’s responses to the questions contained in Article VII hereof, and
that the Subscriber is able to bear the economic risk of an investment in the
Shares.
1.4
The
Subscriber hereby acknowledges and represents that (a) the Subscriber has
knowledge and experience in business and financial matters, prior investment
experience, including investment in securities that are non-listed, unregistered
and/or not traded on a national securities exchange nor on the National
Association of Securities Dealers, Inc. (the “NASD”) automated quotation system
(“NASDAQ”), or the Subscriber has employed the services of a “purchaser
representative” (as defined in Rule 501 of Regulation D), attorney and/or
accountant to read all of the documents furnished or made available by the
Company both to the Subscriber and to all other prospective investors in the
Shares to evaluate the merits and risks of such an investment on the
Subscriber’s behalf; (b) the Subscriber recognizes the highly speculative nature
of this investment; and (c) the Subscriber is able to bear the economic risk
that the Subscriber hereby assumes.
1.5
The
Subscriber hereby acknowledges receipt and careful review of this Agreement,
the
Memorandum (which includes the Risk Factors), including all exhibits thereto,
and any documents which may have been made available upon request as reflected
therein (collectively referred to as the “Offering Materials”) and hereby
represents that the Subscriber has been furnished by the Company during the
course of the Offering with all information regarding the Company, the terms
and
conditions of the Offering and any additional information that the Subscriber
has requested or desired to know, and has been afforded the opportunity to
ask
questions of and receive answers from duly authorized officers or other
representatives of the Company concerning the Company and the terms and
conditions of the Offering.
1.6
a)
In
making
the decision to invest in the Shares the Subscriber has relied solely upon
the
information provided by the Company in the Offering Materials. To the extent
necessary, the Subscriber has retained, at its own expense, and relied upon
appropriate professional advice regarding the investment, tax and legal merits
and consequences of this Agreement and the purchase of the Shares hereunder.
The
Subscriber disclaims reliance on any statements made or information provided
by
any person or entity in the course of Subscriber’s consideration of an
investment in the Shares other than the Offering Materials.
(b)
The
Subscriber represents that (i) the Subscriber was contacted regarding the sale
of the Shares by the Company (or an authorized agent or representative thereof)
with whom the Subscriber had a prior substantial pre-existing relationship
and
(ii) no Shares were offered or sold to it by means of any form of general
solicitation or general advertising, and in connection therewith, the Subscriber
did not (A) receive or review any advertisement, article, notice or other
communication published in a newspaper or magazine or similar media or broadcast
over television or radio, whether closed circuit, or generally available; or
(B)
attend any seminar meeting or industry investor conference whose attendees
were
invited by any general solicitation or general advertising.
1.7
The
Subscriber hereby represents that the Subscriber, either by reason of the
Subscriber’s business or financial experience or the business or financial
experience of the Subscriber’s professional advisors (who are unaffiliated with
and not compensated by the Company or any affiliate or selling agent of the
Company, directly or indirectly), has the capacity to protect the Subscriber’s
own interests in connection with the transaction contemplated
hereby.
1.8
The
Subscriber hereby acknowledges that the Offering has not been reviewed by the
United States Securities and Exchange Commission (the “SEC”) nor any state
regulatory authority since the Offering is intended to be exempt from the
registration requirements of Section 5 of the Securities Act pursuant to
Regulation D promulgated thereunder. The Subscriber understands that the
Securities have not been registered under the Securities Act or under any state
securities or “blue sky” laws and agrees not to sell, pledge, assign or
otherwise transfer or dispose of the Securities unless they are registered
under
the Securities Act and under any applicable state securities or “blue sky” laws
or unless an exemption from such registration is available.
1.9
The
Subscriber understands that the Securities comprising the Shares have not been
registered under the Securities Act by reason of a claimed exemption under
the
provisions of the Securities Act that depends, in part, upon the Subscriber’s
investment intention. In this connection, the Subscriber hereby represents
that
the Subscriber is purchasing the Securities for the Subscriber’s own account for
investment and not with a view toward the resale or distribution to others.
The
Subscriber, if an entity, further represents that it was not formed for the
purpose of purchasing the Securities.
1.10
The
Subscriber understands that there is no public market for the Common Stock
and
that no market may develop for any of such Securities. The Subscriber
understands that even if a public market develops for such Securities, Rule
144
(“Rule 144”) promulgated under the Securities Act requires for non-affiliates,
among other conditions, a one-year holding period prior to the resale (in
limited amounts) of securities acquired in a non-public offering without having
to satisfy the registration requirements under the Securities Act. The
Subscriber understands and hereby acknowledges that the Company is under no
obligation to register any of the Securities under the Securities Act or any
state securities or “blue sky” laws other than as set forth in Article V.
1.11
The
Subscriber consents to the placement of a legend on any certificate or other
document evidencing the Securities that such Securities have not been registered
under the Securities Act or any state securities or “blue sky” laws and setting
forth or referring to the restrictions on transferability and sale thereof
contained in this Agreement. The Subscriber is aware that the Company will
make
a notation in its appropriate records with respect to the restrictions on the
transferability of such Securities. The legend to be placed on each certificate
shall be in form substantially similar to the following:
“THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES
SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY STATE SECURITIES OR “BLUE
SKY LAWS,” AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR
HYPOTHECATED ABSENT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR
COMPLIANCE WITH RULE 144 PROMULGATED UNDER SUCH ACT, OR UNLESS THE COMPANY
HAS
RECEIVED AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY AND
ITS
COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.”
1.12
The
Subscriber understands that the Company will review this Agreement and is hereby
given authority by the Subscriber to call Subscriber’s bank or place of
employment or otherwise review the financial standing of the Subscriber; and
it
is further agreed that the Company, at its sole discretion, reserves the
unrestricted right, without further documentation or agreement on the part
of
the Subscriber, to reject or limit any subscription, to accept subscriptions
for
fractional Shares and to close the Offering to the Subscriber at any time and
that the Company will issue stop transfer instructions to its transfer agent
with respect to such Securities.
1.13
The
Subscriber hereby represents that the address of the Subscriber furnished by
Subscriber on the signature page hereof is the Subscriber’s principal residence
if Subscriber is an individual or its principal business address if it is a
corporation or other entity.
1.14
The
Subscriber represents that the Subscriber has full power and authority
(corporate, statutory and otherwise) to execute and deliver this Agreement
and
to purchase the Shares. This Agreement constitutes the legal, valid and binding
obligation of the Subscriber, enforceable against the Subscriber in accordance
with its terms.
1.15
If
the
Subscriber is a corporation, partnership, limited liability company, trust,
employee benefit plan, individual retirement account, Keogh Plan, or other
tax-exempt entity, it is authorized and qualified to invest in the Company
and
the person signing this Agreement on behalf of such entity has been duly
authorized by such entity to do so.
1.16
The
Subscriber acknowledges that if he or she is a Registered Representative of
an
NASD member firm, he or she must give such firm the notice required by the
NASD’s Rules of Fair Practice, receipt of which must be acknowledged by such
firm in Section 7.4 below.
1.17
The
Subscriber acknowledges that at such time, if ever, as the Securities are
registered (as such term is defined in Article V hereof), sales of the
Securities will be subject to state securities laws.
1.18
(a
)
The
Subscriber agrees not to issue any public statement with respect to the
Subscriber’s investment or proposed investment in the Company or the terms of
any agreement or covenant between them and the Company without the Company’s
prior written consent, except such disclosures as may be required under
applicable law or under any applicable order, rule or regulation.
(b)
The
Company agrees not to disclose the names, addresses or any other information
about the Subscribers, except as required by law; provided, that the Company
may
use the name of the Subscriber for any offering or in any registration statement
filed pursuant to Article V in which the Subscriber’s shares are
included.
1.19
The
Subscriber agrees to hold the Company and its directors, officers, employees,
affiliates, controlling persons and agents and their respective heirs,
representatives, successors and assigns harmless and to indemnify them against
all liabilities, costs and expenses incurred by them as a result of (a) any
sale
or distribution of the Securities by the Subscriber in violation of the
Securities Act or any applicable state securities or “blue sky” laws; or (b) any
false representation or warranty or any breach or failure by the Subscriber
to
comply with any covenant made by the Subscriber in this Agreement (including
the
Confidential Investor Questionnaire contained in Article VII herein) or any
other document furnished by the Subscriber to any of the foregoing in connection
with this transaction.
II.
|
REPRESENTATIONS
BY AND COVENANTS OF THE COMPANY
|
The
Company hereby represents and warrants to the Subscriber that:
2.1
Organization,
Good Standing and Qualification
.
The
Company is a corporation duly organized, validly existing and in good standing
under the laws of the State of Nevada and has full corporate power and authority
to conduct its business.
2.2
Capitalization
and Voting Rights
.
The
Company has authorized 500,000,000 shares of Common Stock, par value $.0001
per
share, of which 118,000,000 shares are outstanding as of the date hereof. Except
as set forth in the Offering Materials, there are no outstanding options,
warrants, agreements, convertible securities, preemptive rights or other rights
to subscribe for or to purchase any shares of capital stock of the Company.
Except as set forth in the Offering Materials and as otherwise required by
law,
there are no restrictions upon the voting or transfer of any of the shares
of
capital stock of the Company pursuant to the Company’s Articles of Incorporation
(the “Articles of Incorporation”), By-Laws or other governing documents or any
agreement or other instruments to which the Company is a party or by which
the
Company is bound.
2.3
Authorization;
Enforceability
.
The
Company has all corporate right, power and authority to enter into this
Agreement and to consummate the transactions contemplated hereby. All corporate
action on the part of the Company, its directors and stockholders necessary
for
the (i) authorization execution, delivery and performance of this Agreement
by
the Company; and (ii) authorization, sale, issuance and delivery of the
Securities contemplated hereby and the performance of the Company’s obligations
hereunder has been taken. This Agreement has been duly executed and delivered
by
the Company and constitutes a legal, valid and binding obligation of the
Company, enforceable against the Company in accordance with its terms, subject
to laws of general application relating to bankruptcy, insolvency and the relief
of debtors and rules of law governing specific performance, injunctive relief
or
other equitable remedies, and to limitations of public policy. The Common Stock,
when issued and fully paid for in accordance with the terms of this Agreement,
will be validly issued, fully paid and nonassessable. The issuance and sale
of
the Common Stock contemplated hereby will not give rise to any preemptive rights
or rights of first refusal on behalf of any person which have not been waived
in
connection with this offering.
2.4
No
Conflict; Governmental Consents
.
(a)
The
execution and delivery by the Company of this Agreement and the consummation
of
the transactions contemplated hereby will not result in the violation of any
material law, statute, rule, regulation, order, writ, injunction, judgment
or
decree of any court or governmental authority to or by which the Company is
bound, or of any provision of the Articles of Incorporation or By-Laws of the
Company, and will not conflict with, or result in a material breach or violation
of, any of the terms or provisions of, or constitute (with due notice or lapse
of time or both) a default under, any lease, loan agreement, mortgage, security
agreement, trust indenture or other agreement or instrument to which the Company
is a party or by which it is bound or to which any of its properties or assets
is subject, nor result in the creation or imposition of any lien upon any of
the
properties or assets of the Company.
(b)
No
consent, approval, authorization or other order of any governmental authority
is
required to be obtained by the Company in connection with the authorization,
execution and delivery of this Agreement or with the authorization, issue and
sale of the Shares, except such filings as may be required to be made with
the
SEC, NASD, NASDAQ and with any state or foreign blue sky or securities
regulatory authority.
2.5
Licenses
.
Except
as otherwise set forth in the Memorandum, the Company has sufficient licenses,
permits and other governmental authorizations currently required for the conduct
of its business or ownership of properties and is in all material respects
in
compliance therewith.
2.6
Litigation
.
The
Company knows of no pending or threatened legal or governmental proceedings
against the Company which could materially adversely affect the business,
property, financial condition or operations of the Company or which materially
and adversely questions the validity of this Agreement or any agreements related
to the transactions contemplated hereby or the right of the Company to enter
into any of such agreements, or to consummate the transactions contemplated
hereby or thereby. The Company is not a party or subject to the provisions
of
any order, writ, injunction, judgment or decree of any court or government
agency or instrumentality which could materially adversely affect the business,
property, financial condition or operations of the Company. There is no action,
suit, proceeding or investigation by the Company currently pending in any court
or before any arbitrator or that the Company intends to initiate.
2.7
Disclosure
.
The
information set forth in the Offering Materials as of the date hereof contains
no untrue statement of a material fact nor omits to state a material fact
necessary in order to make the statements contained therein, in light of the
circumstances under which they were made, not misleading.
2.8
Investment
Company
.
The
Company is not an “investment company” within the meaning of such term under the
Investment Company Act of 1940, as amended, and the rules and regulations of
the
SEC thereunder.
2.9
Intellectual
Property
.
(i)
To
the
best of its knowledge, the Company owns or possesses sufficient legal rights
to
all patents, trademarks, service marks, trade names, copyrights, trade secrets,
licenses, information and other proprietary rights and processes necessary
for
its business as now conducted and as presently proposed to be conducted, without
any known infringement of the rights of others. Except as disclosed in the
Memorandum, there are no material outstanding options, licenses or agreements
of
any kind relating to the foregoing proprietary rights, nor is the Company bound
by or a party to any material options, licenses or agreements of any kind with
respect to the patents, trademarks, service marks, trade names, copyrights,
trade secrets, licenses, information and other proprietary rights and processes
of any other person or entity other than such licenses or agreements arising
from the purchase of “off the shelf” or standard products. The Company has not
received any written communications alleging that the Company has violated
or,
by conducting its business as presently proposed to be conducted, would violate
any of the patents, trademarks, service marks, trade names, copyrights or trade
secrets or other proprietary rights of any other person or entity.
(ii)
Except
as
disclosed in the Memorandum, the Company is not aware that any of its employees
is obligated under any contract (including licenses, covenants or commitments
of
any nature) or other agreement, or subject to any judgment, decree or order
of
any court or administrative agency, that would interfere with their duties
to
the Company or that would conflict with the Company’s business as presently
conducted.
(iii)
Neither
the execution nor delivery of this Agreement, nor the carrying on of the
Company’s business by the employees of the Company, nor the conduct of the
Company’s business as presently conducted, will, to the Company’s knowledge,
conflict with or result in a breach of the terms, conditions or provisions
of,
or constitute a default under, any contract, covenant or instrument under which
any employee is now obligated.
(iv)
To
the
Company’s knowledge, no employee of the Company, nor any consultant with whom
the Company has contracted, is in violation of any term of any employment
contract, proprietary information agreement or any other agreement relating
to
the right of any such individual to be employed by, or to contract with, the
Company because of the nature of the business conducted by the Company; and
to
the Company’s knowledge the continued employment by the Company of its present
employees, and the performance of the Company’s contracts with its independent
contractors, will not result in any such violation. The Company has not received
any written notice alleging that any such violation has occurred. Except as
described in the Memorandum, no employee of the Company has been granted the
right to continued employment by the Company or to any compensation following
termination of employment with the Company except for any of the same which
would not have a material adverse effect on the business of the Company. The
Company is not aware that any officer, key employee or group of employees
intends to terminate his, her or their employment with the Company, nor does
the
Company have a present intention to terminate the employment of any officer,
key
employee or group of employees.
2.10
Title
to Properties and Assets; Liens, Etc
.
The
Company has good and marketable title to its properties and assets, including
the properties and assets reflected in the most recent balance sheet included
in
the Financial Statements, and good title to its leasehold estates, in each
case
subject to no mortgage, pledge, lien, lease, encumbrance or charge, other than
(a) those resulting from taxes which have not yet become delinquent; (b) liens
and encumbrances which do not materially detract from the value of the property
subject thereto or materially impair the operations of the Company; and (c)
those that have otherwise arisen in the ordinary course of business. The Company
is in compliance with all material terms of each lease to which it is a party
or
is otherwise bound.
2.11
Obligations
to Related Parties
.
Except
as described in the Memorandum, there are no obligations of the Company to
officers, directors, stockholders, or employees of the Company other than (a)
for payment of salary or other compensation for services rendered, (b)
reimbursement for reasonable expenses incurred on behalf of the Company and
(c)
for other standard employee benefits made generally available to all employees
(including stock option agreements outstanding under any stock option plan
approved by the Board of Directors of the Company). Except as may be disclosed
in the Memorandum, the Company is not a guarantor or indemnitor of any
indebtedness of any other person, firm or corporation.
III.
|
TERMS
OF SUBSCRIPTION
|
3.1
There
is
no requirement that any minimum number of Shares be sold and therefore no escrow
will be established for subscription funds. Subscription funds may be deposited
by the Company directly into its operating account for use as described in
this
Confidential Offering Memorandum.
3.2
Certificates
representing the Common Stock purchased by the Subscriber pursuant to this
Agreement will be prepared for delivery to the Subscriber within 15 business
days following the Closing at which such purchase takes place. The Subscriber
hereby authorizes and directs the Company to deliver the certificates
representing the Common Stock purchased by the Subscriber pursuant to this
Agreement directly to the Subscriber’s residential or business address indicated
on the signature page hereto.
IV.
|
CONDITIONS
TO OBLIGATIONS OF THE
SUBSCRIBERS
|
4.1
The
Subscriber’s obligation to purchase the Shares at the Closing at which such
purchase is to be consummated is subject to the fulfillment on or prior to
such
Closing of the following conditions, which conditions may be waived at the
option of each Subscriber to the extent permitted by law:
(a)
Covenants
.
All
covenants, agreements and conditions contained in this Agreement to be performed
by the Company on or prior to the date of such Closing shall have been performed
or complied with in all material respects.
(b)
No
Legal Order Pending
.
There
shall not then be in effect any legal or other order enjoining or restraining
the transactions contemplated by this Agreement.
(c)
No
Law
Prohibiting or Restricting Such Sale
.
There
shall not be in effect any law, rule or regulation prohibiting or restricting
such sale or requiring any consent or approval of any person, which shall not
have been obtained, to issue the Securities (except as otherwise provided in
this Agreement).
5.1
Definitions
.
As used
in this Agreement, the following terms shall have the following
meanings.
(a)
The
term
“Holder” shall mean any person owning or having the right to acquire Registrable
Securities or any permitted transferee of a Holder.
(b)
The
terms
“register,” “registered” and “registration” refer to a registration effected by
preparing and filing a registration statement or similar document in compliance
with the Securities Act, and the declaration or order of effectiveness of such
registration statement or document.
(c)
The
term
“Registrable Securities” shall mean: (i) the Common Stock; and (ii) any other
shares of Common Stock with respect to which the Company has granted or may
in
the future grant registration rights pursuant to separate agreements; provided,
however, that securities shall only be treated as Registrable Securities if
and
only for so long as they (A) have not been disposed of pursuant to a
registration statement declared effective by the SEC; (B) have not been sold
in
a transaction exempt from the registration and prospectus delivery requirements
of the Securities Act so that all transfer restrictions and restrictive legends
with respect thereto are removed upon the consummation of such sale; (C) are
held by a Holder or a permitted transferee of a Holder pursuant to Section
5.10;
and (D) may not be disposed of under Rule 144(k) under the Securities Act
without restriction.
5.2
Piggy-Back
Registration
.
The
Holders will be entitled to “piggy-back” registration rights of the shares of
Common Stock on registration statements (other than on Form S-8, S-4 or similar
Forms) filed by the Company. The Company shall use its best efforts to cause
such Registration Statement to become effective as soon as possible.
5.3
Registration
Procedures
.
Whenever required under this Article V to include Registrable Securities in
a
Company registration statement, the Company shall, as expeditiously as
reasonably possible:
(a)
Use
best
efforts to (i) cause such registration statement to become effective, and (ii)
cause such registration statement to remain effective until the earliest to
occur of (A) such date as the sellers of Registrable Securities (the “Selling
Holders”) have completed the distribution described in the registration
statement and (B) such time that all of such Registrable Securities are no
longer, by reason of Rule 144(k) under the Securities Act, required to be
registered for the sale thereof by such Holders. The Company will also use
its
best efforts to, during the period that such registration statement is required
to be maintained hereunder, file such post-effective amendments and supplements
thereto as may be required by the Securities Act and the rules and regulations
thereunder or otherwise to ensure that the registration statement does not
contain any untrue statement of material fact or omit to state a fact required
to be stated therein or necessary to make the statements contained therein,
in
light of the circumstances under which they are made, not misleading; provided,
however, that if applicable rules under the Securities Act governing the
obligation to file a post-effective amendment permits, in lieu of filing a
post-effective amendment that (i) includes any prospectus required by Section
10(a)(3) of the Securities Act or (ii) reflects facts or events representing
a
material or fundamental change in the information set forth in the registration
statement, the Company may incorporate by reference information required to
be
included in (i) and (ii) above to the extent such information is contained
in
periodic reports filed pursuant to Section 13 or 15(d) of the Exchange Act
in
the registration statement.
(b)
Prepare
and file with the SEC such amendments and supplements to such registration
statement, and the prospectus used in connection with such registration
statement, as may be necessary to comply with the provisions of the Securities
Act with respect to the disposition of all securities covered by such
registration statement.
(c)
Make
available for inspection upon reasonable notice during the Company’s regular
business hours by each Selling Holder, any underwriter participating in any
distribution pursuant to such registration statement, and any attorney,
accountant or other agent retained by such Selling Holder or underwriter, all
financial and other records, pertinent corporate documents and properties of
the
Company, and cause the Company’s officers, directors and employees to supply all
information reasonably requested by any such Selling Holder, underwriter,
attorney, accountant or agent in connection with such registration
statement.
(d)
Furnish
to the Selling Holders such numbers of copies of a prospectus, including a
preliminary prospectus as amended or supplemented from time to time, in
conformity with the requirements of the Securities Act, and such other documents
as they may reasonably request in order to facilitate the disposition of
Registrable Securities owned by them.
(e)
Use
best
efforts to register and qualify the securities covered by such registration
statement under such other federal or state securities laws of such
jurisdictions as shall be reasonably requested by the Selling Holders; provided,
however, that the Company shall not be required in connection therewith or
as a
condition thereto to qualify to do business or to file a general consent to
service of process in any such states or jurisdictions, unless the Company
is
already subject to service in such jurisdiction and except as may be required
by
the Securities Act.
(f)
In
the
event of any underwritten public offering, enter into and perform its
obligations under an underwriting agreement, in usual and customary form, with
the managing underwriter of such offering. Each Selling Holder participating
in
such underwriting shall also enter into and perform its obligations under such
an agreement.
(g)
Notify
each Holder of Registrable Securities covered by such registration statement,
at
any time when a prospectus relating thereto is required to be delivered under
the Securities Act, (i) when the registration statement or any post-effective
amendment and supplement thereto has become effective; (ii) of the issuance
by
the SEC of any stop order or the initiation of proceedings for that purpose
(in
which event the Company shall make every effort to obtain the withdrawal of
any
order suspending effectiveness of the registration statement at the earliest
possible time or prevent the entry thereof); (iii) of the receipt by the Company
of any notification with respect to the suspension of the qualification of
the
Registrable Securities for sale in any jurisdiction or the initiation of any
proceeding for such purpose; and (iv) of the happening of any event as a result
of which the prospectus included in such registration statement, as then in
effect, includes an untrue statement of a material fact or omits to state a
material fact required to be stated therein or necessary to make the statements
therein not misleading in the light of the circumstances then
existing.
(h)
Cause
all
such Registrable Securities registered hereunder to be listed on each securities
exchange or quotation service on which similar securities issued by the Company
are then listed or quoted or, if no such similar securities are listed or quoted
on a securities exchange or quotation service, apply for qualification and
use
best efforts to qualify such Registrable Securities for inclusion on the New
York Stock Exchange, American Stock Exchange or listing on a quotation system
of
the National Association of Securities Dealers, Inc.
(i)
Provide
a
transfer agent and registrar for all Registrable Securities registered pursuant
hereunder and CUSIP number for all such Registrable Securities, in each case
not
later than the effective date of such registration.
(j)
Cooperate
with the Selling Holders and the managing underwriters, if any, to facilitate
the timely preparation and delivery of certificates representing the Registrable
Securities to be sold, which certificates will not bear any restrictive legends;
and enable such Registrable Securities to be in such denominations and
registered in such names as the managing underwriters, if any, shall request
at
least two business days prior to any sale of the Registrable Securities to
the
underwriters.
(k)
In
connection with an underwritten offering, cause the officers of the Company
to
provide reasonable assistance in the preparation of, any “road show”
presentation to potential investors as the managing underwriter may determine.
(l)
Comply
with all applicable rules and regulations of the SEC and make generally
available to its security holders earning statements satisfying the provisions
of Section 11(a) of the Securities Act and Rule 158 thereunder (or any similar
rule promulgated under the Securities Act) no later than 50 calendar days after
the end of any 3-month period (or 105 calendar days after the end of any
12-month period if such period is a fiscal year) (i) commencing at the end
of
any fiscal quarter in which Registrable Securities are sold to underwriters
in a
firm commitment or best efforts underwritten offering, and (ii) if not sold
to
underwriters in such an offering, commencing on the first day of the first
fiscal quarter of the Company, after the effective date of a registration
statement, which statements shall cover said period.
(m)
If
the
offering is underwritten and at the request of any Selling Holder, use its
best
efforts to furnish on the date that Registrable Securities are delivered to
the
underwriters for sale pursuant to such registration: (i) opinions dated such
date of counsel representing the Company for the purposes of such registration,
addressed to the underwriters and the transfer agent for the Registrable
Securities so delivered, respectively, to the effect that such registration
statement has become effective under the Securities Act and such Registrable
Securities are freely tradable, and covering such other matters as are
customarily covered in opinions of issuer’s counsel delivered to underwriters
and transfer agents in underwritten public offerings and (ii) a letter dated
such date from the independent public accountants who have certified the
financial statements of the Company included in the registration statement
or
the prospectus, covering such matters as are customarily covered in accountants’
letters delivered to underwriters in underwritten public offerings.
5.4
Furnish
Information
.
It
shall be a condition precedent to the obligation of the Company to take any
action pursuant to this Article V with respect to the Registrable Securities
of
any Selling Holder that such Holder shall furnish to the Company such
information regarding the Holder, the Registrable Securities held by the Holder,
and the intended method of disposition of such securities as shall be reasonably
required by the Company to effect the registration of such Holder’s Registrable
Securities.
5.5
Registration
Expenses
.
The
Company shall bear and pay all Registration Expenses incurred in connection
with
any registration, filing or qualification of Registrable Securities with respect
to registration pursuant to Section 5.2 for each Holder, but excluding
underwriting discounts and commissions relating to Registrable Securities and
excluding any professional fees or costs of accounting, financial or legal
advisors to any of the Holders.
5.6
Underwriting
Requirements
.
In
connection with any offering involving an underwriting of shares of the
Company’s capital stock, the Company shall not be required under Section 5.2 to
include any of the Holders’ Registrable Securities in such underwriting unless
they accept the terms of the underwriting as agreed upon between the Company
and
the underwriters selected by it (or by other persons entitled to select the
underwriters), and then only in such quantity as the underwriters determine
in
their sole discretion will not jeopardize the success of the offering by the
Company. If the total amount of securities, including Registrable Securities,
requested by stockholders to be included in such offering exceeds the amount
of
securities sold other than by the Company that the underwriters determine in
their sole discretion is compatible with the success of the offering, then
the
Company shall be required to include in the offering only that number of such
securities, including Registrable Securities, which the underwriters determine
in their sole discretion will not jeopardize the success of the offering (the
securities so included to be apportioned pro rata among the selling stockholders
according to the total amount of securities entitled to be included therein
owned by each selling stockholder or in such other proportions as shall mutually
be agreed to by such selling stockholders). For purposes of the preceding
parenthetical concerning apportionment, for any selling stockholder who is
a
holder of Registrable Securities and is a partnership or corporation, the
partners, retired partners and stockholders of such holder, or the estates
and
family members of any such partners and retired partners and any trusts for
the
benefit of any of the foregoing persons shall be deemed to be a single “selling
stockholder,” and any pro-rata reduction with respect to such “selling
stockholder” shall be based upon the aggregate amount of shares carrying
registration rights owned by all entities and individuals included in such
“selling stockholder,” as defined in this sentence.
5.7
Delay
of Registration
.
No
Holder shall have any right to obtain or seek an injunction restraining or
otherwise delaying any such registration as the result of any controversy that
might arise with respect to the interpretation or implementation of this
Article.
5.8
Indemnification
.
In the
event that any Registrable Securities are included in a registration statement
under this Article V:
(a)
To
the
extent permitted by law, the Company will indemnify and hold harmless each
Holder, any underwriter (as defined in the Securities Act) for such Holder
and
each person, if any, who controls such Holder or underwriter within the meaning
of the Securities Act or the Exchange Act, against any losses, claims, damages,
or liabilities (joint or several) to which they may become subject under the
Securities Act, or the Exchange Act, insofar as such losses, claims, damages,
or
liabilities (or actions in respect thereof) arise out of or are based upon
any
of the following statements, omissions or violations (collectively a
“Violation”): (i) any untrue statement of a material fact contained in such
registration statement, including any preliminary prospectus or final prospectus
contained therein or any amendments or supplements thereto, (ii) the omission
to
state therein a material fact required to be stated therein, or necessary to
make the statements therein not misleading, or (iii) any violation by the
Company of the Securities Act, the Exchange Act, or any rule or regulation
promulgated under the Securities Act, or the Exchange Act, and the Company
will
pay to each such Holder, underwriter or controlling person, as incurred, any
legal or other expenses reasonably incurred by them in connection with
investigating or defending any such loss, claim, damage, liability, or action;
provided, however, that the indemnity agreement contained in this Section 5.8(a)
shall not apply to amounts paid in settlement of any such loss, claim, damage,
liability, or action if such settlement is effected without the consent of
the
Company (which consent shall not be unreasonably withheld), nor shall the
Company be liable in any such case for any such loss, claim, damage, liability,
or action to the extent that it arises out of or is based upon a Violation
which
occurs in reliance upon and in conformity with written information furnished
expressly for use in connection with such registration by any such Holder,
underwriter or controlling person.
(b)
To
the
extent permitted by law, each Selling Holder will indemnify and hold harmless
the Company, each of its directors, each of its officers, each person, if any,
who controls the Company within the meaning of the Securities Act, any
underwriter, any other Holder selling securities in such registration statement
and any controlling person of any such underwriter or other Holder, against
any
losses, claims, damages, or liabilities (joint or several) to which any of
the
foregoing persons may become subject, under the Securities Act, or the Exchange
Act, insofar as such losses, claims, damages, or liabilities (or actions in
respect thereto) arise out of or are based upon any Violation, in each case
to
the extent (and only to the extent) that such Violation occurs in reliance
upon
and in conformity with written information furnished by such Holder expressly
for use in connection with such registration; and each such Holder will pay,
as
incurred, any legal or other expenses reasonably incurred by any person intended
to be indemnified pursuant to this Section 5.8(b), in connection with
investigating or defending any such loss, claim, damage, liability, or action;
provided
,
however
,
that
the indemnity agreement contained in this Section 5.8(b) shall not apply to
amounts paid in settlement of any such loss, claim, damage, liability or action
if such settlement is effected without the consent of the Holder, which consent
shall not be unreasonably withheld;
provided
,
further,
that, in
no event shall any indemnity under this Section 5.8(b) exceed the greater of
the
cash value of the (i) gross proceeds from the Offering received by such Holder
or (ii) such Holder’s investment pursuant to this Agreement as set forth on the
signature page attached hereto.
(c)
Promptly
after receipt by an indemnified party under this Section 5.8 of notice of the
commencement of any action (including any governmental action), such indemnified
party shall, if a claim in respect thereof is to be made against any
indemnifying party under this Section 5.8, deliver to the indemnifying party
a
written notice of the commencement thereof and the indemnifying party shall
have
the right to participate in, and, to the extent the indemnifying party so
desires, jointly with any other indemnifying party similarly notified, to assume
the defense thereof with counsel selected by the indemnifying party and approved
by the indemnified party (whose approval shall not be unreasonably withheld);
provided, however, that an indemnified party (together with all other
indemnified parties which may be represented without conflict by one counsel)
shall have the right to retain one separate counsel, with the fees and expenses
to be paid by the indemnifying party, if representation of such indemnified
party by the counsel retained by the indemnifying party would be inappropriate
due to actual or potential differing interests between such indemnified party
and any other party represented by such counsel in such proceeding. The failure
to deliver written notice to the indemnifying party within a reasonable time
of
the commencement of any such action, if prejudicial to its ability to defend
such action, shall relieve such indemnifying party of any liability to the
indemnified party under this Section 5.8, but the omission so to deliver written
notice to the indemnifying party will not relieve it of any liability that
it
may have to any indemnified party otherwise than under this Section
5.8.
(d)
If
the
indemnification provided for in this Section 5.8 is held by a court of competent
jurisdiction to be unavailable to an indemnified party with respect to any
loss,
liability, claim, damage, or expense referred to therein, then the indemnifying
party, in lieu of indemnifying such indemnified party hereunder, shall
contribute to the amount paid or payable by such indemnified party as a result
of such loss, liability, claim, damage, or expense in such proportion as is
appropriate to reflect the relative fault of the indemnifying party on the
one
hand and of the indemnified party on the other in connection with the statements
or omissions that resulted in such loss, liability, claim, damage, or expense
as
well as any other relevant equitable considerations. The relative fault of
the
indemnifying party and of the indemnified party shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a
material fact or the alleged omission to state a material fact relates to
information supplied by the indemnifying party or by the indemnified party
and
the parties’ relative intent, knowledge, access to information, and opportunity
to correct or prevent such statement or omission.
(e)
Notwithstanding
the foregoing, to the extent that the provisions on indemnification and
contribution contained in an underwriting agreement entered into in connection
with an underwritten public offering are in conflict with the foregoing
provisions, the provisions in such underwriting agreement shall
control.
(f)
The
obligations of the Company and Holders under this Section 5.8 shall survive
the
completion of the Offering.
5.9
Reports
Under Securities Exchange Act of 1934
.
With a
view to making available to the Holders the benefits of Rule 144 and any other
rule or regulation of the SEC that may at any time permit a Holder to sell
securities of the Company to the public without registration or pursuant to
a
registration on Form S-3, the Company agrees to:
(a)
make
and
keep public information available, as those terms are understood and defined
in
Rule 144, at all times after 90 days after the effective date of the
registration statement;
(b)
file
with
the SEC in a timely manner all reports and other documents required of the
Company under the Securities Act and the Exchange Act; and
(c)
furnish
to any Holder, so long as the Holder owns any Registrable Securities, forthwith
upon request (i) a copy of the most recent annual or quarterly report of the
Company and such other reports and documents so filed by the Company, and (ii)
such other information as may be reasonably requested in availing any Holder
of
any rule or regulation of the SEC which permits the selling of any such
securities without registration or pursuant to such form.
5.10
Permitted
Transferees
.
The
rights to cause the Company to register Registrable Securities granted to the
Holders by the Company under this Article V may be assigned in full by a Holder
in connection with a transfer by such Holder of its Registrable Securities
if:
(a) such Holder gives prior written notice to the Company; (b) such
transferee agrees to comply with the terms and provisions of this Agreement;
(c) such transfer is otherwise in compliance with this Agreement; and
(d) such transfer is otherwise effected in accordance with applicable
securities laws. Except as specifically permitted by this Section 5.10, the
rights of a Holder with respect to Registrable Securities as set out herein
shall not be transferable to any other Person, and any attempted transfer shall
cause all rights of such Holder therein to be forfeited.
6.1
Any
notice or other communication given hereunder shall be deemed sufficient if
in
writing and sent by registered or certified mail, return receipt requested,
or
delivered by hand against written receipt therefor, addressed as
follows:
if
to the
Company, to it at:
BioSolar,
Inc.
27936
Lost Canyon Road, Suite 202
Santa
Clarita, California 91387
Attn:
David Lee, Chief Executive Officer
With
a
copy to:
Sichenzia
Ross Friedman Ference LLP
1065
Avenue of the Americas
New
York,
NY 10018
Attn:
Gregory Sichenzia, Esq.
if
to the
Subscriber, to the Subscriber’s address indicated on the signature page of this
Agreement.
Notices
shall be deemed to have been given or delivered on the date of mailing, except
notices of change of address, which shall be deemed to have been given or
delivered when received.
6.2
Except
as
otherwise provided herein, this Agreement shall not be changed, modified or
amended except by a writing signed by the parties to be charged, and this
Agreement may not be discharged except by performance in accordance with its
terms or by a writing signed by the party to be charged.
6.3
Subject
to the provisions of Section 5.10, this Agreement shall be binding upon and
inure to the benefit of the parties hereto and to their respective heirs, legal
representatives, successors and assigns. This Agreement sets forth the entire
agreement and understanding between the parties as to the subject matter hereof
and merges and supersedes all prior discussions, agreements and understandings
of any and every nature among them.
6.4
Upon
the
execution and delivery of this Agreement by the Subscriber, this Agreement
shall
become a binding obligation of the Subscriber with respect to the purchase
of
Common Stock as herein provided, subject, however, to the right hereby reserved
by the Company to enter into the same agreements with other subscribers and
to
add and/or delete other persons as subscribers.
6.5
NOTWITHSTANDING
THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO,
THE
PARTIES EXPRESSLY AGREE THAT ALL THE TERMS AND PROVISIONS HEREOF SHALL BE
CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK
WITHOUT REGARD TO SUCH STATE’S PRINCIPLES OF CONFLICTS OF LAW. IN THE EVENT THAT
A JUDICIAL PROCEEDING IS NECESSARY, THE SOLE FORUM FOR RESOLVING DISPUTES
ARISING OUT OF OR RELATING TO THIS AGREEMENT IS THE SUPREME COURT OF THE STATE
OF NEW YORK IN AND FOR THE COUNTY OF NEW YORK OR THE FEDERAL COURTS FOR SUCH
STATE AND COUNTY, AND ALL RELATED APPELLATE COURTS, THE PARTIES HEREBY
IRREVOCABLY CONSENT TO THE JURISDICTION OF SUCH COURTS AND AGREE TO SAID VENUE.
6.6
In
order
to discourage frivolous claims the parties agree that unless a claimant in
any
proceeding arising out of this Agreement succeeds in establishing his claim
and
recovering a judgment against another party (regardless of whether such claimant
succeeds against one of the other parties to the action), then the other party
shall be entitled to recover from such claimant all of its/their reasonable
legal costs and expenses relating to such proceeding and/or incurred in
preparation therefor.
6.7
The
holding of any provision of this Agreement to be invalid or unenforceable by
a
court of competent jurisdiction shall not affect any other provision of this
Agreement, which shall remain in full force and effect. If any provision of
this
Agreement shall be declared by a court of competent jurisdiction to be invalid,
illegal or incapable of being enforced in whole or in part, such provision
shall
be interpreted so as to remain enforceable to the maximum extent permissible
consistent with applicable law and the remaining conditions and provisions
or
portions thereof shall nevertheless remain in full force and effect and
enforceable to the extent they are valid, legal and enforceable, and no
provisions shall be deemed dependent upon any other covenant or provision unless
so expressed herein.
6.8
It
is
agreed that a waiver by either party of a breach of any provision of this
Agreement shall not operate, or be construed, as a waiver of any subsequent
breach by that same party.
6.9
The
parties agree to execute and deliver all such further documents, agreements
and
instruments and take such other and further action as may be necessary or
appropriate to carry out the purposes and intent of this Agreement.
6.10
This
Agreement may be executed in two or more counterparts each of which shall be
deemed an original, but all of which shall together constitute one and the
same
instrument.
6.11
Nothing
in this Agreement shall create or be deemed to create any rights in any person
or entity not a party to this Agreement, except (a) for the holders of
Registrable Securities.
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]
VII.
|
CONFIDENTIAL INVESTOR
QUESTIONNAIRE
|
7.1
The
Subscriber represents and warrants that he, she or it comes within one category
marked below, and that for any category marked, he, she or it has truthfully
set
forth, where applicable, the factual basis or reason the Subscriber comes within
that category. ALL INFORMATION IN RESPONSE TO THIS SECTION WILL BE KEPT STRICTLY
CONFIDENTIAL. The undersigned agrees to furnish any additional information
which
the Company deems necessary in order to verify the answers set forth
below.
Category A
|
The
undersigned is an individual (not a partnership, corporation, etc.)
whose
individual net worth, or joint net worth with his or her spouse,
presently
exceeds $1,000,000.
Explanation.
In calculating net worth you may include equity in personal property
and
real estate, including your principal residence, cash, short-term
investments, stock and securities. Equity in personal property and
real
estate should be based on the fair market value of such property
less debt
secured by such property.
|
|
|
Category B
|
The undersigned is an individual (not
a
partnership, corporation, etc.) who had an income in excess of $200,000
in
each of the two most recent years, or joint income with his or her
spouse
in excess of $300,000 in each of those years (in each case including
foreign income, tax exempt income and full amount of capital gains
and
losses but excluding any income of other family members and any unrealized
capital appreciation) and has a reasonable expectation of reaching
the
same income level in the current year.
|
|
|
Category C
|
The undersigned is a director or executive
officer of the Company which is issuing and selling the
Securities.
|
|
|
Category D
|
The
undersigned is a bank; a savings and loan association; insurance company;
registered investment company; registered business development company;
licensed small business investment company (“SBIC”); or employee benefit
plan within the meaning of Title 1 of ERISA and (a) the investment
decision is made by a plan fiduciary which is either a bank, savings
and
loan association, insurance company or registered investment advisor,
or
(b) the plan has total assets in excess of $5,000,000 or (c) is a self
directed plan with investment decisions made solely by persons that
are
accredited investors. (describe entity)
|
|
|
|
|
|
|
Category E
|
The undersigned is a private business
development company as defined in section 202(a)(22) of the Investment
Advisors Act of 1940. (describe entity)
|
|
|
Category F
|
The undersigned is either a corporation,
partnership, Massachusetts business trust, or non-profit organization
within the meaning of Section 501(c)(3) of the Internal Revenue Code,
in
each case not formed for the specific purpose of acquiring the Common
Stock and with total assets in excess of $5,000,000. (describe
entity)
|
|
|
|
|
|
|
Category G
|
The undersigned is a trust with total
assets
in excess of $5,000,000, not formed for the specific purpose of acquiring
the Securities, where the purchase is directed by a “sophisticated
investor” as defined in Regulation 506(b)(2)(ii) under the
Act.
|
|
|
Category H
|
The undersigned is an entity (other
than a
trust) in which all of the equity owners are “accredited investors” within
one or more of the above categories. If relying upon this Category
alone,
each equity owner must complete a separate copy of this
Agreement. (describe entity)
|
|
|
|
|
|
|
Category I
|
The undersigned is not within any of
the
categories above and is therefore not an accredited investor.
The
undersigned agrees that the undersigned will notify the Company at
any
time on or prior to the Closing Date in the event that the representations
and warranties in this Agreement shall cease to be true, accurate
and
complete.
|
7.2
SUITABILITY
(please
answer each question)
(a)
For
an
individual Subscriber, please describe your current employment, including
the
company by which you are employed and its principal business:
(b)
For
an
individual Subscriber, please describe any college or graduate degrees held
by
you:
(c)
For
all
Subscribers, please list types of prior investments:
(d)
For
all
Subscribers, please state whether you have participated in other
private
placements
before:
YES_______
NO_______
(e)
If
your
answer to question (d) above was “YES”, please indicate frequency of such prior
participation in
private
placements
of:
|
|
Public
Companies
|
|
Private
Companies
|
|
Public
or Private VoIP or other
Communications
Companies
|
Frequently
|
|
|
|
|
|
|
Occasionally
|
|
|
|
|
|
|
Never
|
|
|
|
|
|
|
(f)
For
individual Subscribers, do you expect your current level of income to
significantly decrease in the foreseeable future:
YES_______
NO_______
(g)
For
trust, corporate, partnership and other institutional Subscribers, do you expect
your total assets to significantly decrease in the foreseeable future:
YES_______
NO_______
(h)
For
all
Subscribers, do you have any other investments or contingent liabilities which
you reasonably anticipate could cause you to need sudden cash requirements
in
excess of cash readily available to you:
YES_______
NO_______
(i)
For
all
Subscribers, are you familiar with the risk aspects and the non-liquidity of
investments such as the securities for which you seek to subscribe?
YES_______
NO_______
(j)
For all
Subscribers, do you understand that there is no guarantee of financial return
on
this investment and that you run the risk of losing your entire
investment?
YES_______
NO_______
7.3
MANNER
IN WHICH TITLE IS TO BE HELD
.
(circle
one)
(a)
Individual
Ownership
(b)
Community
Property
(c)
Joint
Tenant with Right of
Survivorship
(both parties
must
sign)
(d)
Partnership*
(e)
Tenants
in Common
(f)
Company*
(g)
Trust*
(h)
Other*
*If
Securities are being subscribed for by an entity, the attached Certificate
of
Signatory must also be completed.
7.4
NASD
AFFILIATION
.
Are
you
affiliated or associated with an NASD member firm (please check
one):
Yes
_________
No
__________
If
Yes,
please describe:
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
*If
Subscriber is a Registered Representative with an NASD member firm, have the
following acknowledgment signed by the appropriate party:
The
undersigned NASD member firm acknowledges receipt of the notice required by
Article 3, Sections 28(a) and (b) of the Rules of Fair Practice.
_________________________________
Name
of
NASD Member Firm
By:
______________________________
Authorized
Officer
Date:
____________________________
7.5
The
undersigned is informed of the significance to the Company of the foregoing
representations and answers contained in the Confidential Investor Questionnaire
contained in this Article VII and such answers have been provided under the
assumption that the Company will rely on them.
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]
NUMBER
OF SHARES _________ X $0.10 = $_________ (the “Purchase
Price”)
|
|
|
|
|
|
Signature
|
|
Signature
(if purchasing jointly)
|
|
|
|
|
|
|
Name Typed or Printed
|
|
Name Typed or Printed
|
|
|
|
|
|
|
Title (if Subscriber is an
Entity)
|
|
Title (if Subscriber is an
Entity)
|
|
|
|
|
|
|
Entity Name (if applicable)
|
|
Entity
Name (if applicable)
|
|
|
|
|
|
|
|
|
|
|
|
|
Address
|
|
Address
|
|
|
|
|
|
|
City, State and Zip Code
|
|
City, State and Zip Code
|
|
|
|
|
|
|
Telephone-Business
|
|
Telephone-Business
|
|
|
|
|
|
|
Telephone-Residence
|
|
Telephone-Residence
|
|
|
|
|
|
|
Facsimile-Business
|
|
Facsimile-Business
|
|
|
|
|
|
|
Facsimile-Residence
|
|
Facsimile-Residence
|
|
|
|
|
|
|
Email
|
|
Email
|
|
|
|
|
|
|
Tax ID # or Social Security
#
|
|
Tax
ID # or Social Security #
|
|
|
|
Name
in which securities should be issued:
|
|
|
Dated:
,
2006
This
Subscription Agreement is agreed to and accepted as of
________________
,
2006.
BIOSOLAR,
INC.
By:____________________________________
Name:
Title:
CERTIFICATE
OF SIGNATORY
(To
be
completed if Shares are
being
subscribed for by an entity)
I,
____________________________, am the ____________________________ of
__________________________________________ (the “Entity”).
I
certify
that I am empowered and duly authorized by the Entity to execute and carry
out
the terms of the Subscription Agreement and to purchase and hold the Common
Stock, and certify further that the Subscription Agreement has been duly and
validly executed on behalf of the Entity and constitutes a legal and binding
obligation of the Entity.
IN
WITNESS WHEREOF, I have set my hand this ________ day of _________________,
2006
_______________________________________
(Signature)
SUBSCRIPTION
AGREEMENT
SUBSCRIPTION
AGREEMENT (this “Agreement”) made as of the last date set forth on the signature
page hereof between BioSolar, Inc. (the “Company”), and the undersigned (the
“Subscriber”).
W
I T N E
S S E T H:
WHEREAS,
the Company is conducting a private offering (the “Offering”) consisting of up
to 15,000,000 shares of common stock, par value $.0001 per share (“Shares”);
and
WHEREAS,
the Subscriber desires to purchase that number of Shares set forth on the
signature page hereof on the terms and conditions hereinafter set
forth.
NOW,
THEREFORE, in consideration of the premises and the mutual representations
and
covenants hereinafter set forth, the parties hereto do hereby agree as
follows:
I.
|
SUBSCRIPTION
FOR SHARES AND REPRESENTATIONS BY
SUBSCRIBER
|
1.1
Subject
to the terms and conditions hereinafter set forth and in the Confidential
Offering Memorandum dated July 21, 2006 (such memorandum, together with all
amendments thereof and supplements and exhibits thereto, the “Memorandum”), the
Subscriber hereby irrevocably subscribes for and agrees to purchase from the
Company such number of Shares, and the Company agrees to sell to the Subscriber
as is set forth on the signature page hereof, at a per share price equal to
$0.10 per Share. The purchase price is payable by personal or business check
or
money order made payable to “BioSolar, Inc.
”
contemporaneously with the execution and delivery of this Agreement by the
Subscriber. Subscribers may also pay the subscription amount by, wire transfer
of immediately available funds to:
|
Bank:
|
Bank
of America
|
|
|
19120
Soledad Canyon Road
|
|
|
Santa
Clarita, California 91350
|
|
|
|
|
Account:
|
10234-69102
|
|
|
|
|
ABA:
|
121000358
|
1.2
The
Subscriber recognizes that the purchase of the Shares involves a high degree
of
risk including, but not limited to, the following: (a) the Company remains
a
development stage business with limited operating history and requires
substantial funds in addition to the proceeds of the Offering; (b) an investment
in the Company is highly speculative, and only investors who can afford the
loss
of their entire investment should consider investing in the Company and the
Shares; (c) the Subscriber may not be able to liquidate its investment; (d)
transferability of the Shares (sometimes hereinafter collectively referred
to as
the “Securities”) is extremely limited; (e) in the event of a disposition, the
Subscriber could sustain the loss of its entire investment; (f) the Company
has
not paid any dividends since its inception and does not anticipate paying any
dividends; and (g) the Company may issue additional securities in the future
which have rights and preferences that are senior to those of the Common Stock.
Without limiting the generality of the representations set forth in Section
1.5
below, the Subscriber represents that the Subscriber has carefully reviewed
the
section of the Memorandum captioned “Risk Factors.”
1.3
The
Subscriber represents that the Subscriber is an “accredited investor” as such
term is defined in Rule 501 of Regulation D (“Regulation D”) promulgated under
the Securities Act of 1933, as amended (the “Securities Act”), as indicated by
the Subscriber’s responses to the questions contained in Article VII hereof, and
that the Subscriber is able to bear the economic risk of an investment in the
Shares.
1.4
The
Subscriber hereby acknowledges and represents that (a) the Subscriber has
knowledge and experience in business and financial matters, prior investment
experience, including investment in securities that are non-listed, unregistered
and/or not traded on a national securities exchange nor on the National
Association of Securities Dealers, Inc. (the “NASD”) automated quotation system
(“NASDAQ”), or the Subscriber has employed the services of a “purchaser
representative” (as defined in Rule 501 of Regulation D), attorney and/or
accountant to read all of the documents furnished or made available by the
Company both to the Subscriber and to all other prospective investors in the
Shares to evaluate the merits and risks of such an investment on the
Subscriber’s behalf; (b) the Subscriber recognizes the highly speculative nature
of this investment; and (c) the Subscriber is able to bear the economic risk
that the Subscriber hereby assumes.
1.5
The
Subscriber hereby acknowledges receipt and careful review of this Agreement,
the
Memorandum (which includes the Risk Factors), including all exhibits thereto,
and any documents which may have been made available upon request as reflected
therein (collectively referred to as the “Offering Materials”) and hereby
represents that the Subscriber has been furnished by the Company during the
course of the Offering with all information regarding the Company, the terms
and
conditions of the Offering and any additional information that the Subscriber
has requested or desired to know, and has been afforded the opportunity to
ask
questions of and receive answers from duly authorized officers or other
representatives of the Company concerning the Company and the terms and
conditions of the Offering.
1.6
(a)
In
making
the decision to invest in the Shares the Subscriber has relied solely upon
the
information provided by the Company in the Offering Materials. To the extent
necessary, the Subscriber has retained, at its own expense, and relied upon
appropriate professional advice regarding the investment, tax and legal merits
and consequences of this Agreement and the purchase of the Shares hereunder.
The
Subscriber disclaims reliance on any statements made or information provided
by
any person or entity in the course of Subscriber’s consideration of an
investment in the Shares other than the Offering Materials.
(b)
The
Subscriber represents that (i) the Subscriber was contacted regarding the sale
of the Shares by the Company (or an authorized agent or representative thereof)
with whom the Subscriber had a prior substantial pre-existing relationship
and
(ii) no Shares were offered or sold to it by means of any form of general
solicitation or general advertising, and in connection therewith, the Subscriber
did not (A) receive or review any advertisement, article, notice or other
communication published in a newspaper or magazine or similar media or broadcast
over television or radio, whether closed circuit, or generally available; or
(B)
attend any seminar meeting or industry investor conference whose attendees
were
invited by any general solicitation or general advertising.
1.7
The
Subscriber hereby represents that the Subscriber, either by reason of the
Subscriber’s business or financial experience or the business or financial
experience of the Subscriber’s professional advisors (who are unaffiliated with
and not compensated by the Company or any affiliate or selling agent of the
Company, directly or indirectly), has the capacity to protect the Subscriber’s
own interests in connection with the transaction contemplated
hereby.
1.8
The
Subscriber hereby acknowledges that the Offering has not been reviewed by the
United States Securities and Exchange Commission (the “SEC”) nor any state
regulatory authority since the Offering is intended to be exempt from the
registration requirements of Section 5 of the Securities Act pursuant to
Regulation D promulgated thereunder. The Subscriber understands that the
Securities have not been registered under the Securities Act or under any state
securities or “blue sky” laws and agrees not to sell, pledge, assign or
otherwise transfer or dispose of the Securities unless they are registered
under
the Securities Act and under any applicable state securities or “blue sky” laws
or unless an exemption from such registration is available.
1.9
The
Subscriber understands that the Securities comprising the Shares have not been
registered under the Securities Act by reason of a claimed exemption under
the
provisions of the Securities Act that depends, in part, upon the Subscriber’s
investment intention. In this connection, the Subscriber hereby represents
that
the Subscriber is purchasing the Securities for the Subscriber’s own account for
investment and not with a view toward the resale or distribution to others.
The
Subscriber, if an entity, further represents that it was not formed for the
purpose of purchasing the Securities.
1.10
The
Subscriber understands that there is no public market for the Common Stock
and
that no market may develop for any of such Securities. The Subscriber
understands that even if a public market develops for such Securities, Rule
144
(“Rule 144”) promulgated under the Securities Act requires for non-affiliates,
among other conditions, a one-year holding period prior to the resale (in
limited amounts) of securities acquired in a non-public offering without having
to satisfy the registration requirements under the Securities Act. The
Subscriber understands and hereby acknowledges that the Company is under no
obligation to register any of the Securities under the Securities Act or any
state securities or “blue sky” laws other than as set forth in Article V.
1.11
The
Subscriber consents to the placement of a legend on any certificate or other
document evidencing the Securities that such Securities have not been registered
under the Securities Act or any state securities or “blue sky” laws and setting
forth or referring to the restrictions on transferability and sale thereof
contained in this Agreement. The Subscriber is aware that the Company will
make
a notation in its appropriate records with respect to the restrictions on the
transferability of such Securities. The legend to be placed on each certificate
shall be in form substantially similar to the following:
“THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES
SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY STATE SECURITIES OR “BLUE
SKY LAWS,” AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR
HYPOTHECATED ABSENT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR
COMPLIANCE WITH RULE 144 PROMULGATED UNDER SUCH ACT, OR UNLESS THE COMPANY
HAS
RECEIVED AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY AND
ITS
COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.”
1.12
The
Subscriber understands that the Company will review this Agreement and is hereby
given authority by the Subscriber to call Subscriber’s bank or place of
employment or otherwise review the financial standing of the Subscriber; and
it
is further agreed that the Company, at its sole discretion, reserves the
unrestricted right, without further documentation or agreement on the part
of
the Subscriber, to reject or limit any subscription, to accept subscriptions
for
fractional Shares and to close the Offering to the Subscriber at any time and
that the Company will issue stop transfer instructions to its transfer agent
with respect to such Securities.
1.13
The
Subscriber hereby represents that the address of the Subscriber furnished by
Subscriber on the signature page hereof is the Subscriber’s principal residence
if Subscriber is an individual or its principal business address if it is a
corporation or other entity.
1.14
The
Subscriber represents that the Subscriber has full power and authority
(corporate, statutory and otherwise) to execute and deliver this Agreement
and
to purchase the Shares. This Agreement constitutes the legal, valid and binding
obligation of the Subscriber, enforceable against the Subscriber in accordance
with its terms.
1.15
If
the
Subscriber is a corporation, partnership, limited liability company, trust,
employee benefit plan, individual retirement account, Keogh Plan, or other
tax-exempt entity, it is authorized and qualified to invest in the Company
and
the person signing this Agreement on behalf of such entity has been duly
authorized by such entity to do so.
1.16
The
Subscriber acknowledges that if he or she is a Registered Representative of
an
NASD member firm, he or she must give such firm the notice required by the
NASD’s Rules of Fair Practice, receipt of which must be acknowledged by such
firm in Section 7.4 below.
1.17
The
Subscriber acknowledges that at such time, if ever, as the Securities are
registered (as such term is defined in Article V hereof), sales of the
Securities will be subject to state securities laws.
1.18
(a)
The
Subscriber agrees not to issue any public statement with respect to the
Subscriber’s investment or proposed investment in the Company or the terms of
any agreement or covenant between them and the Company without the Company’s
prior written consent, except such disclosures as may be required under
applicable law or under any applicable order, rule or regulation.
(b)
The
Company agrees not to disclose the names, addresses or any other information
about the Subscribers, except as required by law; provided, that the Company
may
use the name of the Subscriber for any offering or in any registration statement
filed pursuant to Article V in which the Subscriber’s shares are
included.
1.19
The
Subscriber agrees to hold the Company and its directors, officers, employees,
affiliates, controlling persons and agents and their respective heirs,
representatives, successors and assigns harmless and to indemnify them against
all liabilities, costs and expenses incurred by them as a result of (a) any
sale
or distribution of the Securities by the Subscriber in violation of the
Securities Act or any applicable state securities or “blue sky” laws; or (b) any
false representation or warranty or any breach or failure by the Subscriber
to
comply with any covenant made by the Subscriber in this Agreement (including
the
Confidential Investor Questionnaire contained in Article VII herein) or any
other document furnished by the Subscriber to any of the foregoing in connection
with this transaction.
II.
|
REPRESENTATIONS
BY AND COVENANTS OF THE COMPANY
|
The
Company hereby represents and warrants to the Subscriber that:
2.1
Organization,
Good Standing and Qualification
.
The
Company is a corporation duly organized, validly existing and in good standing
under the laws of the State of Nevada and has full corporate power and authority
to conduct its business.
2.2
Capitalization
and Voting Rights
.
The
Company has authorized 500,000,000 shares of Common Stock, par value $.0001
per
share, of which 119,500,000 shares are outstanding as of the date hereof. Except
as set forth in the Offering Materials, there are no outstanding options,
warrants, agreements, convertible securities, preemptive rights or other rights
to subscribe for or to purchase any shares of capital stock of the Company.
Except as set forth in the Offering Materials and as otherwise required by
law,
there are no restrictions upon the voting or transfer of any of the shares
of
capital stock of the Company pursuant to the Company’s Articles of Incorporation
(the “Articles of Incorporation”), By-Laws or other governing documents or any
agreement or other instruments to which the Company is a party or by which
the
Company is bound.
2.3
Authorization;
Enforceability
.
The
Company has all corporate right, power and authority to enter into this
Agreement and to consummate the transactions contemplated hereby. All corporate
action on the part of the Company, its directors and stockholders necessary
for
the (i) authorization execution, delivery and performance of this Agreement
by
the Company; and (ii) authorization, sale, issuance and delivery of the
Securities contemplated hereby and the performance of the Company’s obligations
hereunder has been taken. This Agreement has been duly executed and delivered
by
the Company and constitutes a legal, valid and binding obligation of the
Company, enforceable against the Company in accordance with its terms, subject
to laws of general application relating to bankruptcy, insolvency and the relief
of debtors and rules of law governing specific performance, injunctive relief
or
other equitable remedies, and to limitations of public policy. The Common Stock,
when issued and fully paid for in accordance with the terms of this Agreement,
will be validly issued, fully paid and nonassessable. The issuance and sale
of
the Common Stock contemplated hereby will not give rise to any preemptive rights
or rights of first refusal on behalf of any person which have not been waived
in
connection with this offering.
2.4
No
Conflict; Governmental Consents
.
(a)
The
execution and delivery by the Company of this Agreement and the consummation
of
the transactions contemplated hereby will not result in the violation of any
material law, statute, rule, regulation, order, writ, injunction, judgment
or
decree of any court or governmental authority to or by which the Company is
bound, or of any provision of the Articles of Incorporation or By-Laws of the
Company, and will not conflict with, or result in a material breach or violation
of, any of the terms or provisions of, or constitute (with due notice or lapse
of time or both) a default under, any lease, loan agreement, mortgage, security
agreement, trust indenture or other agreement or instrument to which the Company
is a party or by which it is bound or to which any of its properties or assets
is subject, nor result in the creation or imposition of any lien upon any of
the
properties or assets of the Company.
(b)
No
consent, approval, authorization or other order of any governmental authority
is
required to be obtained by the Company in connection with the authorization,
execution and delivery of this Agreement or with the authorization, issue and
sale of the Shares, except such filings as may be required to be made with
the
SEC, NASD, NASDAQ and with any state or foreign blue sky or securities
regulatory authority.
2.5
Licenses
.
Except
as otherwise set forth in the Memorandum, the Company has sufficient licenses,
permits and other governmental authorizations currently required for the conduct
of its business or ownership of properties and is in all material respects
in
compliance therewith.
2.6
Litigation
.
The
Company knows of no pending or threatened legal or governmental proceedings
against the Company which could materially adversely affect the business,
property, financial condition or operations of the Company or which materially
and adversely questions the validity of this Agreement or any agreements related
to the transactions contemplated hereby or the right of the Company to enter
into any of such agreements, or to consummate the transactions contemplated
hereby or thereby. The Company is not a party or subject to the provisions
of
any order, writ, injunction, judgment or decree of any court or government
agency or instrumentality which could materially adversely affect the business,
property, financial condition or operations of the Company. There is no action,
suit, proceeding or investigation by the Company currently pending in any court
or before any arbitrator or that the Company intends to initiate.
2.7
Disclosure
.
The
information set forth in the Offering Materials as of the date hereof contains
no untrue statement of a material fact nor omits to state a material fact
necessary in order to make the statements contained therein, in light of the
circumstances under which they were made, not misleading.
2.8
Investment
Company
.
The
Company is not an “investment company” within the meaning of such term under the
Investment Company Act of 1940, as amended, and the rules and regulations of
the
SEC thereunder.
2.9
Intellectual
Property
.
(i)
To
the
best of its knowledge, the Company owns or possesses sufficient legal rights
to
all patents, trademarks, service marks, trade names, copyrights, trade secrets,
licenses, information and other proprietary rights and processes necessary
for
its business as now conducted and as presently proposed to be conducted, without
any known infringement of the rights of others. Except as disclosed in the
Memorandum, there are no material outstanding options, licenses or agreements
of
any kind relating to the foregoing proprietary rights, nor is the Company bound
by or a party to any material options, licenses or agreements of any kind with
respect to the patents, trademarks, service marks, trade names, copyrights,
trade secrets, licenses, information and other proprietary rights and processes
of any other person or entity other than such licenses or agreements arising
from the purchase of “off the shelf” or standard products. The Company has not
received any written communications alleging that the Company has violated
or,
by conducting its business as presently proposed to be conducted, would violate
any of the patents, trademarks, service marks, trade names, copyrights or trade
secrets or other proprietary rights of any other person or entity.
(ii)
Except
as
disclosed in the Memorandum, the Company is not aware that any of its employees
is obligated under any contract (including licenses, covenants or commitments
of
any nature) or other agreement, or subject to any judgment, decree or order
of
any court or administrative agency, that would interfere with their duties
to
the Company or that would conflict with the Company’s business as presently
conducted.
(iii)
Neither
the execution nor delivery of this Agreement, nor the carrying on of the
Company’s business by the employees of the Company, nor the conduct of the
Company’s business as presently conducted, will, to the Company’s knowledge,
conflict with or result in a breach of the terms, conditions or provisions
of,
or constitute a default under, any contract, covenant or instrument under which
any employee is now obligated.
(iv)
To
the
Company’s knowledge, no employee of the Company, nor any consultant with whom
the Company has contracted, is in violation of any term of any employment
contract, proprietary information agreement or any other agreement relating
to
the right of any such individual to be employed by, or to contract with, the
Company because of the nature of the business conducted by the Company; and
to
the Company’s knowledge the continued employment by the Company of its present
employees, and the performance of the Company’s contracts with its independent
contractors, will not result in any such violation. The Company has not received
any written notice alleging that any such violation has occurred. Except as
described in the Memorandum, no employee of the Company has been granted the
right to continued employment by the Company or to any compensation following
termination of employment with the Company except for any of the same which
would not have a material adverse effect on the business of the Company. The
Company is not aware that any officer, key employee or group of employees
intends to terminate his, her or their employment with the Company, nor does
the
Company have a present intention to terminate the employment of any officer,
key
employee or group of employees.
2.10
Title
to Properties and Assets; Liens, Etc
.
The
Company has good and marketable title to its properties and assets, including
the properties and assets reflected in the most recent balance sheet included
in
the Financial Statements, and good title to its leasehold estates, in each
case
subject to no mortgage, pledge, lien, lease, encumbrance or charge, other than
(a) those resulting from taxes which have not yet become delinquent; (b) liens
and encumbrances which do not materially detract from the value of the property
subject thereto or materially impair the operations of the Company; and (c)
those that have otherwise arisen in the ordinary course of business. The Company
is in compliance with all material terms of each lease to which it is a party
or
is otherwise bound.
2.11
Obligations
to Related Parties
.
Except
as described in the Memorandum, there are no obligations of the Company to
officers, directors, stockholders, or employees of the Company other than (a)
for payment of salary or other compensation for services rendered, (b)
reimbursement for reasonable expenses incurred on behalf of the Company and
(c)
for other standard employee benefits made generally available to all employees
(including stock option agreements outstanding under any stock option plan
approved by the Board of Directors of the Company). Except as may be disclosed
in the Memorandum, the Company is not a guarantor or indemnitor of any
indebtedness of any other person, firm or corporation.
III.
|
TERMS
OF SUBSCRIPTION
|
3.1
There
is
no requirement that any minimum number of Shares be sold and therefore no escrow
will be established for subscription funds. Subscription funds may be deposited
by the Company directly into its operating account for use as described in
this
Confidential Offering Memorandum.
3.2
Certificates
representing the Common Stock purchased by the Subscriber pursuant to this
Agreement will be prepared for delivery to the Subscriber within 15 business
days following the Closing at which such purchase takes place. The Subscriber
hereby authorizes and directs the Company to deliver the certificates
representing the Common Stock purchased by the Subscriber pursuant to this
Agreement directly to the Subscriber’s residential or business address indicated
on the signature page hereto.
IV.
|
CONDITIONS
TO OBLIGATIONS OF THE SUBSCRIBERS
|
4.1
The
Subscriber’s obligation to purchase the Shares at the Closing at which such
purchase is to be consummated is subject to the fulfillment on or prior to
such
Closing of the following conditions, which conditions may be waived at the
option of each Subscriber to the extent permitted by law:
(a)
Covenants
.
All
covenants, agreements and conditions contained in this Agreement to be performed
by the Company on or prior to the date of such Closing shall have been performed
or complied with in all material respects.
(b)
No
Legal Order Pending
.
There
shall not then be in effect any legal or other order enjoining or restraining
the transactions contemplated by this Agreement.
(c)
No
Law
Prohibiting or Restricting Such Sale
.
There
shall not be in effect any law, rule or regulation prohibiting or restricting
such sale or requiring any consent or approval of any person, which shall not
have been obtained, to issue the Securities (except as otherwise provided in
this Agreement).
5.1
The
Subscriber understands that the Company may file with the Securities and
Exchange Commission ("
SEC")
a
registration statement on Form SB-2 (the "Registration Statement") to register
certain shares of the Company’s common stock and to exercise its reasonable best
efforts to cause the Registration Statement to become effective. The Company
may
also request a broker-dealer to file with the National Association of Securities
Dealers (the "NASD") to secure the listing or quotation of its Common Stock
on
the Over the Counter Bulletin Board market maintained by the National
Association of Securities Dealers, Inc.
5.2
As
an
inducement to NASD market makers to establish a public market for the common
stock, the Subscriber hereby agrees that from the date of the Confidential
Offering Memorandum and until one (1) year after the Registration Statement
is
declared effective by the SEC, the Subscriber will not exercise any rights
to
sell any unregistered shares of the Company's Common Stock as may be permitted
under SEC Rule 144.
6.1
Any
notice or other communication given hereunder shall be deemed sufficient if
in
writing and sent by registered or certified mail, return receipt requested,
or
delivered
by hand against written receipt therefor, addressed as follows:
if
to the
Company, to it at:
BioSolar,
Inc.
27936
Lost Canyon Road, Suite 202
Santa
Clarita, California 91387
Attn:
David Lee, Chief Executive Officer
With
a
copy to:
Sichenzia
Ross Friedman Ference LLP
1065
Avenue of the Americas
New
York,
NY 10018
Attn:
Gregory Sichenzia, Esq.
if
to the
Subscriber, to the Subscriber’s address indicated on the signature page of this
Agreement.
Notices
shall be deemed to have been given or delivered on the date of mailing, except
notices of change of address, which shall be deemed to have been given or
delivered when received.
6.2
Except
as
otherwise provided herein, this Agreement shall not be changed, modified or
amended except by a writing signed by the parties to be charged, and this
Agreement
may not
be discharged except by performance in accordance with its terms or by a writing
signed by the party to be charged.
6.3
Subject
to the provisions of Section 5.10, this Agreement shall be binding upon and
inure to the benefit of the parties hereto and to their respective heirs, legal
representatives, successors and assigns. This Agreement sets forth the entire
agreement and understanding between the parties as to the subject matter hereof
and merges and supersedes all prior discussions, agreements and understandings
of any and every nature among them.
6.4
Upon
the
execution and delivery of this Agreement by the Subscriber, this Agreement
shall
become a binding obligation of the Subscriber with respect to the purchase
of
Common Stock as herein provided, subject, however, to the right hereby reserved
by the Company to enter into the same agreements with other subscribers and
to
add and/or delete other persons as subscribers.
6.5
NOTWITHSTANDING
THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO,
THE
PARTIES EXPRESSLY AGREE THAT ALL THE TERMS AND PROVISIONS HEREOF SHALL BE
CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK
WITHOUT REGARD TO SUCH STATE’S PRINCIPLES OF CONFLICTS OF LAW. IN THE EVENT THAT
A JUDICIAL PROCEEDING IS NECESSARY, THE SOLE FORUM FOR RESOLVING DISPUTES
ARISING OUT OF OR RELATING TO THIS AGREEMENT IS THE SUPREME COURT OF THE STATE
OF NEW YORK IN AND FOR THE COUNTY OF NEW YORK OR THE FEDERAL COURTS FOR SUCH
STATE AND COUNTY, AND ALL RELATED APPELLATE COURTS, THE PARTIES HEREBY
IRREVOCABLY CONSENT TO THE JURISDICTION OF SUCH COURTS AND AGREE TO SAID VENUE.
6.6
In
order
to discourage frivolous claims the parties agree that unless a claimant in
any
proceeding arising out of this Agreement succeeds in establishing his claim
and
recovering a judgment against another party (regardless of whether such claimant
succeeds against one of the other parties to the action), then the other party
shall be entitled to recover from such claimant all of its/their reasonable
legal costs and expenses relating to such proceeding and/or incurred in
preparation therefor.
6.7
The
holding of any provision of this Agreement to be invalid or unenforceable by
a
court of competent jurisdiction shall not affect any other provision of this
Agreement, which shall remain in full force and effect. If any provision of
this
Agreement shall be declared by a court of competent jurisdiction to be invalid,
illegal or incapable of being enforced in whole or in part, such provision
shall
be interpreted so as to remain enforceable to the maximum extent permissible
consistent with applicable law and the remaining conditions and provisions
or
portions thereof shall nevertheless remain in full force and effect and
enforceable to the extent they are valid, legal and enforceable, and no
provisions shall be deemed dependent upon any other covenant or provision unless
so expressed herein.
6.8
It
is
agreed that a waiver by either party of a breach of any provision of this
Agreement shall not operate, or be construed, as a waiver of any subsequent
breach by that same party.
6.9
The
parties agree to execute and deliver all such further documents, agreements
and
instruments and take such other and further action as may be necessary or
appropriate to carry out the purposes and intent of this Agreement.
6.10
This
Agreement may be executed in two or more counterparts each of which shall be
deemed an original, but all of which shall together constitute one and the
same
instrument.
6.11
Nothing
in this Agreement shall create or be deemed to create any rights in any person
or entity not a party to this Agreement, except (a) for the holders of
Registrable Securities.
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]
VII.
|
CONFIDENTIAL
INVESTOR QUESTIONNAIRE
|
7.1
The
Subscriber represents and warrants that he, she or it comes within one category
marked below, and that for any category marked, he, she or it has truthfully
set
forth, where applicable, the factual basis or reason the Subscriber comes within
that category. ALL INFORMATION IN RESPONSE TO THIS SECTION WILL BE KEPT STRICTLY
CONFIDENTIAL. The undersigned agrees to furnish any additional information
which
the Company deems necessary in order to verify the answers set forth
below.
Category
A
The
undersigned is an individual (not a partnership, corporation, etc.) whose
individual net worth, or joint net worth with his or her spouse, presently
exceeds $1,000,000.
Explanation.
In calculating net worth you may include equity in personal property and real
estate, including your principal residence, cash, short-term investments, stock
and securities. Equity in personal property and real estate should be based
on
the fair market value of such property less debt secured by such
property.
Category
B
The
undersigned is an individual (not a partnership, corporation, etc.) who had
an
income in excess of $200,000 in each of the two most recent years, or joint
income with his or her spouse in excess of $300,000 in each of those years
(in
each case including foreign income, tax exempt income and full amount of capital
gains and losses but excluding any income of other family members and any
unrealized capital appreciation) and has a reasonable expectation of reaching
the same income level in the current year.
Category
C
The
undersigned is a director or executive officer of the Company which is issuing
and selling the Securities.
Category
D
The
undersigned is a bank; a savings and loan association; insurance company;
registered investment company; registered business development company; licensed
small business investment company (“SBIC”); or employee benefit plan within the
meaning of Title 1 of ERISA and (a) the investment decision is made by a plan
fiduciary which is either a bank, savings and loan association, insurance
company or registered investment advisor, or (b) the plan has total assets
in
excess of $5,000,000 or (c) is a self directed plan with investment decisions
made solely by persons that are accredited investors. (describe
entity)
Category
E
The
undersigned is a private business development company as defined in section
202(a)(22) of the Investment Advisors Act of 1940. (describe entity)
Category
F
The
undersigned is either a corporation, partnership, Massachusetts business trust,
or non-profit organization within the meaning of Section 501(c)(3) of the
Internal Revenue Code, in each case not formed for the specific purpose of
acquiring the Common Stock and with total assets in excess of $5,000,000.
(describe entity)
Category
G
The
undersigned is a trust with total assets in excess of $5,000,000, not formed
for
the specific purpose of acquiring the Securities, where the purchase is directed
by a “sophisticated investor” as defined in Regulation 506(b)(2)(ii) under the
Act.
Category
H
The
undersigned is an entity (other than a trust) in which all of the equity owners
are “accredited investors” within one or more of the above categories. If
relying upon this Category alone, each equity owner must complete a separate
copy of this Agreement. (describe entity)
Category
I
The
undersigned is not within any of the categories above and is therefore not
an
accredited investor.
The
undersigned agrees that the undersigned will notify the Company at any time
on
or prior to the Closing Date in the event that the representations and
warranties in this Agreement shall cease to be true, accurate and
complete.
7.2
SUITABILITY
(please
answer each question)
(a)
For
an
individual Subscriber, please describe your current employment, including the
company by which you are employed and its principal business:
(b)
For
an
individual Subscriber, please describe any college or graduate degrees held
by
you:
(c)
For
all
Subscribers, please list types of prior investments:
(d)
For
all
Subscribers, please state whether you have participated in other
private
placements
before:
YES_______
NO_______
(e)
If
your
answer to question (d) above was “YES”, please indicate frequency of such prior
participation in
private
placements
of:
|
Public
Companies
|
Private
Companies
|
Public
or Private VoIP or other
Communications
Companies
|
Frequently
|
|
|
|
Occasionally
|
|
|
|
Never
|
|
|
|
(f)
For
individual Subscribers, do you expect your current level of income to
significantly decrease in the foreseeable future:
YES_______
NO_______
(g)
For
trust, corporate, partnership and other institutional Subscribers, do you expect
your total assets to significantly decrease in the foreseeable future:
YES_______
NO_______
(h)
For
all
Subscribers, do you have any other investments or contingent liabilities which
you reasonably anticipate could cause you to need sudden cash requirements
in
excess of cash readily available to you:
YES_______
NO_______
(i)
For
all
Subscribers, are you familiar with the risk aspects and the non-liquidity of
investments such as the securities for which you seek to subscribe?
YES_______
NO_______
(j)
For all
Subscribers, do you understand that there is no guarantee of financial return
on
this investment and that you run the risk of losing your entire
investment?
YES_______
NO_______
7.3
MANNER
IN WHICH TITLE IS TO BE HELD
.
(circle
one)
(a)
Individual
Ownership
(b)
Community
Property
(c)
Joint
Tenant with Right of
Survivorship
(both parties
must
sign)
(d)
Partnership*
(e)
Tenants
in Common
(f)
Company*
(g)
Trust*
(h)
Other*
*If
Securities are being subscribed for by an entity, the attached Certificate
of
Signatory must also be completed.
7.4
NASD
AFFILIATION
.
Are
you
affiliated or associated with an NASD member firm (please check
one):
Yes
_________
No
__________
If
Yes,
please describe:
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
*If
Subscriber is a Registered Representative with an NASD member firm, have the
following acknowledgment signed by the appropriate party:
The
undersigned NASD member firm acknowledges receipt of the notice required by
Article 3, Sections 28(a) and (b) of the Rules of Fair Practice.
_________________________________
Name
of
NASD Member Firm
By:
______________________________
Authorized
Officer
Date:
____________________________
7.5
The
undersigned is informed of the significance to the Company of the foregoing
representations and answers contained in the Confidential Investor Questionnaire
contained in this Article VII and such answers have been provided under the
assumption that the Company will rely on them.
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]
NUMBER
OF SHARES _________ X $0.10 = $_________ (the “Purchase
Price”)
|
|
|
Signature
|
|
Signature
(if purchasing jointly)
|
|
|
|
|
|
|
Name
Typed or Printed
|
|
Name
Typed or Printed
|
|
|
|
|
|
|
Title
(if Subscriber is an Entity)
|
|
Title
(if Subscriber is an Entity)
|
|
|
|
|
|
|
Entity
Name (if applicable)
|
|
Entity
Name (if applicable
|
|
|
|
|
|
|
|
|
|
Address
|
|
Address
|
|
|
|
|
|
|
City,
State and Zip Code
|
|
City,
State and Zip Code
|
|
|
|
|
|
|
Telephone-Business
|
|
Telephone-Business
|
|
|
|
|
|
|
Telephone-Residence
|
|
Telephone-Residence
|
|
|
|
|
|
|
Facsimile-Business
|
|
Facsimile-Business
|
|
|
|
|
|
|
Facsimile-Residence
|
|
Facsimile-Residence
|
|
|
|
|
|
|
Email
|
|
Email
|
|
|
|
|
|
|
Tax
ID # or Social Security #
|
|
Tax
ID # or Social Security #
|
Dated:
_____________
,
2006
This
Subscription Agreement is agreed to and accepted as of
________________
,
2006.
|
|
|
|
BIOSOLAR,
INC.
|
|
|
|
|
By:
|
|
|
Name:
|
|
Title:
|
CERTIFICATE
OF SIGNATORY
(To
be
completed if Shares are
being
subscribed for by an entity)
I,
____________________________, am the ____________________________ of
__________________________________________ (the “Entity”).
I
certify
that I am empowered and duly authorized by the Entity to execute and carry
out
the terms of the Subscription Agreement and to purchase and hold the Common
Stock, and certify further that the Subscription Agreement has been duly and
validly executed on behalf of the Entity and constitutes a legal and binding
obligation of the Entity.
IN
WITNESS WHEREOF, I have set my hand this ________ day of _________________,
2006
INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We
consent to the use in this Registration Statement of BioSolar, Inc. on Form
SB-2, of our report, dated September 27, 2006, which includes an emphasis
paragraph relating to an uncertainty as to the Company’s ability to continue as
a going concern, appearing in the Prospectus, which is part of this Registration
Statement.
We
also
consent to the reference to our Firm under the caption “Experts” in the
Prospectus.
/s/
HJ
Associates & Consultants, LLP
HJ
Associates & Consultants, LLP
Salt
Lake
City, Utah
November
21, 2006